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Poly(N-isopropylacrylamide) (PNIPAAm) is a well-known temperature-sensitive 
polymer and has a transition temperature (Ttr) or lower critical solution temperature 
(LCST) of about 32oC.  PNIPAAm has been widely investigated in biotechnology, 
medical diagnosis, and drug delivery.  However, few degradable or pH-triggered drug 
delivery systems have been reported. The aim of this study was to design 
biodegradable and environmentally sensitive microspheres and micelles for controlled 
delivery of bioactive agents.     
 
Firstly, PNIPAAm-b-PLA microspheres containing bovine serum albumin (BSA, as a 
model protein) were fabricated using a water-in-oil-in-water double emulsion solvent 
evaporation method.  BSA was well entrapped within the microspheres. High 
encapsulation efficiency (over 80%) was achieved.  The in vitro degradation behavior 
of microspheres was investigated. It was found that the microspheres were erodible, 
and polymer degradation occurred in the PLA block. A PVA concentration of 0.2% 
(w/v) in the internal aqueous phase yielded microspheres with an inter-connected 
porous structure, leading to fast matrix erosion and sustained BSA release. BSA 
release was faster at the temperature below the LCST.  In addition, microspheres 
fabricated with PNIPAAm-b-PLA having 1:5 molar ratio of PNIPAAm to PLA and a 
PVA concentration of 0.2% (w/v) in the internal aqueous phase were able to provide a 
sustained release of BSA over three weeks in PBS (pH 7.4) at 37ºC.  
 
P(NIPAAm-co-DMAAm)-b-PLGA with different PLGA contents as well as different 
LG ratios were synthesized, and used to fabricate micelles for targeted delivery of 
 x
doxorubicin (DOX) and paclitaxel using a membrane dialysis method. The micelles 
prepared from the block copolymer had a very low CAC value in both water and PBS 
buffer (pH 7.4).  Drug loading level depended on the balance between hydrophilic and 
hydrophobic block. The TEM morphologies showed that micelles were spherical and 
had a uniform size distribution, which is consistent with the particle size analysis by 
dynamic light scattering. The LCST of the micelles in PBS was above 37ºC.  In 
particular, it is determined by the shell instead of the core.  The micelles were stable 
in both PBS and PBS containing 10% FBS at 37ºC.  Drug release from the micelles 
was responsive to external temperature changes.  Drug release was much faster at a 
temperature above the LCST than at body temperature. Drug-loaded micelles showed 
higher cytotoxicity against cancer cells at a temperature above the LCST.  The IC50 of 
drug-loaded micelles also depended on the nature of drugs and cells.   
 
In addition, pH-triggered temperature sensitive block copolymer, folate-conjugated 
poly(NIPAAm-co-DMAAm-co-MAm)-b-PUA was synthesized, and utilized to 
fabricate micelles for intracellular delivery of anticancer drugs to tumours.  The mean 
diameters of the empty and DOX-loaded micelles were less than 100 nm. The lower 
critical solution temperature (LCST) of the micelles and in vitro drug release were 
pH-dependent. DOX-loaded folate-conjugated micelles were taken up rapidly by 
cancer cells via endocytosis.  DOX-loaded micelles killed cancer cells efficiently.  
DOX micelles had a longer circulation time in the blood. More importantly, the 
enhanced accumulation of DOX in tumors using the micelles would lead to higher 
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 2
Many of the pharmacological properties of free drugs can be improved through the use of 
drug delivery system (DDS) (Allen and Cullis, 2004).  It was reported that the world 
market of advanced drug delivery system is currently valued at $50 billion a year, 
occupying 12.5% of world total pharmaceutical sales. Some examples of free drugs that 
can be improved by the use of DDS are listed in Table 1.1 (Allen and Cullis, 2004). 
There are various types of drug delivery systems, among which polymeric drug delivery 
systems (PDDS) have been designed to deliver drugs in a predetermined manner 
(Robinson and Lee, 1990).  These systems possess one or more of the following 
advantages over conventional drug formulations: firstly, it is designed to deliver unstable 
and/or insoluble drugs with predetermined therapeutic rate for a predefined period of time 
by maintaining a relatively constant, effective drug level in the body with concomitant 
minimization of undesirable side effects; secondly, it can localize the drugs to be released 
by spatial placement of a controlled release system adjacent to or in the diseased tissue or 
organ; thirdly, it can be designed to target the drug to specific tissues or organs; finally, it 
is easy to process and its chemical and physical properties is readily controlled via 
molecular synthesis.  To date, many PDDS, such as reservoir devices (Lehmann et al., 
1979), monolithic devices (Davis and Illum, 1988), polymeric colloidal particles (Yang 
and Wan et al., 2001; Bittner et al., 1999; Couvreur and Puisieux, 1993; Govender et al., 
1999; Lu and Yeh et al., 2004) (microparticles, microspheres and nanoparticles), micelles 
(Yokoyama and Miyauchi et al., 1990; Toncheva et al., 2003) and polymer-drug 
conjugate (Yoo and Oh et al., 1999), have been developed and reported. Of these 
systems, microspheres and micelles are particularly of interest due to their controllable 
properties. 
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The use of micropheres involves the encapsulation of a pharmaceutical product within a 
polymer matrix by microencapsulation techniques (Mathiowitz et al., 1999).  They are 
usually spherical with a size range from 1-250 µm. The polymer can be natural or 
synthetic, non-degradable or biodegradable.  For non-degradable micropsheres, the drug 
release is diffusion-controlled. However, most research is aimed at investigating 
biodegradable polymer systems, which degrade into biologically acceptable compounds, 
often through the process of hydrolysis, and leaving their incorporated drugs in the 
targeted area. Examples of such polymers include polyester (Li and Vert, 1999), 
poly(phosphoesters)  (Mao et al., 1999) and poly(ortho ester)s (Heller and Gurny, 1999).  
By varying the polymer composition, microstructure and the rate of matrix degradation, 
subsequently, drug release can be controlled. 
 
However, a major problem with microspheres is the non-specific uptake by the 
reticuloendothelial system (RES) (Kwon and Kataoka, 1995). In addition, microspheres 
could be very large and not suitable for injection. To overcome these problems, 
polymeric micelles have been proposed. They are only tens of nanometers in diameter 
and thus avoid the scavenging by the RES.  Moreover, they have enhanced vascular 
permeability and retention (EPR) through tumor tissues compared to healthy tissue 
(Torchilin, 2001).  Micelles self-assembling from amphiphilic polymer in aqueous 
solution are generally characterized by a core-shell structure (Jones and Leroux, 1999).  
The core consists of a hydrophobic block and acts as the reservoir for insoluble drugs.  
The shell consists of a hydrophilic block and is responsible for the micelle stabilization 
and interaction with plasmatic proteins and cell membranes. Finally, drug release is 
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achieved via diffusion and polymer degradation mechanisms. For example, Kataoka and 
his co-workers have investigated the use of polymer micelles as a means of delivering 
doxorubicin (DOX, an anticancer agent). The results showed that the system could 
effectively deliver the drugs to a solid cancerous tumor via EPR effect, showing much 
stronger activity than the free DOX (Nakanishi et al., 2001). The EPR effect is 
considered as a passive targeting method, but the drug targeting can be further enhanced 
by the introduction of an active targeting agent (e.g., environmental stimuli or cell-
specific targeting signal) controlled by the polymer design. With such multiple targeting 
functions, drug release is induced only at a therapeutic site by external stimuli after drug 
carriers accumulate at a solid tumor site by a passive targeting mechanism utilizing the 
EPR effect and avoidance of the RES. 
 
The polymer used in these drug delivery systems acts as a carrier and a protective agent 
for an active drug during the transportation process until the drug is released in the body.  
Therefore, selecting a suitable polymer is critical for this system. Recently, smart 
polymers, which respond to small external stimulus changes such as temperature 
(Yokoyama and Okano et al., 1996), pH (Siegel et al., 1988), electric field (Sawahata et 
al., 1990) and magnetic field (Kost and Langer, 1991), have been developed for 
biological applications (Kost and Langer, 1991). The drug release rate of such responsive 
polymeric systems can be adjusted in response to physiological need. Among these 
systems, temperature sensitive delivery system based on a temperature sensitive polymer, 
poly(N-isopropylacrylamide) (PNIPAAm), is one of the most promising approaches for 
controlled drug delivery.  PNIPAAm is a well-known thermo-responsive polymer and 
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shows remarkable hydration-dehydration properties in response to small temperature 
changes.  This transition is referred to as lower critical solution temperature (LCST).  The 
LCST of PNIPAAm is about 32°C (Heskins and Guillet, 1968), but it can be modified by 
incorporation of hydrophilic or hydrophobic comonomers (Kaneko and Nakamura, 
1999).   This unique property is very important for practical applications.  This is because 
the body temperature often deviates from normal temperature (37°C) in the physiological 
presence of pathogens or pyrogens (You and Ick, 1998).  This variation during illness as 
well as external controlled temperature changes can be a useful stimulus that activates the 
release of therapeutic agents from the temperature responsive drug carriers. Therefore, 
thermo-responsive carriers play an important role in drug delivery.   
 
However, temperature sensitive micelles may not be easily accessible to deep organs or 
tumors (Soppimath et al., 2005).  An alternative approach to targeting drugs to tumor 
tissues is to use pH-triggered temperature sensitive carriers. The pH values of disease 
sites such as tumor tissues are significantly lower (pH 7.0 in the tumor tissue, pH 5.0-6.0 
in endosome and pH 4-5 in lysosomes) than under normal physiological conditions (pH 
7.4) (Haag, 2004).  The polymer carriers remain intact until they have reached tumor 
tissue or been taken up by a cell, subsequently, these carriers release drug under low pH 
conditions (Van et al., 2003).  Thus, the drug targeting to disease sites can be further 
improved by combining temperature sensitivity and pH sensitivity.   
 
The purpose of this research was to systematically study biodegradable and 
environmentally sensitive (temperature sensitive as well as pH-triggered temperature 
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sensitive) drug carriers and to explore their applications in drug delivery. This objective 
is implemented by three approaches. Firstly, PNIPAAm-b-PLA (poly(N-
isopropylacrylamide)-b-poly(D,L-lactide) )  block copolymers were synthesized and used 
to prepare BSA (Bovine Serum Albumin) -loaded microspheres, the degradation and in 
vitro protein release were investigated.  Secondly, P(NIPAAm-co-DMAAm)-b-PLGA 
(poly(N-isopropylacrylamide-co-N, N-dimethylacrylamide)-b-poly(D,L-lactide-co-
glycolide)) block copolymers with various compositions were synthesized. Model 
anticancer drugs, doxorubicin (DOX) and paclitaxel were loaded into the micelles using 
these polymers.  Physicochemical properties, in vitro drug release as well as cytotoxicity 
against various cell lines were investigated and compared. Thirdly, a multifunctional 
polymer, folate-conjugated poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide-co-
methacrylate)-b-poly(10-undecenoic acid) was synthesized, and used to fabricate DOX-
loaded micelles for specific and intracellular delivery of anticancer drugs to tumor cells.  
 
The results obtained from this work provided an optimal process for developing 
biodegradable and environmentally sensitive polymer drug carriers with high 
encapsulation efficiency. It also provided a clear explanation of degradation mechanism 
of such drug carriers, which is useful for exploring their potential in vivo applications.  In 
addition, in vitro drug release and in vitro cytotoxicity studies showed that the drug-
loaded micelles are environmentally responsive.  Furthermore, the enhanced 
accumulation in tumors and longer circulation of DOX using DOX-loaded micelles made 
from folate-conjugated poly(N-isopropylacrylamide-co-N, N-dimethylacrylamide-co-
methacrylate)-b-poly(10-undecenoic acid) may result in a higher efficacy for cancer 
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therapy.  Finally, the environmentally sensitive drug release from such drug carriers may 
improve therapeutic efficiency clinically.     
The following chapter provides a brief summary of basic properties and the results of 
some recent research work on polymeric drug delivery system. The polymer properties, 
some science and technical aspects on drug carriers as well as their applications in protein 
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Table 1.1  Non-ideal properties of drugs and their therapeutic implications 
Problem Implication Effect of DDS 
Poor solubility A convenient pharmaceutical format 
is difficult to achieve, as 
hydrophobic drugs may precipitate in 
aqueous media. Toxicities are 
associated with the use of excipients 
such as cremphor (the solubilizer for 
paclitaxel in Taxol). 
 
DDS such as lipid micelles 
or liposomes provide both 
hydrophilic and 
hydrophobic environments, 
enhancing drug solubility. 
Tissue damage on 
extravasation 
Inadvertent extravasation of 
cytotoxic drugs leads to tissue 
damage, e.g. tissue necrosis with free 
doxorubicn. 
 
Regulated drug release from 
the DDS can reduce or 
eliminate tissue damage on 
accidental extravasation. 
Rapid breakdown 
of the drug in vivo 
Loss of activity of the drug follows 
administration, e.g. loss of activity of 
camptothecins at physiological pH 
DDS protects the drug from 
premature degradation and 
functions as a sustained 
release system. Lower doses 




Drug is cleared too rapidly, by the 
kidney, for example, requiring high 
doses or continuous infusion. 
DDS can substantially alter 
the pK of the drug and 
reduce clearance, rapid 
renal clearance of small 




Drugs that have widespread 
distribution in the body can affect 
normal tissues, resulting in dose-
limiting side effects, such as the 
cardiac toxicity of doxorubicin 
 
The particulate nature of 
DDS lowers the volume of 
distribution and helps to 
reduce side effects in 
sensitive, nontarget tissues. 
Lack of selectivity 
for target tissues 
Distribution of the drug to normal 
tissues leads to side effects that 
restrict the amount of drugs that can 
be administrated. Low 
concentrations of drugs in target 
tissues will result in suboptimal 
therapeutic effects. 
DDS can increase drug 
concentrations in diseased 
tissues such as tumors by 
the EPR effect. Ligand-
mediated targeting of the 
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Controlled drug delivery systems have an enormous impact on pharmaceutical 
technology. They greatly improve the performance of many existing drugs and enable the 
use of entirely new therapies.  Such systems are designed to have following functions.  
Firstly, they attempt to maintain the drug in the desired therapeutic range by a single 
administration. Secondly, they attempt to preserve drugs from being rapidly destroyed by 
the body, which is very important for biologically sensitive molecules such as proteins 
and peptides. Thirdly, they allow localized delivery of the drug to a particular body 
compartment. Other advantages include the reduced need for follow-up care, increased 
comfort and improved compliance (Robinson and Lee, 1999). 
 
Among various drug delivery systems, polymer-based drug delivery system (PDDS) is 
one of the most effective and efficient approaches (Gombotz and Pettie, 1995; Sinha and 
Khosla, 1998; Langer, 1998). The concept of PDDS is that it consists of a drug and a 
polymeric carrier capable of delivering the drug to a specific site where the drug is to be 
released from the carrier.  Although other controlled delivery systems have some similar 
advantages as mentioned above, potential disadvantages do exist.  For instance, the 
materials may be toxic or non-biocompatible, resulting in undesirable side effects.  Also, 
surgery may also be required to implant or remove the system in some cases. Moreover, 
the higher cost of other controlled release systems may limit their application.  In PDDS, 
a polymer is combined with drugs in a pre-designed manner so that drug delivery can be 
tailored and controlled (Lisa, 1997). In addition to the advantages as stated above, PDDS 
are easy to process. In particular, their chemical and physical properties can be easily 
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controlled via molecular synthesis. Furthermore, it allows targeted delivery of the drug to 
specific tissues or organs.  
 
The type of polymer used for controlled release can be natural or synthetic, biodegradable 
or non-biodegradable (Leong and Langer, 1998).   As drug carriers, these polymers exist 
in the form of matrices, reservoirs, polymer-drug conjugate, hydrogels, micropsheres, 
nanoparticles, micelles and so on.  They can be administered via parenteral, implantation, 
oral, insert and transdermal routes (Robinson and Lee, 1999). Polymers used in drug 
delivery system, controlled release mechanisms, drug carriers and their application in 
drug delivery will be reviewed as follows.   
 
2.1 Polymers 
An appropriate selection of polymers is necessary in order to develop a successful drug 
delivery system since the polymer is used as a protector for drug during drug transfer in 
the body until the drug is released. An ideal polymer for drug delivery should meet the 
following requirements. Firstly, the polymer must be biocompatible and biodegradable.  
In other words, the polymer should be able to degrade in vivo into smaller fragments that 
can be excreted from the body. The term degradation refers to the process of polymer 
chain cleavage, which leads to a loss in molecular weight. Degradation induces the 
subsequent erosion (mass loss) of the materials.  Two different erosion mechanisms have 
been proposed: homogeneous or bulk erosion and heterogeneous or surface erosion (Li 
and Vert et al., 1995).  Bulk eroding polymers degrade all over their cross section 
because the penetration of water into the polymer bulk is faster than the degradation of 
                                                                                              Chapter 2   Literature Review   
 12
polymer.  In contrast, degradation is faster than the penetration of water into bulk for 
surface eroding polymers.  Therefore, these polymers erode mainly from their surface.  
However, erosion of most polymers exhibits both mechanisms (Winzenburg et al., 2004).  
If the polymer is non-biodegradable, the molecular weight of the polymer should be small 
enough to be excreted through the kidneys.  Otherwise, it must be surgically removed 
after drugs are released.  Secondly, the degradation products must be non-toxic and not 
triggering any inflammatory response. Also, they must also have an appropriate physical 
structure, with minimal undesired aging, and be readily processable.  Finally, the 
degradation of the polymer should occur within a reasonable period of time.   
 
A range of materials has been employed to control the release of drugs and other active 
agents. The materials that are currently being used or studied for controlled drug delivery 
include natural and synthetic polymers.  
 
2.1.1 Natural polymers 
Natural polymers are always biodegradable and bioabsorbable.  These polymers offer 
many unique and advantageous properties that make them versatile materials.  First of all, 
because they are naturally occurring material, they exhibit high biocompatibility and 
safety.  Chitosan, polysaccharides, albumin and collagen are typical examples of natural 
polymers (Chourasia and Jain, 2004).  Various drug carriers based on these polymers 
have been reported. In addition, natural polymers can be modified for a specific 
application. Furthermore, drug release rate from chitosan can be tailored via regulating 
the degree of crosslinking (Miyazaki et al., 1994).  Chitosan also has a number of other 
good properties, further modification of its amine functional groups can be carried out to 
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obtain polymers with a range of properties for protein delivery or gene delivery 
(Dumitriu, 2002). 
 
Since the application of the natural polymers is limited due to their physicohemical 
limitations, there is significant exploration of synthetic materials which can be readily 
tailored to offer properties for specific applications (Uhrich et al., 1999).  The ability to 
design biomaterials with specific release, mechanical and processing properties has 
opened opportunities for synthetic polymers in the area of controlled release.   
 
2.1.2 Synthetic polymers  
In broad terms, synthetic polymers may be classified as either biodegradable or non-
biodegradable.  
 
 2.1.2.1 Biodegradable polymers 
Biodegradable polymers have recently captured much attention mainly because their use 
eliminates the need for removing the implant after the drug has been released.  
Biodegradable polymers gradually dissolve by hydrolytic or enzymatic cleavage of the 
polymeric structure by simple dissolution.  Hydrophobic biodegradable polymers can be 
converted to small, water-soluble molecules by backbone cleavage.  These breakdown 
products should be non-toxic. These polymers, for example, polyanhydrides, 
poly(orthoesters), polyurethanes, polyphophazenes, polyphosphoesters, polyesters 
(polycaprolactones, PCL, poly(lactic acid), PLA, poly(glycolide), PGA and their 
copolymers), are suitable as carriers for the administration of drugs to any organs.  In the 
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following subsections, the chemical and physical properties of various biodegradable 
polymers will be reviewed. 
 
(a) Polyesters 
Most of the degradable polymers have hydrolysable groups, such as ester, orthoester, 
carbonate, amide, anhydride, urea, in their backbone.  The ester bond-containing 
polyesters are the most attractive because of their outstanding biocompatibility and 
versatility with regards to physical, chemical and biological properties (Li and Vert et al., 
1999).  Polyesters of lactide and glycolide have been used for more than three decades for 
a variety of medical applications.  Extensive research has been devoted to the use of these 
polymers as carriers for controlled delivery of a wide range of bioactive agents ( Jian and 
et al., 1999).  They have been widely used for delivery of proteins (Yang and Chia et al., 
2000), peptides (Yang and Shi et al., 2003) and anticancer drugs (Liggins and Burt, 
2001).  Injectable formulations containing microspheres of lactide/glycolide polymers 
have received the most attention in recent years (Jiang and Gupta et al., 2005). 
 
Synthesis 
Polyesters are usually synthesized by ring-opening melt polymerization of lactide and 
glycolide at 140°C-180°C for 2-10h using a tin catalyst.  Several mechanisms of this 
reaction were proposed, including anionic (Kurcok et al., 1992), cationic (Nijenhuis et al., 
1992), coordination-inseration (Kohn et al., 1983). 
         Anionic polymerization: It is generally conducted in solution under comparatively 
mild reaction conditions compared to other methods.  Many initators can be used, 
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including acetate, carbonate, or octoate salts of calcium, sodium, magnesium, potassium 
and lithium metals. The active species for chain propagation are alcoholate or carboxylate 
groups due to the opening of lactide rings by nucleophilic substitution.  The ring is 
opened by cleavage of O-acyl bonds when a strong nucleophile attacks the basic 
alcoholate-type on the carbonyl.  This configuation is kept during lactide polymerization. 
Anionic polymerization is a living process.  It leads to polymers with different chain ends 
such as carboxylic acid group depending on the initation and termination mechanism 
(Kurcok et al., 1992). 
 
Cationic polymerization: The initiators used in the cationic polymerization of 
lactides include strong acids, Lewis acids (Nijenhuis et al., 1992) and acylating or 
alkylating agents.  During the initiation step, active species of oxonium or carbocation are 
formed. These carbocation cycles are unstable.  In the absence of other strong 
nucleophiles (e.g., water and alcohols), the propagation step consists of nucleophilic 
attack of the active species by the endocyclic oxygen of another monomer molecule.  
Most of the mechanisms described in literature are based on coinitiation by impurities 
such as water or lactic acid.  Coinitation will lead to polymers with different chain ends 
depending on the coinitator. 
 
Coordination-inseration: This mechanism was proposed for a class of initiators 
derived from transition metals such as Zn, Al, Ti and Sn (Dubois et al., 1991).  It was 
regarded as the most versatile and efficient method to prepare PLA, PLG, PCL and 
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various copolymers.  With this method, high Mw and high conversion ratio can be easily 
achieved.  
 
The common polymerization catalysts are tin compounds such as tin octoate or tin 
hexanoate.  A hypothetical mechanism of the ring opening polymerization of lactide with 
tin as catalyst was suggested by Kissel (Kissel and Brich, 1991) (Figure 2.1).   In this 
mechanism, the Lewis acid property of the tin catalyst activates the ester carbonyl group 
in the dilactone.  The activated species react with the alcohol initiator to form an unstable 
intermediate that opens to become the ester alcohol.   
 
Figure 2.1 Mechanism of ring opening polymerization using tin octoate as catalyst 
 
 
As discussed above, many initiators and catalysts have been reported.  Among them, 
stannous octoate is used widely.  Also, it has been approved by the U.S. FDA for surgical 
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and pharmacological applications. Stannous octoate thus are used as catalysis in this 
study for polymer synthesis.  The variety of synthetic pathways provides a means to 
modify the molecular characteristics of polymers such as molecular weight (Mw) and 
polydispersity, end group nature and chain structure.  These characteristics greatly 
determine the physicochemical properties, especially that of degradability.   
 
Polymer properties 
The polymer characteristics are affected by comonomer composition, crytallinity and 
molecular weight. Lactic acid contains an asymmetric α-carbon, which is typically 
described as the D- or L- form in stereochemistry.  They form homopolymers poly(D-
lactide) (PDLA) and poly(L-lactide) (PLLA), respectively.   The physicochemical 
properties of PDLA and PLLA are similar.  However, the poly(D, L-lactide) is less 
crystalline than the D or L-lactide homopolymers.  PLA and its copolymers with less than 
50% glycolic acid content are soluble in common solvents such as CHCl3, DCM, THF 
and ethyl acetate.  PGA is insoluble in common solvents but soluble in 
hexafluoroisopropanol.   
 
Factors influencing polymer degradation  
Polyester hydrolyzes by random chain scission (bulk erosion) through hydrolytic 
cleavage of ester groups (Figure 2.2), resulting in a continuing decline of Mw without 
significant loss of weight compared to the polymer in the beginning.  When the Mw 
reaches about 5K, the cleavage of the chain is accompanied by a loss of weight due to the 
diffusion of small polymeric fragments from the matrix.  Various factors can affect the 
                                                                                              Chapter 2   Literature Review   
 18
degradation of polyesters, including chemical structure, molecular weight and 
distribution, crystallinity, size of the matrix, porosity, drug load and drug/polymer 
interactions, physical factors and degradation conditions such as buffer concentration, 
enzyme and temperature. 
 
Effect of composition:  The composition of polymer chains, such as the contents of 
L-LA, D-LA and GA units, greatly affect the degradation rate of PLGA polymers. This is 
because the composition of polymers determines the hydrophilicity of the matrix. GA 
units are more hydrophilic than LA ones. Accordingly, they are more inclined to 
hydrolysis. In a degradation study (Wu and Wang, 2001), a series of polymers having 
similar molecular weights but different compositions (PLGA 50/50, 65/35, 75/25, 85/15) 
were used and compared.    The degradation rate increases with the increasing glycolic 
acid content, which varies from 0.0222 to 0.0544 day-1 for PLLA to PLGA50/50 (Wu and 
Wang, 2001). Based on these results, the degradation rates can be tailored by varying the 
proportion of LA to GA.   
 
Effect of molecular weight and distribution:  Hydrolytically degraded ester bond 
produce one carboxyl and one hydroxyl end group (Figure 2.2).  Polyester with low Mw 
will yield relatively high concentration of end groups over entire polymer samples.  
However, in high Mw polyesters, relatively low number of carboxylic acid end groups 
may slow down the degradation process. 
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Figure 2.2   Hydrolytically degraded ester bond   
 
Crystallinity: The degree of crystallinity (amorphousness or semicrystallinity) 
plays a critical role in both the enzymatic and non-enzymatic degradation processes.  The 
degradation of semicrystalline polyester in aqueous media occurs in two stages.  Firstly, 
water diffuses into the amorphous regions with random hydrolytic attack of ester bond.  
After most of the amorphous regions on the edges have been degraded, hydrolytic attacks 
move towards the center of crystallites.  For example, fast cured PGA (lower 
crystallinity) showed an in vivo half life of 0.85 month, while slow-cured PGA (higher 
crystallinity) degraded much slower, with an in vivo half life of 5 month. This was caused 
by the crystallinity difference (Miller et al., 1977).  Additionally, morphologies can affect 
degradation rate even with similar crystallinity.  For instance, the degradation rate of 
PGA pellets was found to be much faster than that of fibers due to the presence of long-
range order in fibers.  Thus, chain orientation could also play an important role in the 
hydrolytic degradation (Ginde and Gupta, 1987).   
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(b)Polyanhydrides 
Polyanhydrides are prepared by melt condensation polymerization. Starting with a 
dicarboxylic acid monomer, a prepolymer of a mixed anhydride is formed with acetic 
anhydride.  The final polymer is obtained by heating the prepolymer under vacuum to 
remove the acetic anhydride byproduct.  The most frequently investigated  
poly(anhydrides) are based on sebacic acid (SA) and p-(carboxyphenoxy) propane 
(Einmahal et al., 1999).  Aliphatic polyanhydrides are used as biomaterials due to their 
hydrolytic instability.  They hydrolyze rapidly due to the lability of the anhydride links 
(Domb and Nudelman, 1995).  Thus, the main application of aliphatic polyanhydride is in 
short-term controlled delivery of bioactive agents.  Polyanhydride undergoes surface 
erosion, which enables a zero order kinetic profile and a good control over the rate and 
the duration of the release. By varying the monomer ratios in polyanhydride copolymers, 
degradation can last from one week to several years (Kumar and Langer et al., 2002). 
 
(c) Polyorthoesters 
Since the late 1970s, four generations of poly (ortho esters) (POEs) have been 
synthesized to produce biodegradable carriers for drug delivery (Figure 2.3).  Because 
POEs are extremely hydrophobic material, the amount of water available to react with the 
hydrolytically labile ortho ester bond is limited. They undergo predominantly surface 
erosion, allowing the release of drugs to be controlled by surface erosion (Heller and 
Barr, 2002).  Since ortho ester bonds are acid labile, one way of controlling polymer 
erosion rates is to lower the pH at the polymer-water interface.   A considerable amount 
of work has been done in attempts to achieve control of erosion rates via acid sensitivity 
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(Heller and Barr, 2004). Yang et al. (2003) reported novel POE/PLGA double walled 
micropsheres, where, the degradation of the POE core was accelerated due to the acidic 
microenvironment produced by the hydrolysis of the outer PLGA layer.  Further, POE 
IV, a self catalyzed polymer, is a modification of POE II, allowing control over erosion 
rates without the need to add acidic excipients (Ng et al., 1997). POE has been widely 
used in drug delivery (Heller and Barr, 2004).       
 
 
Figure 2.3  Four generations of poly (ortho esters) 
 
2.1.2.2 Nonbiodegradable polymers 
Some of the synthetic nonbiodegradable polymers materials that are currently being used 
or studied for controlled drug delivery include poly(ethylene oxide) (PEO), 
Poly(ethylene-co-vinyl acetate), poly(2-hydroxy ethyl methacrylate), poly(N-vinyl 
pyrrolidone), poly(methyl methacrylate), poly(vinyl alcohol), poly(acrylic acid), 
polyacrylamide and poly(methacrylic acid) (Peppas, 1997).  A number of controlled 
release systems using such polymers are under study (Edelman and Langer, 1993; Chen 
and Hoffman, 1995).   
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(a) Poly(ethylene oxide) (PEO)  
PEO and PEG are polymers containing the repeating unit [-CH2CH2-O-].  PEG is a 
subspecies of PEO that contains a hydroxyl group on each end of the chain.  PEO is an 
outstanding biocompatible, non-toxic, non-immunogenic and water-soluble material 
(Abuchowski et al., 1977).  PEO is usually synthesized by the aqueous anionic 
polymerization of ethylene oxide.  Initiators for polymerization of ethylene oxide can be 
anhydrous alkanols such as methanol or derivatives such as methoxyethoxy ethanol to 
produce a monoalkyl capped PEO (Greenwald et al., 2003).  The polymerization reaction 
can be modulated and a range of Mw (1000-50,000) can be obtained.   PEO has been 
widely used in both medicine and biotechnology.  It has also been successfully applied in 
different drug delivery systems to enhance their systematic characteristics.  One of the 
applications of PEG is PEG-protein conjugate for controlled release system (Nucci et al., 
1991). Such conjugates have significantly increased circulation time and reduced 
immunogenicity and antigenicity, and allows for the retention of a large portion of the 
bioactivity of proteins.  It has been postulated that these effects are due to a shell of PEG 
molecules around the protein that sterically hinders the proteins from reacting with 
immune cells and protects proteins from proteolytic inactivation.   PEG has also been 
conjugated to small organic molecules such as anticancer drugs doxorubicin and 
paclitaxel to improve drug solubility.  For example, mPEG paclitaxel 7- carbonates has 
much higher solubility than paclitaxel and thus increasing the possibility of more 
effective drug delivery (Greenwald et al., 1996). 
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Another important feature of PEG is that PEG can be made with a range of terminal 
functional groups, which allows it to be easily incorporated into block copolymer 
systems.  There are many examples of amphiphilic block copolymers incorporating PEG, 
including polystyrene-block-poly(ethylene oxide), poly(ethylene oxide)-block-
poly(propylene oxide)-block-poly(ethylene oxide) and the diblock or multiblock of 
polyesters (PLLA, PDLLA, PLGA, PCL and their copolymers) with poly(ethylene 
oxide). These polyester-block-poly(ethylene oxide) copolymers have been widely used to 
prepare microspheres (Kissel and Li et al., 1996 ), nanoparticles (Li and Pei et al., 2001) 
and micelles (Jette et al., 2004). 
 
To date, controlled released systems for maintaining constant drug release rate have been 
extensively studied and tested.  However, there are a number of clinical situations where 
such an approach may not be sufficient.  These include the delivery of proteins such as 
insulin for patients with diabetes mellitus (Brownlee and Cerami, 1979) as well as cancer 
chemotherapy (Yokoyama and Okano, 1996).  Thus, drug delivery patterns can be further 
improved by responsive delivery, which is the adjustment of drug delivery to match 
biological rhythms. 
 
(b) Responsive polymers 
In recent years, several research groups have been developing responsive systems that 
would more closely resemble the normal physiological process in which the amount of 
drug released can be changed according to physiological needs.  Drug release rates can be 
activated by an external stimuli such as magnetism (Hsieh et al., 1981), ultrasound 
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(Mitragotri et al., 1995), light (Suzuki and Tanaka, 1990), temperature changes (Chung et 
al., 1999) and electrical effects (Wong et al., 1994) or self regulated stimuli such as pH 
sensitive polymers (Lee and Na et al., 2003), ionic strength (Kristein et al., 1985) and 
glucose concentration (Ito et al., 1989).  Among these responsive carriers, thermo-
responsive delivery system based on poly(N-isopropylacrylamide) (PNIPAAm), has been 
of interest in the field of controlled drug delivery.   
Temperature responsive polymers 
Temperature responsible polymers possess temperature-dependent solubility in water.  
They are insoluble above or below a certain temperature, called the lower or upper 
critical solution temperature (LCST or UCST). In general, most drug delivery 
applications utilize LCST systems. When the temperature is below the LCST, water 
molecules surround hydrophobic group of polymers to make polymer soluble.  Once 
LCST is reached, ordered water cages break and expose hydrophobic groups, 
hydrophobic association occurs. Thermodynamically, polymers that phase separate from 
water on increasing temperature are driven by entropy changes. This is because the 
entropy of the two-phase polymer and water systems (random water molecules structure) 
is greater than that of polymer solution (ordered water molecules structure). Thus, 
hydrophobic association is favorable at a temperature above the LCST. 
 
Among the temperature responsive polymer, poly(N-isopropylacrylamide) (PNIPAAm) is 
the most well-known one and demonstrates a transition temperature (Ttr) or lower critical 
solution temperature (LCST) of about 32oC (Heskin and Guillet, 1968). PNIPAAm in an 
aqueous solution has reversible solubility and exhibits a remarkable hydration-
dehydration change in response to temperature (Chen and Yang et al., 1990). Below the 
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LCST, PNIPAAm is well soluble in water. However, as the temperature is increased 
above the LCST, it becomes hydrophobic and precipitates out from the aqueous solution.  
The abrupt shrinking and the resulting insolubility of LCST systems when the 
environmental temperature is above the LCST allows the copolymer of the invention to 
leave the aqueous phase and assume a hydrophobic phase, thereby facilitating interaction 
with cell membranes. Furthermore, temperature sensitive monomeric units can be co-
polymerized with hydrophilic co-monomers such as acrylamide (AAm), or other types of 
modified co-monomers to achieve a higher or lower LCST (Yoshida et al., 1994). This 
unique property is very important for its applications in drug delivery.  Such copolymers 
can be applied as a functional drug delivery material for controlling drug release rate.  
pH responsive polymers 
Studies have been performed by several groups on polymers containing weak acidic or 
basic groups in the polymeric chain.  Some examples of these polymers include, 
poly(acrylic acid) (Ito et al., 1989), poly(L-histidine) (Lee and Na et al., 2003).  The 
charge density of these polymers depends on the pH or ionic composition of the medium.  
Altering the pH will cause the changes in solubility or other properties of the polymer.  
For polyacidic polymers, acidic groups will be protonated at low pH and hence 
deionized.  Thus it will become more hydrophobic.  With increasing pH, acidic groups 
will be ionized and hence the solubility will increase.   
 
2.2 Mechanisms of controlled drug release  
Drug release mechanisms can be physical or chemical in nature.  Diffusion is always 
involved in drug release from non-biodegradable matrix and membrane devices.  Release 
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by diffusion is driven by concentration gradient, osmotic pressure and matrix swelling.  
However, for matrices that are biodegradable or contain drug conjugate, release can also 
be controlled by hydrolytic or enzymatic cleavage of relevant chemical bonds.  
Accordingly, mechanisms of drug release have been classified into diffusion, swelling 












Figure 2.4 A diagram of drug release mechanisms 
As shown in Figure 2.4, the continuous release of drugs can occur either by diffusion of 
the drug from the polymer matrix, by matrix swelling or by the erosion of the polymer 
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2.2.1 Physically-controlled release mechanism 




A device is considered diffusion-controlled when the diffusion of active agent through 
any part of the device controls the release rate. The polymer forming the device remains 
relatively unaffected by the polymer-environmental fluid interaction. There are two types 
of diffusion-controlled systems: reservoirs and matrices.  For the former case, the drug 
reservoir is surrounded by a polymeric membrane.  The drug core can be in either solid or 
liquid form, and the membrane can be microporous or nonporous.  If the drug core is 
maintained in a saturated state, the transport of drug molecules across the membrane will 
be kept constant (zero-order release), as the driving force is unchanged. However, the 
saturated state would be difficult to maintain if the drug has high water solubility.   
 
The most widely used devices are the matrix systems in which the drug is dissolved or 
dispersed in the polymer.  One characteristic of these systems is that the release rate 
decreases with time as a result of increasing diffusion distance for the drug solutes to 
travel from the core to the surface.  The amount of drug released is often proportional to 
the square root of elapsed time.  In addition to permeation through the polymer phase, the 
drug molecules can also diffuse through channels created by dissolution of the drug 
phase.  Release of macromolecules with low permeability generally occurs via these 
pores.  Since the extent and size of the pores and channels created are determined by the 
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drug incorporated, the loading level and particle size of the drug solutes have a profound 
influence on release kinetics. Below a critical loading level, some of the isolated drug 
particles may be trapped inside the matrix.  
 
The release behavior of these diffusion-controlled systems is highly dependent on the 
physical properties of the drug.  In addition to loading level and particle size of the 
solutes, the drug solubility in the polymer and drug diffusivity in the polymer phase are 
also important parameters.  The shape of the device, which determines the surface area 
available and the path length for diffusion, is also critical. 
 
2.2.1.2 Swelling 
Swelling-controlled release systems are formed by dissolving or dispersing the active 
agent in a polymeric matrix which is initially dry.  However, when this matrix is placed 
in an environmental fluid thermodynamically compatible with the polymer, the fluid is 
absorbed into the polymer, causing it to swell.  The swelling increases the aqueous 
solvent content in the formulation as well as the polymer mesh size, allowing the drug to 
diffuse through the swollen network to the external environment.  The release rate is 
therefore mainly related to the swelling phenomenon. Most of the materials used in 
swelling-controlled release systems are hydrogels, e.g. poly(hydroxy methyl 
methacrylate), polyacrylamide, and poly(ethylene glycols). The size of the pores located 
within the network, which is related to the extent of crosslinking and the degree of 
swelling, determines the protein release rate.  The rate at which protein is released from 
the hydrogel network can be modified by varying the degree of physical entanglement 
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within the gel, by altering the chemical crosslink density or by altering the interactions 
between the polymer matrix and the molecules of interest.   
 
2.2.2 Chemically-controlled release mechanism 
Chemical reaction controlled release systems are delivery systems in which the polymer 
is not merely a passive carrier but an active participant in the release process. Two 
common chemically-controlled systems are biodegradable matrix in which the drug is 
dispersed, and polymer-drug conjugate in which the drug molecules are chemically 
bonded to the side chains of the polymer. 
 
2.2.2.1 Polymer degradation 
The active agent in erosion-controlled devices is physically immobilized in the polymer 
and is released by the erosion of the polymer. While these devices can be made in both 
the reservoir and monolithic forms, the latter is more suitable for the purpose of drug 
delivery. In an ideal system, the polymeric carrier would undergo surface erosion, 
releasing the active agent at a rate proportional to the erosion rate. Systems with constant 
erosion rate and symmetric matrix geometry would produce zero-order (constant) release 
rates. However, erosion in practical systems is seldom solely from the surface inwards. 
Bulk erosion leading to a loss of physical integrity of the matrix and its eventual collapse, 
is frequently observed.  Moreover, drug molecules can also diffuse through the matrix. 
The release is commonly intermediate between zero-order and first order kinetics. 
Various polymers have been utilized in forming erodible devices, including copolymers 
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of lactic and glycolic acid. It has also been reported that polyanhydrides and POE 
undergo surface erosion.  Bioerodible polymer remains a very actively researched area. 
 
2.2.2.2 Polymer-drug conjugates 
In polymer-drug conjugates, the active agent itself is chemically bound to the polymeric 
backbone. Release occurs by hydrolytic or enzymatic cleavage of this bond. The polymer 
itself may be degradable in these systems. The release rate of the polymer-drug conjugate 
depends on the rate of cleavage of the polymer-drug bond.  If the drug is attached to the 
polymer via a spacer, the hydrolysis of both the polymer-spacer and the spacer-drug 
bonds is relevant.   
 
In general, many degradation systems use a combination of these mechanisms. 
 
2.2.3 Responsive drug release 
In addition to the mechanisms discussed above, another method of controlled release is 
responsive drug delivery in which the drug is released in a pulsatile manner only when 
required by the body.  As described earlier, responsive systems based on thermo 
responsive or pH responsive polymers have been widely investigated.  It would be 
desirable that polymeric systems could be designed to release increased levels of drug 
when needed, mimicking the body’s physiological processes (Kost and Langer, 2001).  In 
general, responsive drug delivery systems have two components: a sensor that detects the 
environmental conditions that stimulates drug release and a delivery device that releases 
the drug (Uhrich et al., 1999).  Drug release can be activated by an external stimulus 
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(such as magnetism, ultrasound, temperature changes and electrical effects) or self 
regulated stimuli (such as pH sensitive polymers, pH sensitive drug solubility and 
enzyme-substrate reactions).  The concept of responsive drug release can be used for any 
drug therapy in which a sensor and delivery device can be coupled.  Signals that have 
been employed to trigger drug release include: temperature in which thermosensitive 
hydrogels swell and collapse in response to temperature variations; pH in which ionizable 
groups within the polymer control polymer interactions.  For diabetes treatment, 
responsive drug delivery systems have been proposed, using the enzyme glucose oxidase 
as the sensor.  When blood sugar levels rise, glucose oxidase converts glucose to gluconic 
acid, resulting in lowered pH.  This pH decrease is then used as signal for insulin release 
(Kost and Horbett et al., 1985).  The drug is released by using pH sensitive polymers that 
either swell or degrade in acidic environment.   
 
2.3 Drug delivery systems 
Various delivery systems for controlled drug delivery have been developed in recent 
years.  These include monolithic devices, reservoir devices, polymer-drug conjugate, 
hydrogels, lipsomes, polymeric colloidal particles (microparticles, microspheres or 
nanoparticles) and micelles. 
 
2.3.1 Monolithic devices 
 Monolithic devices are possibly the most commonly used drug delivery systems.  In such 
a device, the drug is uniformly dispersed within the polymer matrix.  Monolithic devices 
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are normally formed by the compression of the polymer/drug mixture or by dissolution or 
melting. 
 
2.3.2 Reservoir devices 
In reservoir devices, the drug is encapsulated by a film or membrane made of a rate-
controlling material. The only structure effectively limiting the release of the drug is the 
polymer layer surrounding the reservoir. Since this polymer coating is essentially uniform 
and of fixed thickness, the diffusion rate of the active agent can be kept fairly stable 
throughout the lifetime of the delivery system if the drug is in a saturated state (Stannett 
et al., 1979).  Otherwise, the drug release rate of the drug decreases with time as the drug 
concentration decreases.  To design reservoir devices with desired properties, various 
factors such as additives, polymer functionality, porosity and film casting conditions that 
can affect the diffusion process should be optimized.  However, there are some 
difficulties with regards to protein delivery using reservoir devices.  Large molecules 
such as proteins diffuse very slowly through polymer films.  Moreover, unforeseen 
membrane failure may occur, resulting in massive release of entrapped drugs. 
 
2.3.3 Hydrogel  
Hydrogel is defined as soft solid like material that can absorb a substantial amount of 
water while maintaining a distinct three-dimensional structure (Brornberg and Ron, 
1998). One of the most useful features of hydrogen’s swelling ability is that swelling can 
be triggered by a change in the environment surrounding the delivery system. Depending 
upon the polymer, the environmental change can involve temperature, pH, or ionic 
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strength, and the system can either shrink or swell upon a change in any of these 
environmental factors. For most of these polymers, the structural changes are reversible 
and repeatable upon additional changes in the external environment.  One example is 
temperature sensitive PNIPAAm hydrogel.  PNIPAAm hydrogel possesses a three-
dimensional network structure, which is insoluble but has characteristics of reversible 
swelling. The polymer chains undergo a coil (soluble)-globule (insoluble) transition when 
the external temperature cycles across the LCST at about 33oC (Zhang and Yang et al., 
2001). Thus, at the temperature below the LCST, PNIPAAm hydrogel absorbs water and 
exists in a swollen state. But it turns to shrink and displays an abrupt volume decrease as 
the environmental temperature is higher than the LCST. 
 
Generally, the main reason for this distinctive property of the PNIPAAm hydrogel has 
been attributed to its uniquely rapid alteration in hydrophilicity and hydrophobicity (Feil 
et al., 1993; Inomata et al., 1990; Tokuhiro et al., 1991).  When the hydrophilic groups in 
the side chains of the PNIPAAm hydrogel connect with water molecules through 
hydrogen bonds, these hydrogen bonds act cooperatively to form a stable hydration shell 
around the hydrophobic groups, which leads to the great water-uptake of the PNIPAAm 
hydrogel at temperatures below the LCST. However, as the external temperature 
increases, the hydrogen bonding interactions become weakened or destroyed, thus the 
hydrophobic interactions among the hydrophobic groups grow to be stronger which 
induces the freeing of the entrapped water molecules from the network. When the 
temperature reaches or is above the LCST, the hydrophobic interactions become fully 
dominant. With a rapid water release, the polymer chains contract or collapse abruptly 
                                                                                              Chapter 2   Literature Review   
 34
and the phase separation of the PNIPAAm hydrogel system occurs. This phase separation 
is thermoreversible, which makes this hydrogel especially useful for drug delivery 
applications. A lot of work has been done on the application of PNIPAAm hydrogel for 
protein delivery.  For example, Braxel and Peppas (1996) reported pulsatile delivery of 
streptokinase (a fibrinolytic enzyme used to treat coronary thrombosis) using poly(N-
isopropylacrylamide-co-methacrylic acid) hydrogel. However, PNIPAAm-based 
hydrogels are not degradable and their monomers and cross-linkers may be toxic. 
Recently, biocompatible and/or degradable gels, based on poly(lactide-co-glycolide)-
poly(ethylene glycol)-poly(lactide-co-glycolide) (PLGA-PEG-PLGA) and poly(ethylene 
oxide) (PEO)-poly(propylene oxide) PPO-PEO, have been developed (Jeong et al., 2000). 
 
2.3.4 Polymer-drug conjugate 
Drugs can be attached to soluble synthetic polymers such as PEG via degradable 
linkages. This process alters the drug’s size and solubility, resulting in different 
pharmacokinetics and biodistribution.  One example involves covalent attachment of 
mPEG to proteins (PEGylation).  α-interferon, with a Mw of 19 kDa, used for treatment 
of hepatitis C, is cleared rapidly from the blood plasma of human body.  However, 
PEGylated α-interferon has a half-life about eight times that of native α-interferon in 
vivo, allowing weekly subcutaneous dosage of the conjugated protein.    The continued 
presence of circulating α-interferon activity allows for increased antiviral efficacy 
compared to unmodified protein (Greenwald et al., 2003).  The current size of the 
PEGylated protein market is about $1.0 billion per year.  It is expected that this market 
will grow to over $6.0 billion by 2008 (Sinha and Trehan, 2003).   
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2.3.5 Microspheres 
Microspheres are attractive drug carriers because they can be used to protect drugs 
against degradation and can be administered via injection, avoiding the need for surgery 
(Baldwin and Saltzman, 1998).    Micropsheres are also able to control drug release from 
the site of administration and in some particular cases to improve their passage through 
biological barriers.   Microspheres can be composed of biodegradable or non-
biodegradable polymers.    They can be produced in a wide range of sizes (1-100µm). 
Drugs may be dispersed in microspheres in either macroscopic (particulates) or molecular 
(dissolution) form.   
 
2.3.5.1 Micropsheres fabrication 
Generally, microspheres can be fabricated by either emulsion solvent-
evaporation/extraction or spray drying methods. One of the most common methods of 
preparing microspheres is the oil-in-water (O/W) solvent evaporation method (Johnson et 
al., 1991).  It involves the dispersion of an organic solution of the polymer and the drug 
into a continuous aqueous phase.  Hydrophobic drugs are successfully encapsulated in 
microspheres using this method.  However, poor encapsulation efficiency was observed 
for hydrophilic drugs.  A typical emulsion method for hydrophilic drugs is based on the 
water-in-oil-in-water double emulsion (w/o/w) process (Alonso et al., 1993).  First, the 
drug is dissolved or suspended in an aqueous solution and the polymer is dissolved in an 
organic solvent, and the two solutions are sonicated to form a first emulsion. DCM is 
considered as one of the most suitable solvents for the preparation of micropsheres as it is 
highly volatile and readily dissolves a range of polymers.  The first emulsion is then 
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poured into an aqueous medium and stirred to form a double emulsion. The first emulsion 
droplets are hardened by solvent evaporation or extraction, yielding microspheres. The 
size of microspheres can be controlled by varying fabrication conditions, including 
stirring rate, polymer concentration, surfactant and internal water volume (Yang et al., 
2000).  
 
When an A-B block copolymer (A: hydrophobic, B: hydrophilic) is used in the double 
emulsion process, the hydrophilic B block intends to migrate to the external aqueous 
phase and yields core-shell structured particles. Gref et al. (1994) reported that 
poly(ethylene glycol)-poly(lactide-co-glycolide) nanoparticles of 150 nm were obtained 
by this method. The emulsion method is suitable to encapsulate both hydrophilic and 
hydrophobic drugs.  
 
2.3.5.2 Microspheres for protein delivery 
Proteins form an integral part of the body as they carry out all important physiological 
and biological processes. For example, proteins can act as ligands for signalling, enzymes 
for facilitating metabolic activities, antibodies in immune system interactions and carry 
out transcription and translation of DNA (Sinha and Trehan, 2003).  Protein drugs are 
becoming very important therapeutic agents due to our understanding of their roles in 
physiology and pathology as well as the rapid growing biotechnology/genetic 
engineering.  The development of DNA-recombination techniques has allowed the 
discovery of many new proteins (Lee, 1991).   Moreover, it allows proteins to be made 
available in a large scale.    
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Several hundred protein drugs including insulin, hormones, growth factors, monoclonal 
antibodies and proteins for curing various diseases are currently undergoing clinical trials 
(Talmadse, 1993).  However, all proteins have a short biological half-life.  They are 
difficult to administer orally because they are unstable and are easily degraded by 
enzymes.  Most proteins can not easily pass through biological barriers because of their 
poor diffusivity and low partition coefficient.  To resolve these problems, the entrapment 
of proteins within microparticles, especially microspheres, has been investigated 
extensively (Couvreur et al., 1997).  This is because microspheres are able to protect 
proteins against degradation and control their release from the site of administration.  For 
example, insulin was encapsulated in blends of PEG with PLA and PLGA using w/o/w 
techniques. The encapsulation efficiency was 48% and 56%, respectively.  Such 
microspheres were capable of controlling the release of insulin for 28 days (Sinha and 
Trehan, 2003).  PLGA/PEG microspheres exhibited more extensive degradation over 4 
weeks as compared to PLA/PEG.  PLA/PEG microspheres thus resulted in more stable 
particle morphology along with reduced fragmentation and aggregation of associated 
insulin.  Microspheres have also been used to deliver proteins to local tissue sites.  When 
microspheres are implanted in a tissue, released proteins accumulate at the delivery site.  
It is possible to achieve the desired release rate and let proteins accumulate within the 
tissue by designing microspheres of proper size, composition and microstructure 
(Baldwin et al., 1998). Another advantage of using microspheres for protein delivery is 
that they can improve protein passage through biological barriers in some particular cases 
(Krewson et al., 1996).  
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As mentioned before, since certain therapy requires fluctuating protein levels, polymer-
based responsive delivery systems using microspheres have thus been investigated. Lynn 
and Amiji et al. proposed novel micropsheres composed of poly(β-amino ester), whose 
solubility is influenced by solution pH (Lynn and Amiji et al., 2001).  The polymer was 
insoluble in aqueous media in the pH range 7.0 to 7.4, and the transition between 
solubility and insolubility occurred at pH near 6.5.  Based on the difference between 
extracellular and endosomal/lysosomal pH (7.4 and 5.0-6.5, respectively), these 
microspheres were designed to release drugs in the intracellular pH range.  In vitro 
release experiments showed that the microspheres dissolved rapidly in buffer with pH 
5.1, leading to instantaneous release of drug from microspheres (80% was released over 1 
h).  In contrast, less than 20% of the drug molecules were released for microspheres 
incubated at PBS (pH 7.4) over 60 h.  CLSM results suggested that these microspheres 
could be internalized and digested by macrophages.  Therefore, poly(β-amino ester) 
microspheres retained the drug at extracellular or cytoplasmic pH value and released the 
drug in the range of endosomal/lysosomal pH value. 
 
Despite many attractive features provided by microspheres, there are still problems 
associated with protein delivery.  The most important factor affecting effectiveness of 
microspheres in protein delivery is the complexity of protein structure.  Proteins must 
maintain specific, folded, three-dimensional structure (conformation) during the 
encapsulation process to allow delivery of biologically active native protein upon 
administration.  Studies have shown that the fabrication process may cause degradation 
of proteins.  Furthermore, when encapsulated proteins remain in the body for a long time, 
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they may denature or aggregate as a result of exposure to moisture at 37°C.  This will 
lead to loss of biological activity and possibly produce an immune response. However, if 
the protein is recognized as self-protein, the probability of immune response is reduced.  
It is therefore essential to keep the protein in its native conformation in both the 
fabrication and the release process.   
 
BSA is a commonly used model protein in the development of controlled release system 
(Yang and Chia et al., 2000).  The surface-active property of BSA makes it stable in the 
first emulsion process.  Therefore, BSA, with a molecular weight of 58 kDa, was used as 
the model protein to explore the possibility of using thermo-responsive polymer 
microspheres for protein delivery in this study. 
 
Microspheres (1-250 µm) are considered the first generation colloidal carriers, which are 
able to control drug release. Despite promising results with microspheres, their usefulness 
is limited by their distribution and in particular by their recognition by the mononuclear 
phagocyte system.  Recently, much interest has been directed towards the development of 
second generation drug carriers, nanoparticles (<1µm) (Barrat et al., 2002).   Such 
carriers can deliver drugs directly to the target site (Langer, 1998). 
 
2.3.6 Nanoparticles 
Nanoparticles, usually smaller than 1µm, can be made by polymers (Feng et al., 2004) 
polymer-drug complex or lipsomes (Guo et al., 2003).  Nanoparticles have special 
properties that can be exploited to improve drug delivery.  Nanoparticles are often taken 
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up by cells due to their fine size. According to the process used for the preparation of the 
nanoparticles, they are classified into nanospheres and nanocapsules.  Nanospheres are 
matrix systems in which drugs are dispersed throughout the particles.  They are usually 
prepared by O/W or W/O/W method (Brigger et al., 2002).  Unlike nanospheres, 
nanocapsules are vesicular systems in which the drug is confined to an aqueous or oily 
cavity surrounded by a single polymeric membrane.  With appropriate design, drugs such 
as peptides, proteins and anticancer drugs can be loaded into nanoparticles that are not 
recognized by the immune system and can be targeted to particular tissue types.  A lot of 
research has been done on using nanoparticles as drug carriers. For example, Feng’s 
group has investigated PLGA nanopaticles for controlled release of paclitaxel.  
Paclitaxel-loaded PLGA nanoparticles were prepared using O/W emulsion method.  Drug 
release profile was determined by the polymer type and its molecular weight, the ratio of 
the copolymers, the emulsifier used, the ratio of the oil to water in the encapsulation 
process, the drug properties, the drug loading level, and other preparation parameters.  
The release profiles were thus adjustable by varying these parameters (Feng and Chien, 
2003).   However, it is still possible that these hydrophobic nanoparticles be captured by 
the macrophages of the mononuclear phagocytes system (MPS) after intravenous 
administration.  Recently, a great deal of work has been devoted to developing stealth 
nanoparticles (Gref et al., 1994).  By introducing hydrophilic polymers such as PEG on 
the surface, nanospheres will have a prolonged half-life in the blood.  This allows them to 
selectively target inflamed regions with a leaky vasculature.    There are two ways of 
introducing hydrophilic polymers either by adsorption of surfactants or by formation of 
block copolymers such as PEG-PLGA. 
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2.3.7 Micelles 
Polymeric micelles were first proposed as drug carriers in 1984 (Bader et al., 1984).  
Polymeric micelles are self-assembled from amphiphilic block or random copolymers.  
Here, a block copolymer is composed of one segment of an A homopolymer with a B 
homopolymer (A-B), while random copolymers have randomly arranged repeat units in 
their backbone (A-B-A-B or A-A-A-B-B-A-B and so on) (Kumar and Ravikumar et al., 
2001).  Normally, the size of polymeric micelles is less than 200 nm. Two forces are 
involved in the formation of micelles. One is the attractive force, leading to the assembly 
of molecules. The other is the repulsive force, preventing unlimited growth of the 
micelles. Amphiphilic copolymers tend to self assemble when put in a solvent in which 
either the hydrophilic or the hydrophobic segment is soluble. When the solvent is an 
aqueous phase, micelles are formed with a hydrophilic shell and a hydrophobic core at a 
polymer concentration above the critical association concentration (CAC). With the core-
shell structure, polymeric micelles can solubilize insoluble drugs in the core while the 
outer shell is responsible for interactions with biocomponents.  In addition, the 
hydrophilic shell can prevent unwanted interactions between the particles and the 
reticuloendothelial system (RES). It was reported that drug-loaded polymeric micelles 
might accumulate to a greater extent than free drug in tumor tissues as compared to 
healthy tissues due to an increased vascular permeability and impaired lymphatic 
drainage (Jones and Leroux, 1999). This is referred to as the enhanced permeability and 
retention effect (EPR) (Matsumura and Maeda, 1986). The EPR effect is considered as a 
passive targeting method, but the drug targeting could be further enhanced by the 
introduction of an environment-responsive polymer segment or a signal on the surface of 
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the micelles which can recognize tumor cells (Jones and Leroux, 1999). This is known as 
active targeting method.  Nowadays, polymeric micelles are regarded as one of the most 
suitable carriers for delivering anticancer drugs.  The use of these micelles for anticancer 
drug delivery requires the determination of several important parameters such as particle 
size, critical association concentration (CAC), drug loading capacity, physical stability 
and drug release.  Since these parameters strongly depend on the procedure used in the 
preparation of micelles, micellar shell and the micellar core, these factors as well as the 
applications of the micelles in anticancer drug delivery will be reviewed in the following 
subsections. 
 
2.3.7.1 Fabrication of micelles 
There are two methods used for the preparation of drug-loaded micelles, dialysis method 
and direct dissolution method (Allen and Cullis, 1999).  The selection of the method to be 
used depends on the solubility of the block or copolymer in water.  In the case of direct 
dissolution, polymer is simply dissolved in an aqueous medium. This method is used for 
micelles preparation from pluronics and polymers with a good solubility in water.  The 
dialysis method is most often used to prepare micelles using poorly soluble polymers.  In 
the dialysis method, the drug and polymer are added to an organic solvent, and then the 
solution is dialyzed against water.  During the process of dialysis, micelles are formed 
and the drug is loaded into the core as the organic solvent is removed.   Some studies 
have reported that the micelle size and drug loading capacity depend on the organic 
solvent used (Kim and Shin et al., 1998).   In a study reported by Lee and Kim (2003), 
the use of THF as the organic solvent gave rise to the micelles with a drug loading 
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content of 0.5%.  In contrast, when acetonitrile was used, the micelles obtained had a 
much higher loading content of 2.4%.  In addition, Chung (Chung et al., 1999) reported 
that the dialysis temperature had a great effect on the particle size and drug loading.  It 
was found that the optimum temperature for forming PNIPAAm-b-PBMA micelles with 
efficient drug incorporation and small particle size was 20°C.  This is because a thermo-
responsive polymer was used in the experiment, and it would precipitate above the LCST, 
leading to lower drug loading level.  According to these studies, the size and drug loading 
capacity of the micelles can be modulated by varying fabrication conditions.   
 
2.3.7.2 Shell of micelles 
The micellar shell acts as a stabilizing interface between the hydrophobic micelle core 
and the external medium.  In most cases, PEG/PEO with molecular weight ranging from 
1000 to 12000 is used as the hydrophilic block to form the shell of the micelles.  The 
outer PEG shell of micelles can inhibit the surface adsorption of biological components 
such as proteins and protect the core through steric stabilization. It has been demonstrated 
that PEO prevented the adsorption of proteins (Deng et al., 1996) and thus formed a 
biocompatible polymeric shell.  Also, it can influence the extent to which primary 
micelles aggregate to form large secondary clusters.  Additionally, the surface density of 
PEG and the thickness of the PEG shell can influence the stability of micelles.  Usually, 
the density of PEG at the surface of micelles is determined by aggregation number.  The 
larger the aggregation number, the more PEG blocks on the surface of micelles.   The 
surface properties of the micelles such as charge, hydrophilicity and steric stability have a 
great effect on the biodistribution of the drug-loaded micelles.    The high PEO surface 
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density of the 1.5:2 PEG-PLA micelles led to an improved biodistribution with reduced 
liver uptake compared to that of 2:5 PEG-PLA micelles (Hagan and Coombes et al., 
1996).   
 
As described in the previous paragraphs, drug targeting can be improved by the 
introduction of a signal on the surface the micelles, which can recognize tumor cells or an 
environment-responsive polymer segment.  Block copolymers with a functional group at 
one end of the PEG chain were used to introduce the targeting signal on the outer shell of 
the micelles.   The specificity results from a receptor-ligand interaction. Specific ligands 
will bind to receptors on the plasma membrane of the target tissue. It was reported that 
micelles prepared from PEG-distearyl phosphoethanolamine (PEG-PE) were convalently 
modified with the nucleosome-specific monoclonal antibody 2C5 (Gao and Lukyanov et 
al., 2003).  These antibody conjugated paclitaxel-loaded micelles recognized specific 
tumor cells and showed enhanced cytotoxicity compared to normal paclitaxel-loaded 
micelles.   Another widely used signal is folic acid.  Folic acid constitutes an attachable 
ligand with high affinity for a receptor that is commonly over expressed on ovarian, 
breast carcinomas and other cancers (Lu and Low, 2003).   
 
Other than PEG, several other hydrophilic polymers such as PNIPAAm, poly(acrylic 
acid) (PAAc) have been used as the shell of micelles.  As stated earlier, PNIPAAm is a 
temperature-sensitive polymer with LCST of 32oC. The LCST can be modified by the 
incorporation of hydrophilic or hydrophobic comonomer. This unique property is very 
important for active targeting.  Okano’s group tested a series of DOX-loaded thermo-
responsive micelles with PNIPAAm shells (Chung et al., 1999; Kohori et al., 1999).  It 
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was found that these micelles exhibited reversible structural changes upon heating or 
cooling across the LCST (32oC). Such DOX-loaded micelles showed a dramatic thermo-
responsive on/off switching behavior for both drug release and in vitro cytotoxicity based 
on the temperature responsive structural changes.    
 
2.3.7.3 Core of micelles  
As mentioned above, the core of micelles, which consists of hydrophobic polymer, serves 
as a reservoir for drugs.  The hydrophobic core generally consists of biodegradable 
polymers such as PLA, PLGA or non-biodegradable polymers such as alkyl chain, 
polystyrene (PSt) and poly(methyl methacrylate) (PMMA).  Usually, the core exists in 
two states:  one is a liquid-like core; another is a solid-like core (Allen and Eisenberg, 
1999).  Whether it is liquid-like or solid-like, it has a large influence on the drug loading, 
physical stability and drug release of the thermo-responsive micelles.   The physical state 
of the core under normal physiological conditions (37°C) depends on the glass transition 
temperature (Tg) of the core-forming block.  The polymer is liquid above the Tg, while it 
is solid below the Tg.  Several studies have described the use of polymers such as 
polystyrene (PSt) (Zhang and Eisenberg, 1995) or poly(methyl methacrylate) (PMMA)  
(Inouse and Chen, 1998) as constituents of the micellar core.    These polymers have 
solid-like core, which exhibited low drug loading capacity (5.0%) but remarkable 
stability. In contrast, the liquid-like core composed of poly(butylmethylacrylate) (PBMA) 
offered high drug loading capacity (9.6%), but the stability of these micelles is not good 
(Chung et al., 1999).   Furthermore, the state of the micelle core has a significant effect 
on the rate of drug release from the thermo-responsive micelles. Chung et al. (1999) 
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compared the anticancer drug (DOX) release between PNIPAAm-b-Pst and PNIPAAm-
b-PBMA micelles.   It was found that drug release from the PNIPAAm-b-PBMA was 
initiated by increasing the temperature above the LCST (over 80% was released), while it 
was suppressed below the LCST (about 10% was released).  This is because PNIPAAm 
shell collapsed above the LCST, inducing the deformation of the micellar structure, 
leading to faster drug release (Chung et al., 2000).   However, the drug release from the 
PNIPAAm-b-PSt was suppressed at temperatures both above and below the LCST.  This 
can be explained by the fact that the PSt core possessing a much higher Tg (100°C), 
retained its structure regardless of outer shell (PNIPAAm) changes.  Thus, the movement 
of the drug out of a solid core was slower. 
 
In addition to affecting drug loading and drug release, micellar core is also sensitive to 
physicological environment such as pH value in some cases (Lee and Na et al., 2003).  
Micelles composed of pH responsive components offered pH sensitivity that responds 
reversibly or irreversibly to changes in solution pH.   As mentioned earlier, pH sensitivity 
allows the delivery system to be self-regulated. This is because the tumor extracellular 
pH is different from surrounding normal tissues.  The measured pH values of most 
tumors are below 7.2.  Moreover, there is a significant drop in the pH value 
intracellularly from pH 5.0-6.0 in endosomes to around pH 4.0-5.0 in primary and 
secondary lysosomes.  Furthermore, a large number of lysosomal enzymes such as 
phosphatases and nucleases became active in the acidic environment of these vesicles.  
Therefore, the low pH values in extracellular tumor tissues, intracellular properties as 
well as the presence of lysosomal enzymes can be used for the development of new 
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polymeric nanocarriers which release drugs from pH sensitive micelles in specific tumor 
cells (Haag, 2004).  Lee et al. (2003) reported pH sensitive micelles PEG-poly(L-
histidine), where poly(L-histidine) acted as pH sensitive polymer. Mixed micelles 
prepared from poly(L-histidine)  and PEG-PLA were destabilized in the pH range of 7.2-
6.6, leading to accelerated DOX release.  
 
2.3.7.4 Micelles for delivery of anticancer drugs 
There are hundreds of anticancer drugs currently available for clinical application.    
Doxorubicin (DOX) and paclitaxel are most commonly used ones.  However, since they 
are toxic to both tumor and normal cells, the efficacy of chemotherapy is limited by the 
serious side effects (Brigger and Dubernet, 2002).  Because polymeric micelles offer a lot 
of advantages as discussed earlier, they seem to be one of the most promising carriers for 
the delivery of anticancer drugs.   
 
Doxorubicin (DOX) 
DOX is an anthracycline antibiotic that exerts its effects on cancer cells via inhibiting the 
synthesis of DNA as well as DNA transcription (Yoo and Park, 2000).  DOX has 
undesirable side effects such as cardiotoxicity and myelosupression, which lead to a 
limited therapeutic efficacy.  A number of studies have been conducted to target DOX 
delivery to cancer tissues using polymeric micelles.  Kataoka’s research team reported a 
novel amphiphilic block copolymer PEG-poly(β-benzyl-L-aspartate) (PEG-PBLA) 
synthesized from the ring-opening polymerization of (β-benzyl-L-aspartate N-carboxy-
anhydride (BLA-NCA) ( Nakanishi et al., 2001).  DOX was physically loaded into PEG-
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PBLA micelles, which was proved via GPC.  It is noteworthy that DOX entrapped in 
micelles interacted only slightly with serum, making them stable in body.  However, free 
DOX readily interacted with serum in aqueous solutions.  Kataoka’s research team also 
developed pH-sensitive micelles based on PEG-Pasp (poly(aspartate-hydraxzone-
adriamycin) block copolymer for DOX delivery. DOX was conjugated with PEO-b-PAsp 
through an acid-labile hydrazone linker (Bae et al., 2003).  Release kinetics demonstrated 
the effective cleavage of the hydrazone bonds at pH 5 with release of DOX. The 
released DOX molecules accumulated in the cell nuclei and effectively suppressed the 
growth of cancer cells.  However, the release was negligible under physiological 
conditions in the cell culture medium (pH 7.4).  Compared to the chemical conjugated 
approach, physical entrapment of drugs offer more advantages including easy preparation 
and enhanced drug bioavailability.  For example, DOX was physical loaded into micelles 
prepared from PEG-PBLA with a high drug loading level of 15% and particle size of 50-
70 nm.  Blood circulation of DOX was greatly improved by use of PEG-PBLA micelles 
as carrier.  Most of all, DOX loaded micelles showed a considerably higher antitumor 
activity compared to free DOX against mouse C26 tumor by intravenous injection 
(Kaotaoka and Matsumot et al., 2000).  Recently, Okano’s group have developed thermo-
responsive micelles from poly(N- isopropylacrylamide)  with various cores.   In a study 
by his group, temperature responsive micelles prepared from PNIPAAm-PBMA were 
developed (Chung et al., 1999).   Both blank micelles and DOX loaded micelles showed a 
dramatic thermo-responsive on/off switch behavior for both drug release and in vitro 
cytotoxicity, resulting from temperature responsive structural changes of a micellar shell.  
Furthermore, the properties of micelles also depended on the core block, which was 
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presented in Section 2.3.7.3.  The micelles self-assembled from PEG-PCL block 
copolymers were also studied for DOX delivery (Shuai and Ai et al., 2004). The micelles 
size was greatly affected by PLC length.  The micelle diameter increased from 22.9 nm to 
104.9 nm with an increased PCL length in the copolymer composition.  No hemolysis 
observed with DOX-loaded PEG-PCL micelles, indicating they were very stable in the 
blood.  More recently, an effective ligand (cRGDfK) was conjugated to the surface of 
DOX-loaded PEG-PCL micelles for active targeting (Nasongkla et al., 2004). A 
remarkable increase in the uptake of ligand-conjugated micelles in the cells was 
observed.   A higher density of ligand molecules led to a higher level of cellular 
internalization of these micelles via receptor-mediated endocytosis.  
 
Paclitaxel 
Paclitaxel is a unique antimicrotubule agent that promotes polymerization of tubululin, 
leading to cell death by disrupting the dynamics necessary for cell division.  It is a 
promising anticancer drug with special effects against breast and ovarian cancers, colon 
and non-small cell lung cancers.   One major limitation of paclitaxel is its difficulty in 
clinical administration. Paclitaxel is highly hydrophobic with water solubility less than 
0.5ppm.  Paclitaxel is thus formulated in a 50:50 mixture of Cremophor EL 
(polyoxyethylated castor oil) and dehydrated alcohol.   However, Cremophor EL is very 
toxic and shows side effects such as hypersensitivity reactions, nephrotoxicity and 
neurotoxicity.  Formulation strategies based on polymeric micelles have been studied. 
Several reports have showed controllable encapsulation and high antitumor of paclitaxel-
loaded micelles based on biodegradable block copolymers such as PEG-PLA and PEG-
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PCL.  It was reported that up to 25% of paclitaxel was successfully loaded into PEG-PLA 
micelles (Zhang and Jackson et al., 1996).  It is demonstrated that the solubilization of 
paclitaxel in the core of micelles did not alter the chemical nature of drugs.    PCL is 
another interesting core forming block.  PEG-PCL micelles with high drug loading (20%) 
and narrow size distribution were obtained.  In addition, these blank micelles showed low 
in vivo toxicity using male ICR mice (Kim and Lee, 2001).   To further enhance stability 
of micelles, PEG-PCL micelles were cross-linked by radical polymerization of the double 
bonds introduced into the PCL blocks.  Both encapsulation efficiency and stability 
increased markedly (Shuai and Merdan et al., 2004).  Additionally, efficient cellular 
internalization of fluorescence-labeled paclitaxel encapsulated in these cross-linked 
micelles was observed.  In addition to polyester, lipid was used as hydrophobic blocks, 
which can provide additional advantages for enhancing micelles stability. A series of 
PEG-phosphatidylethanolamine (PEG-PE) conjugates was synthesized using egg PE 
(transphosphotidylated) and N-hydroxysuccinimide esters of methoxy-PEG succinates 
(Torchilin, 2001).  Paclitaxel can be efficiently loaded into PEG-PE micelles.  In 
addition, it was found that they can accumulate in certain tumors via the EPR effect more 
efficiently compared to other carriers because of their small size (Gao and Lukyanov et 
al., 2002). Another important finding is a novel formulation of PEG-PE/ePC mixed 
micelles loaded with paclitaxel and conjugated with 2C5 antibody.  These micelles could 
recognize a variety of tumor cells in vitro and showed a dramatically enhanced 
cytotoxicity against tumor cells. 
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Various other examples of polymeric micelles for anticancer drug delivery can be found 
in literature.  Because of their superior advantages including small size, high solubility, 
simple sterilization and controlled release of drugs, polymeric micelles are expected to be 
an ideal carrier for chemotherapy with the best efficacy and the least side effects in near 
future.     
 
2.4 Motivation and research objectives 
As reviewed in this chapter, polymeric controlled drug delivery systems offer sustained 
drug delivery in a constant release rate. However, such an approach may not be sufficient 
in some therapy situations.  These include the delivery of proteins and cancer 
chemotherapy. It would be desirable that polymer systems could be further optimized to 
release increased levels of drugs when needed.  Several research groups have been 
developing responsive systems in which drug release can be tailored according to 
physicological needs.  
 
Temperature sensitive carriers have been widely used in drug delivery area such as 
protein delivery and anticancer drug delivery.   Previous studies have used PNIPAAm-
based hydrogels for protein delivery, and it has been proven that protein release has 
responded to the temperature changes.  However, PNIPAAm hydrogels are not 
degradable and their monomers and cross-linkers may be toxic.  Another major limitation 
of hydrogels is that surgery may be required to implant or remove the system. As 
reviewed in the previous section, polymeric microspheres are an attractive carrier for 
protein delivery because they can be used to protect protein against degradation and 
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administered via injection, avoiding the use of surgery.  However, there is a big problem 
facing protein delivery from PNIPAAm microspheres.  Since PNIPAAm is a highly 
hydrophilic polymer, PNIPAAm microspheres can only be fabricated with the inverse 
emulsion method.  This method uses an organic solvent as a medium, leading to the 
inactivity of the protein during fabrication. To overcome this problem, a hydrophobic 
polymer poly(lactide-co-glycolide) (PLGA, the most widely used polymer with superior 
biocompatibility and biodegradability) or polylactide (PLA) (Rahman and Mathiowitz, 
2004) is built into the PNIPAAm chain. By doing so, a block copolymer can be formed 
and this copolymer is more hydrophobic than PNIPAAm alone.  Therefore, we can use 
double emulsion instead of inverse emulsion to fabricate thermo-responsive 
microspheres. Unlike the inverse emulsion method, the double emulsion requires a mild 
environment, which may stabilize the protein and enhance protein encapsulation 
efficiency. 
 
It was also shown in the previous section that thermo-responsive micelles have been used 
to deliver anticancer drugs.  An in vitro study on DOX-loaded PNIPAAm-b-PBMA 
micelles showed that the release rate of DOX from the micelles was much higher when 
the temperature was above the LCST than below the LCST.  Due to enhanced drug 
release and increased interaction between micelles and the cells, the micelles expressed 
high cytotoxicity against tumor cells above the LCST (Chung et al., 2000).  However, so 
far, most cores reported for the thermo-responsive micelles are all non-degradable.  In 
order to be considered as clinically relevant drug carriers, the core must be both 
biocompatible and biodegradable.  Hence, it is desirable to develop temperature sensitive 
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micelles with biodegradable cores.  Kohori et al. (1999) used poly(D,L-lactide) as the 
core-forming segment, which is biodegradable.  Nevertheless, the encapsulated 
doxorubicin (DOX) release was very slow at temperatures both below and above the 
LCST.  It might be due to the high hydrophobicity of the inner core of the micelles. It is 
desirable that the properties of the core-forming block can be tailored to achieve desired 
release profiles.   
 
In addition, temperature responsiveness of micelles can be triggered by pH change in the 
environment without external heating via a pH sensitive core-forming block (Soppimath 
et al., 2005).   
 
The objective of this study is to systematically study two biodegradable thermo-
responsive drug carriers and explore their applications in controlled delivery of proteins 
and anticancer drugs.    The specific objectives of this study are: 
1. To synthesize and characterize thermo-responsive PNIPAAm-b-PLA and 
P(NIPAAm-co-DMAAm)-b-PLGA  block copolymers.   
2. To prepare bovine serum albumin (BSA, a model hydrophilic protein)-loaded 
microspheres using the PNIPAAm-b-PLA block copolymer by the double 
emulsion method, and to study the degradation of the microspheres and in vitro 
protein release from microspheres. 
3. To fabricate the anticancer drug (DOX) and paclitaxel-loaded micelles using 
the P(NIPAAm-co-DMAAm)-b-PLGA  block copolymer by the dialysis 
method, to investigate the stability of the micelles under physiological 
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conditions and to examine the effect of hydrophobic content on the drug 
loading, morphology of micelles, in vitro anticancer drug release and to study 
cytotoxicity of drug-loaded micelles against various animal and human cancer 
cells at different temperatures as well as cellular uptake of doxorubicin-loaded 
micelles.  
4. To synthesize a multifunctional polymer, folate conjugated poly(N-
isopropylacrylamide-co-N,N-dimethylacrylamide-co-methacrylate)-b-poly(10-
undecenoic acid)  and to fabricate DOX-loaded micelles for specific and 
intracellular delivery of anticancer drugs to tumor cells, to examine in vivo 
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The materials and methodology employed in the course of the research project are 
presented as follows.  Included are the methods for polymer synthesis, microspheres and 
micelles fabrication as well as analyses. 
 
3.1 Materials 
N-isopropylacrylamide (NIPAAm, purchased from Sigma-Aldrich) was purified by re-
crystallization from n-hexane. N, N-dimethylacrylamide and 10-undecenoic acid (98%) 
was purchased from sigma and pre-vacuum distilled before use. D, L-lactide was bought 
from Sigma-Aldrich and purified by re-crystallization from ethyl acetate. Poly(D,L-
lactide) (PLA) and glycolide (99.0%) was purchased from Polyscience. Bovine serum 
albumin (BSA) (fraction V, 58 kDa), poly(vinyl alcohol) (PVA, 87-89 mol % 
hydrolyzed, Mw 31,000-50,000), fetal serum albumin (FBS) were supplied from 
Invitrogen Corporation. Doxorubicin hydrochloride (DOX), paclitaxel, pyrene, 2-
hydroxyethanethiol, 3-mercaptopropionic acid (MPA), 2-aminoethyl methacrylate 
hydrochloride (90%), 2-hydroxyethanethiol, 2-aminoethanethiol (AET), N-
hydroxysuccinimaide (NHS), dicyclohexylcarbodiimide (DCC), tin(II)2-ethylhexanoate, 
3-[4,5-dimethylthiazolyl-2]-2,5-diphenyl tetrazolium bromide (MTT), L-glutamine,  
acetonitrile (HPLC grade), anhydrous dichloromethane (DCM), anhydrous dimethyl 
sulfoxide (DMSO), N, N-dimethylacetamide (DMAc), methanol(HPLC grade), 
dichloromethane (DCM) and dimethylformamide (DMF) were purchased from Sigma-
Aldrich, and used as received. Ammonium persulphate (APS) was purchased from Bio-
Rad Laboratories. Tetrahydrofuran (THF) and toluene were purchased from Merck, and 
dried over sodium. 4T1 (mouse breast cancer cell line) were purchased from ATCC.  
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MDA-MB-435S (human breast carcinoma cell line) was purchased from Interlab Cell 
Line Collection (Italy).  All other chemicals were of analytical grade, and used as 
received. 
3.2 Polymer synthesis 
3.2.1 Synthesis of poly(N-isopropylacrylamide-co-N, N-dimethylacrylamide)-b-
poly(D,L-lactide-co-glycolide) ((P(NIPAAm-co-DMAAm)-b-PLGA) 
The diblock copolymers with different contents and compositions of PLGA were 
synthesized (Figure 3.1) according to the method reported previously (Kohori et al., 
1998;  Liu and Yang, 2003). Briefly, hydroxyl-terminated poly(N-isopropylacrylamide-
co-N, N-dimethylacrylamide) precursor polymer was prepared by the radical 
copolymerization using benzoyl peroxide (BPO) as an initiator and 2-hydroxyethanethiol 
as a chain transfer agent (CTA). For instance, N-isopropylacrylamide (20.0 g, 176.9 
mmol), N, N-dimethylacrylamide (4.37 g, 44.2 mmol), 2-hydroxyethanethiol (172.5 mg, 
2.21 mmol) and BPO (89.2 mg, 0.295 mmol) were dissolved in 30 mL THF.  The 
solution was degassed by bubbling with nitrogen for 20 minutes. The reaction mixture 
was refluxed for 8 hours under nitrogen. Upon completion, the product was precipitated 
out by the addition of diethyl ether. The products were purified by re-precipitation twice 
from dichloromethane-diethyl ether using a slow liquid-liquid diffusion method. The 
diblock copolymers of P(NIPAAm-co-DMAAm)-b-PLGA were synthesized by the ring-
opening esterification polymerization of D,L-lactide (LA) and glycolide (GA) with the 
hydroxy-terminated precursor in toluene using tin(II) 2-ethylhexanoate as the catalyst. It 
should be noted that all monomers and precursor polymer should be dried at vacuum 
oven before reaction. The reaction mixture was refluxed at 120°C for 24 hours under 
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nitrogen. The reaction mixture was refluxed at 120°C for 24 h under nitrogen (Figure 
3.1). The 1H-NMR spectra of the polymers were recorded using a Bruker Avance 400 
spectrometer (400 MHz), and chloroform-d (CDCl3) was used as the solvent.  Chemical 
shifts were expressed in parts per million (δ) using residual protons in the indicated 
solvents as the internal standards. The IR spectra were recorded on a Fourier transform 
infrared spectrometer (Perkin-Elmer Spectrum 2000, KBr).  The molecular weight was 
determined by gel permeation chromatography (GPC, Waters, polystyrene standards) in 
THF (elution rate: 1ml/min) at 25°C. Optical transmittance of aqueous polymer solution 
(5 mg/mL) at various temperatures was measured at 500 nm with a UV¯VIS spectrometer 
(Shimadzu, UV-2501PC, Japan). Sample cells were thermostated with a temperature-
controller (Shimadzu, TCC-240A, Japan). Heating rate was 0.1°C/min. The LCST values 
of polymer solutions were determined at the temperatures showing an optical 
transmittance of 50%.  The properties of the precursor polymers and the resulting block 
copolymers are listed in Tables 4.1.  
 
Figure 3.1   Synthesis route of P(NIPAAm-co-DMAAm)-b-PLGA 
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3.2.2 Synthesis of folate-conjugated poly(N-isopropylacrylamide-co- N, N-
dimethylacrylamid-co-methacrylate)-b-PUA (Poly(NIPAAm-co-DMAAm-co-
MAm)-b-PUA) 
3.2.2.1 Synthesis of Poly(NIPAAm-co-DMAAm-co-MAm)-COOH  
Carboxylic acid-terminated poly(N-isopropylacrylamide-co- N, N-dimethylacrylamide) 
precursor polymer was prepared by the radical copolymerization using benzoyl peroxide 
(BPO) as an initiator and 3-mercaptopropionic acid as a chain transfer agent. For 
instance, N-isopropylacrylamide (20.0 g, 176.9 mmol), N, N-dimethylacrylamide (3.50 g, 
35.38 mmol), 2-aminoethyl methacrylate hydrochloride (90%) (158.4mg, 0.86 mmol), 
MPA (269mg, 2.54mmol) and BPO (85.6 mg, 0.35 mmol) were dissolved in 30 mL THF 
(Figure 3.2).  The solution was degassed by bubbling with nitrogen for 20 minutes. The 
reaction mixture was refluxed for 8 h under nitrogen at 85°C. Upon completion, the 
product was precipitated out by the addition of diethyl ether. The products were purified 
by re-precipitation three times from THF-diethyl ether using a slow liquid-liquid 
diffusion method and then vacuum dried.  Then, it was placed in a dialysis membrane 
(Spectra/Por 7, MWCO 2000, Spectrum Laboratories Inc.) and dialyzed against distilled 
water for 1 week.  The dialyzed solution was freeze-dried.   
3.2.2.2 Synthesis of folate-conjugated Poly(NIPAAm-co-DMAAm-co-MAm)-COOH 
The carboxylic acid group of folic acid (1.0g, 2mmol) dissolved in 20 ml DMSO was 
pre-activated with DCC (0.495g, 2.4mmol) and NHS (0.463g 4mmol) at room 
temperature (Figure 3.3 (a)).  In the reaction, dicyclohexylurea (DCU) was formed and 
removed by filtration. The vacuum-dried precursor polymer was added to the reaction 
solution (Figure 3.3(b)).  The reaction was kept at room temperature for 48 h. The 
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resulting solution was placed in a dialysis membrane (Spectra/Por 7, MWCO 2000, 
Spectrum Laboratories Inc.) and dialyzed against distilled water for 1 week. The dialyzed 
solution was then freeze-dried.   
3.2.2.3 Synthesis of poly(10-undecenoic acid)-NH2  
Amine group-terminated poly(10-undecenoic acid) precursor polymer was prepared by 
the radical copolymerization using the redox agent ammonium persulfate (APS)  as an 
initiator and 2-aminoethanethiol as a chain transfer agent. Briefly, 10-undecenoic acid 
(40.0 g, 217.0mmol) was first converted into sodium salt by reacting with sodium 
hydroxide solution (0.1M), the pH of the solution was adjust to 8.0.  The solution was 
bubbled with N2 for overnight.  Then, AET (2.0%-2.5% molar ratio) and APS (4% mass 
ratio) were added to the solution with stirring (Figure 3.4).  The reaction was kept at 
70°C for 48 h.  Upon completion, the crude product was precipitated by the addition of 
cold ethanol.  The pale yellow power was obtained after filtration.  It was re-dispersed 
three times in ethanol to remove un-reacted monomer.  The product was dialyzed against 
distilled water (Spectra/Por® C E, MWCO 1000, Spectrum Laboratories Inc.) to remove 
salt.  The final white product was obtained by freeze-drying. 
3.2.2.4 Conjugation of poly(10-undecenoic acid)-NH2 to folate-conjugated  
poly(NIPAAm-co-DMAAm-co-MAm)-COOH 
The carboxylic acid group of folate-conjugated poly(NIPAAm-co-DMAAm-co-MAm)-
COOH (1 mmol) was activated using DCC (1.2 mmol) and NHS (2 mmol) in DCM.  
DCU was removed by filtration and excess diethyl ether was added to precipitate the 
activated folate-conjugated poly(NIPAAm-co-DMAAm-co-MAm)-COOH.  The vacuum 
dried products and an excess amount of poly(10-undecenoic acid)-NH2 were dissolved in 
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DMSO and stirred at room temperature for 48 h (Figure 3.5).  The un-reacted poly(10-
undecenoic acid)-NH2 was removed by dialysis against DMSO for 1 week (DMSO was 
replenished daily, dialysis membrane with a Mw cut-off of 3,500 Da).  The solution in 
the dialysis tubing was further dialyzed against de-ionized (DI) water for another week. 
The final yellowish product was obtained by freeze-drying.  The final product was 
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Figure 3.3 Synthesis folate-conjugated Poly(NIPAAm-co-DMAAm-co-MAm)-COOH. 









H2C - CH  SCH2CH2NH2
y
























































































3.3.1 Microspheres preparation 
BSA-loaded micropsheres were fabricated using PNIPAAm-b-PLA and PLA polymers 
by a W/O/W double emulsion solvent evaporation method. Briefly, 600 mg polymer was 
dissolved in 12 mL DCM. 70 mg BSA was dissolved in 0.3 mL PBS containing 0.05% or 
0.2% (w/v) PVA (the internal aqueous phase). The two solutions were mixed and 
sonicated for 20 seconds using a VC sonicator (Sonics & Materials Inc., CT, USA) to 
produce the first emulsion (water-in-oil, W/O). This emulsion was poured into 250 mL 
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PBS containing 0.2% (w/v) PVA to produce a double emulsion (water-in-oil-in-water, 
W/O/W). The solution was kept at 15°C, and stirred for 3.5 hours using a mixer (Cole-
Parmer Instrument Co., IL, USA) with the stirring speed of 300 rpm.  The resultant 
microspheres were filtered, washed and vacuum-dried overnight and stored at 4°C. The 
fabrication process was illustrated in Figure 3.6. The abbreviation, PNIPAAm-b-PLA 
(1:5, 0.2%), represents the microspheres fabricated with PNIPAAm-b-PLA having 1:5 












   Figure 3.6  Microspheres fabrication using W/O/W emulsion technique  
 
3.3.2 Characterization and analyses of microspheres 
3.3.2.1 Evaluation of protein encapsulation efficiency 
Polymer in DCM










Drug in PBS 
Drug in PBS 
                                                                                         Chapter 3 Materials and Methods 
 65
The BSA amount lost in the external aqueous phase during the fabrication process was 
analyzed by a high performance size exclusion chromatography (HPSEC). The HPSEC 
system consisted of a 1050 Quatern Pump, an 1100 autosampler injector and a Diode-
Array UV detector. A Zorbax GF-250 column (4.6 mm × 25 cm, Dupont Company) was 
used as the separation column. The flow rate of the mobile phase (PBS, pH 7.0) was 1.0 
mL/min, and the UV detection was at 210 nm. The encapsulation efficiency multiplied by 
100% was calculated as the ratio of actual and theoretical BSA content.  In this study, a 
confocal laser scanning microscope (Olympus FV500, Japan) was used to observe BSA 
distribution within the microspheres using BSA-FITC. An excitation wavelength of 488 
nm was employed and an emission signal at 525 nm was detected. The laser power was 
10%. All the observations were conducted using the same resolution.  
3.3.2.2 Inherent viscosity (ηinh) measurement 
The inherent viscosity of polymer in methylene chloride was determined according to 
ISO/DIS 3105 and ASTM D2515/D446 using the Schott Gerate AVS360, Viscometer: 
DIN Ubbelohde (Type: Capillary No. 52510/I Appt. No. 904473) at 25 °C. The inherent 
viscosity is calculated using the equation 3.1 as following: 
ηinh = ln (t/t0)/C                                          (3.1) 
where t0 is flow time of solvent, t is flow time of polymer solution and C is the concentration 
of the sample in g/dL. 600 mg of solid polymer was dissolved in 12 ml of solvent and 
filtered before being filled into the viscometer. Sample concentration was 0.5 g/dL. 
3.3.2.3 Particle size analysis 
The mean diameter and particle size distribution of the dried microspheres were 
measured using a laser light-scattering particle size analyzer (Coulter LS 230, a 
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microvolume module, Coulter Corporation, USA) after soaking the microspheres in an 
aqueous solution..   
3.3.2.4 Morphological analysis 
The surface and internal morphologies of the micropsheres were observed using a 
scanning electron microscope (SEM, Model JSM-5600, Tokyo, Japan). Microspheres and 
their sectioned samples were mounted on metal holders, and vacuum coated with a gold 
layer prior to SEM examination. 
3.3.2.5 Chemical composition of the microspheres surface 
The X-ray photoelectron spectroscope (XPS) was employed to investigate the chemical 
composition of the microspheres surface. The XPS measurements were performed using 
a VG ESCA LAB 220I-XL spectrometer with a magnesium anode source producing Mg 
Kα (1253.6 eV photons) X-ray with the pass energy of 20 eV for high-resolution narrow 
scans and 150 eV for low-resolution wide scans. The XPS data analysis was carried out 
using the software from VG ESCA LAB. To compensate for surface charges, all XPS 
binding energies were referred to the adventitious C 1s peak at the binding energy of 
285.0 eV. Atomic concentration was determined from the peak areas under each peak 
component and correcting using the manufacturer’s atomic sensitivity factors (ASF) with 
an estimated maximum error of ±5%. Spectral curve fitting was performed using the 
manufacturer-supplied software. 
3.3.2.6 Elemental analysis 
The composition of PLA, PNIPAAm, PNIPAAm-b-PLA and BSA was studied by 
elemental analysis using Perkin-Elmer Instruments Analyzer 2400. 
3.3.2.7 FT-IR spectrum 
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A Fourier transform infrared spectrophotometer (FT-IR, Perkin-Elmer Spectrum 2000) 
was employed to explore the interactions between BSA and polymer. The samples were 
pressed into potassium bromide pellets prior to FTIR analysis. 
3.3.2.8 Water uptake studies 
A fixed amount of micropsheres was incubated in PBS (pH 7.4) at 37°C or 22°C (room 
temperature). The weight of the micropsheres was measured at predetermined time 
intervals. Water uptake was calculated from the following formula:  
                      Water update (%) = [(Ww - Wd)×100]/ Wd,  
where Ww represents the weight of wet samples, Wd represents the weight of the dried 
samples. 
3.3.2.9  In vitro protein release 
In vitro BSA release analyses of microspheres were carried out in triplicate in PBS buffer 
(pH 7.4) at 37°C or 22°C. 40 mg of the dried microspheres were suspended in 1 mL PBS 
buffer. The medium for each sample was periodically removed, and replenished with 
fresh PBS buffer. The BSA content in the medium was analyzed using HPSEC as 
described in Section 3.3.2.1.  
3.3.2.10  In vitro weight loss 
170 mg of the dried microspheres were immersed in 5 mL PBS buffer at 37°C. The 
supernatant from each sample was removed, and replenished with fresh PBS periodically. 
At preset time intervals, samples were separated, and freeze-dried to constant weight. 
Mass loss was then examined gravimetrically.  
3.3.2.11 Nuclear magnetic resonance (NMR) 
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The 1H-NMR spectra of the degrading microspheres were studied using a Bruker Avance 
400 spectrometer (400 MHz), and chloroform-d (CDCl3) was used as the solvent. 
3.3.2.12 Molecular weight determination 
Molecular weights of the polymers and degrading microspheres were determined by a gel 
permeation chromatography (GPC) (Waters 2690, MA, USA) with a Differential 
Refractometer Detector (Waters 410, MA, USA). The mobile phase used was THF with a 
flow rate of 1 mL/min. Weight average molecular weights as well as polydispersity 
indices were calculated from a calibration curve using a series of polystyrene standards 
(Polymer Laboratories Inc., MA, USA, with molecular weight ranging from 1350 to 
151,700).  
3.3.2.13 Specific surface area and pore size analyses 
The specific surface area and pore size analyses were carried out using a Nova 3000 
analyzer (Quantachrome Instruments Corporate, FL, USA). Sorption measurements were 
performed using ultra-pure nitrogen gas as the adsorbate and liquid nitrogen as a coolant. 
Surface area was calculated by the Brunauer-Emmett-Teller (BET) method using 6 
adsorption points in the p/p0 range of 0.05- 0.3. Average pore diameter was determined 
by the Barrett, Joyner and Halenda (BJH) method using 6 desorption points in the p/p0 
range of 0.995-0.3 (Crotts and Sah et al., 1997). Data analysis was performed using Nova 
Enhanced Reduction Software Version 2.13.  
 
3.4 Micelles 
3.4.1 Micelles  preparation and evaluation of encapsulation efficiency as well as drug 
loading capacity 
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3.4.1.1 DOX-Loaded micelles 
Blank and DOX-loaded micelles were prepared by a membrane dialysis method. For 
blank micelles, the block copolymer (20 mg) was dissolved in 4 mL DMAc. The solution 
was then dialyzed against DI water at 20°C for 24 hours using a dialysis membrane with 
a molecular weight cut-off of 2,000 Da (Spectra/Por 7, Spectrum Laboratories Inc.). The 
water was replaced hourly for the first 3 hours. For DOX-loaded micelles, the block 
copolymer (20 mg) was dissolved in 2 mL of DMAc. DOX (10 mg) was neutralized with 
two moles excess triethylamine in 2 mL of DMAc. The DOX solution was added into the 
polymer solution and mixed by vortex for 5 minutes. The mixture was dialyzed against 
DI water at 20°C for 48 hours using a dialysis membrane with a molecular weight cut-off 
of 2,000 Da. After dialysis, the solution in the dialysis bag was collected and filtered with 
0.45 µm syringe filter and freeze-dried for two days. To determine DOX loading level, a 
known amount of DOX-loaded nanoparticles was dissolved in 1 mL of DMAc. The DOX 
concentration was estimated by using the UV¯VIS spectrophotometer at 485 nm. The 
drug loading was calculated based on the standard curve obtained from DOX in DMAc. 
The yield of micelles was calculated as the weight ratio of micelles recovered to initial 
polymer and drug.    
3.4.1.2 Paclitaxel-loaded micelles 
Paclitaxel-loaded micelles were prepared by dialysis method.  20 mg of polymer was 
dissolved in 4 ml of DMF, followed by addition of Paclitaxel. This solution was dialysis 
against de-ionized water for 24 h.  The water was replaced hourly at the first 3 hours.  
After dialysis, the solution in the dialysis bag was collected and filtered with 0.45 µm 
syringe filter and freeze-dried for two days.  2 mg of drug-loaded micelles was first 
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dissolved in 1 mL of Chloroform, and 3 mL of ether was added to precipitate the 
polymer.  The suspension was centrifuged at 10000rpm for 5 min.  The supernatant was 
removed and dried.  The sample was first dissolved in 2 mL mobile phase, which was 
composed of ammonium acetate aqueous solution (20 mM), methanol and acetonitrile 
(volume ratio 35: 20: 45).  Then paclitaxel content was analyzed using high performance 
liquid chromatography (HPLC).  The HPLC system consisted of a Waters 2690 
separation module and Waters 996 PDA detector (Waters corporation, USA).  A Waters 
SymmetyshieldTM C8 4.6×15.0 cm column fitted with C8 guard column was used.  The 
temperature of column and samples were set at 28°C and 20°C, respectively.  The 
detection wavelength was set at 229 nm.  A calibration curve was constructed to 
determine paclitaxel concentration in the range of 5 to 50 ppm and the r2 value was 0.999.  
Drug loading level and encapsulation efficiency were calculated as the following 
formula: Actual loading level (wt %) = mass of drug in micelles / mass of polymer and 
drug after dialysis × 100 %; Encapsulation efficiency (wt %) = mass of drug encapsulated 
/ mass of drug loaded × 100 % 
3.4.2 Characterization and analyses of the micelles 
3.4.2.1 Nuclear magnetic resonance (NMR) 
The 1H-NMR spectra of the core-shell structure of the micelles were studied using a 
Bruker Avance 400 spectrometer (400 MHz). Chloroform-d (CDCl3) and D2O, was used 
as the solvent, respectively. 
3.4.2.2 Fluorescence measurements 
The critical association concentration (CAC) of the block polymer in DI water and PBS 
was estimated by fluorescence spectroscopy using pyrene as a probe. Fluorescence 
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spectra were recorded by a LS50B luminescence spectrometer (Perkin Elmer, USA) at 
room temperature. Aliquots of pyrene solutions in acetone (6.16×10-5 M, 100 µL) were 
added to 15 mL volumetric flasks, and the acetone was allowed to evaporate. Then, 10 
mL of polymer solutions with different concentrations ranging from 0.01 ppm to 500 
ppm were added to the vials. The final pyrene concentration is 6.16×10-7 M. The 
solutions were equilibrated for 24 hours at 20 °C. The excitation spectra were recorded 
from 300 to 360 nm with an emission wavelength of 395 nm. Both excitation and 
emission bandwidths were set at 2.5 nm.  The intensity ratios of I336.5 to I334.5 were plotted 
as a function of logarithm of polymer concentration. The CAC value was taken from the 
intersection of the tangent to the curve at the inflection with the horizontal tangent 
through the points at low concentrations. 
3.4.2.3 Particle size and zeta potential analyses 
The particle size and zeta potential of the micelles in PBS were measured by Zetasizer 
3000 HAS (Brookhaven Instrument Ltd., US) equipped with a He-Ne laser beam at 658 
nm (scattering angle: 90°). Each sample was filtrated with 0.45 µm syringe filter prior to 
analysis. The concentration of micelles in PBS buffer is 1.5 mg/mL. Each measurement 
was repeated 5 times. An average value was obtained from the five measurements. The 
effect of proteins was studied by measuring the size of micelles in PBS buffer containing 
10 (v/v) % FBS at 37ºC. The size measurements were performed by multimodel analysis. 
3.4.2.4 Transmission electron microscopy (TEM) examinations 
The morphologies of the blank and DOX-loaded micelles were analyzed by TEM (Philips 
CM300, Holland). Several drops of the freshly prepared micelles solution containing 0.01 
(w/v) % phosphotungstic acid were placed on a copper grid coated with carbon film and 
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air-dried at room temperature. The TEM observations were carried out with an electron 
kinetic energy of 300 k eV. 
3.4.2.5 Atomic force microscopy (AFM) 
AFM (Nanoscope, USA) was performed by the tapping mode, micelles solution was put 
on the silicon wafer and dried at room temperature, and then the wafer was attached on a 
metallic sample stand using double-sided adhesive tapes and scanned by the AFM 
maintained in a constant temperature and vibration-free environment. 
3.4.2.6 Differential Scanning Calorimetry (DSC) 
The melting temperature of pacitaxel and the Tg of block copolymer as well as drug 
loaded micelles were measured with DSC (2920 Modulated, TA instruments, USA).  The 
measurements were carried out using standard at temperatures ranging from 20°C to 
300°C with a heating rate of 20°C/min. 
3.4.2.7 Wide angle X-ray diffractometer (WAXRD) measurement 
X-ray diffraction (XRD) patterns were recorded using Bruker GADDS diffractometer 
with area detector operating under voltage of 40kV and current of 40mA using CuKa 
radiation (l=1.5418 nm).  
3.4.2.8 Polymer degradation studies 
The polymer (100 mg) was immersed in 3 mL PBS buffer (pH 7.4) at 37°C. The 
supernatant from each sample was removed, and replenished with fresh PBS buffer 
periodically. At preset time intervals, the samples were separated, and freeze-dried to 
constant weight. Mass loss was then examined gravimetrically. The molecular weights of 
the degraded samples were determined by GPC as described in 3.3.2.12.  
3.4.2.9 In vitro drug release 
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(a) DOX-loaded polymeric micelles 
The DOX-loaded micelles solutions prepared were diluted to 1 mg/mL. The diluted 
solutions (5 mL) were transferred to dialysis membrane tubes with a molecular weight 
cut-off of 10,000 (Spectra/Por 7, Spectrum Laboratories Inc.). The tubes were then 
immersed in a beaker containing 30 mL PBS buffer, which was shaken with a speed of 
100 rev/min. The release of DOX from the micelles was measured at 37.0°C (below the 
LCST) and 39.5°C (above the LCST), respectively. At specific time intervals, 1 mL 
solution was withdrawn from the release medium and replaced with fresh PBS buffer. 
The DOX content in the samples was analyzed using the UV¯VIS spectrophotometer at 
485 nm. 
(b) Paclitaxel-loaded polymeric micelles  
The paclitaxel-loaded polymeric micelles solution was diluted to 1mg/mL.  The solutions 
were (5 mL) transferred in a dialysis membrane tube (Spectra/Por® 7, MWCO =10, 000), 
and then the membrane was immersed in a beaker containing 50 mL PBS. The release of 
paclitaxel from micelles was measured under mechanical shaking (100 rev/min) 
incubated at 37°C (below the LCST) and 39.5°C (above the LCST), respectively.   At 
specific time intervals, the entire medium was removed and replaced with fresh buffer.  
The extraction of paclitaxel was carried out by adding 5 mL of dichloromethane (DCM) 
into the collected medium. The mixture was then vigorously vortexed for 3 minutes and 
left for phase separation.  The extraction efficiency was determined to be 62%. The 
organic phase was drawn out carefully and left to evaporate overnight. The samples were 
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dissolved in 2 mL of mobile phase and analyzed with HPLC as described in Section 
3.4.1.2.    
3.4.3 Cellular distribution and cytotoxicity test 
3.4.3.1 Cellular distribution 
The cover glass was put in the 24-well plate before cells were seeded. Free DOX (10 
mg/L) and DOX-loaded polymer micelles (DOX concentration: 10 mg/L) in RPMI 1640 
medium were incubated with 4T1 cells for 4 h before examination.   The cells on the 
cover glass were thoroughly washed three times with PBS and visualized by CLSM 
(Olympus FV300, Japan).  DOX was excited at 532 nm with emission at 595 nm.  The 
laser power was 10%. All the observations were conducted using the same resolution. 
The image of MDA-MB-435S (human breast carcinoma cell line) cells followed the same 
protocol as 4T1 cells. It should be noted that the culture medium for MDA-MB-435S 
cells was DMEM medium. 
3.4.3.2 Cytotoxicity test 
The 4T1 mouse breast cancer cells (ATCC) were cultured in RPMI1640 supplemented 
with 10% FBS, 5% penicillin, 2 mM L-glutamine (Sigma) and incubated at 37°C, 5 % 
CO2. The cells were seeded onto 96-well plates at 10, 000 cells per well and incubated for 
one day. Free DOX, DOX-loaded polymer D micelles in RPMI1640 were filtered with 
0.22 µm syringe filters and diluted with the growth medium to give final DOX 
concentrations of 0.1, 1.0, 5.0, 10.0, 20.0, 30.0, 50.0mg/L. The blank polymer D micelles 
in RPMI1640 was filtered and diluted to 1, 10, 50.0 and 100.0, 300.0, 600.0 mg/L. The 
media in the wells were replaced with 100 µL of the pre-prepared samples. The plates 
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were then returned to the incubator and maintained in 5% CO2, at 37°C and 39.5°C, for 
48 hours.  
Fresh growth media and 10 µL aliquots of MTT solution were used to replace the mixture 
in each well after the designated period of exposure. The plates were then returned to the 
incubator and maintained in 5% CO2, at 37°C, for a further 3 hours. The growth medium 
and excess MTT in each well were then removed. DMSO (150 µL) was then added to 
each well to dissolve the internalised purple formazan crystals. An aliquot of 100 µL was 
taken from each well and transferred to a fresh 96-well plate. Each sample was tested in 
eight replicates per plate. Three plates were used for each period of exposure, making a 
total of 24 replicates per sample.  The plates were then assayed at 550 nm and 690 nm. 
The absorbance readings of the formazan crystals were taken to be that at 550 nm 
subtracted by that at 690 nm. The results were expressed as a percentage of the 
absorbance of the blank control.  
Similarly, cell cytotoxicity of free drugs, drug-loaded micelles against MDA-MB-435S 
followed the same protocol as that of 4T1 cells.  It should be noted that the culture 
medium for MDA-MB-435S cells was DMEM medium. 
3.4.4 Animal experiment 
Female balb/c (body weight 19-21 g) was subcutaneously implanted at mammal with an 
ATCC 4T1 mouse breast cancer epidermal carcinoma xenograft cell line, (107 cells per 
animal).  Tumors were allowed to grow for 2 weeks.  Tumor volume was calculated 
using the formula: (4/3)πa2b (Yoo and Park, 2004), where a and b are the length of minor 
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and major axis of tumor, respectively. It was found that the tumor volume ranged from 
612.5 mm3 to 864.3 mm3.  Free DOX and micelles containing equivalent amount of DOX 
were administrated through the tail vein of animals at an equivalent dose of DOX = 5 
mg/kg.  At 10min, 30 min, 2h and 4h, the animals were sacrificed and then liver, lung, 
heart, spleen, kidney, blood and tumor were removed and kept at freezer (-80°C) for 
future analysis.  The organs were weighted and homogenized.  DOX distributed in 
different organs was extracted using chloroform and isopropanol and analyzed as 
described in literature (Yoo and Park, 2004).   Briefly, homogenized tissue was added 
into an acidic hydrolysis buffer containing 2.0 M HCl solution at 80°C for 10 min.   
Supernatant was collected and then, 0.9 ml of chlorform: isopropanol (3:1, v/v) was 
added.   After vigorous vortex-mixing, an organic layer was collected by centrifugation at 
16000 rpm for 15 min at room temperature.  The solution was dried and redissolved in 
mobile phase and analyzed by HPLC.  The HPLC system consisted of a Waters 2690 
separation module and Waters 2475 multi λ Fluorescence detector. The mobile phase was 
composed of 0.01% trifluoroacetic acid aqueous solution and acetonitrile; increasing the 
percentage of aceonitrile from 5% to 45% in 40 min.  DOX peak was detected at an 












































The rapid development of protein and peptide based drugs in the recent years has spurred 
a great demand for suitable delivery carriers, which are able to protect the proteins from 
hostile environment and to manipulate the protein release utilizing environmental stimuli 
such as temperature changes.  Poly(N-isopropylacrylamide) (PNIPAAm) shows a well 
defined LCST at about 32oC.  PNIPAAm in an aqueous solution has reversible solubility 
and exhibits a remarkable hydration-dehydration change in response to temperature. 
Below the LCST, PNIPAAm is well soluble in water. However, as the temperature is 
increased above the LCST, it becomes hydrophobic and precipitates out from the aqueous 
solution. The LCST can be adjusted by introducing a hydrophobic or hydrophilic 
segment to PNIPAAm (Chen and Hoffman, 1995; Yoshida et al., 1994). Many 
researchers have examined the potential of PNIPAAm-based hydrogels for encapsulating 
and delivering proteins (Yeh et al., 1995; Bittner et al., 1999; Pistel et al., 2001). 
 
Recently, there has been an increasing research interest on the development of protein 
delivery systems using poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) 
microspheres because of their superior biodegradability and biocompatibility as well as 
easy administration (Cohen et al., 1991; Lam et al., 2000; Kostanski et al., 2000; Cleand 
et al., 2001; Shive and Anderson, 1997). However, the release pattern of protein-loaded 
PLGA microspheres was characterized as an initial burst followed by a non-release. To 
circumvent this problem, several approaches have been explored in order to accelerate 
protein diffusion and polymer erosion by blending or copolymerization with 
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poly(ethylene glycol) (PEG) or poly(vinyl alcohol) (Yeh et al., 1995; Bittner et al., 1997; 
Pistel et al., 2001).    
 
The aim of my study in protein delivery was to explore the possibility of using 
PNIPAAm-b-PLA microspheres. Specifically, PNIPAAm-b-PLA with different 
PNIPAAm contents were synthesized, and utilized to fabricate microspheres containing 
bovine serum albumin (BSA) by a water-in-oil-in-water (w/o/w) double emulsion solvent 
evaporation method. The surface and internal morphologies, in vitro degradation and 
BSA release of the microspheres were investigated. The effect of emulsifier 
concentration in the internal aqueous phase on microspheres erosion and protein release 
was studied. In addition, erosion and protein release of PLA microspheres were also 
studied as a comparison. 
 
4.2 Results and discussion 
4.2.1 Synthesis of PNIPAAm-b-PLA 
Hydroxy-terminated PNIPAAm precursor polymer was prepared by the radical 
copolymerization, where hydroxy group was introduced to the end of the copolymer by 
telomerization using hydroxyethanethiol (chain transfer agent, CTA). PNIPAAm-b-PLA 
block copolymers were synthesized by ring opening esterification polymerization of D,L-
lactide with the hydroxy-terminated precursor in toluene. Two PNIPAAm-b-PLA block 
copolymers with various lengths of PLA were obtained. The yield of the block 
copolymers was 52% and 60%, respectively.   The 1H-NMR spectra of block copolymer 
(the same as that of blank microspheres illustrated in Figure 4.7 B) showed that the peak 
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at δ 4.1 (signal b) was contributed to the protons of -NHCHMe2 moieties. The broad peak 
at δ 5.1-5.3 (signal a) was from –CHMeO- groups in the lactide moieties. The molar ratio 
of the monomers was obtained from the integration values of Signals a and b. The 
increase in molecular weight after polymerization (Table 4.1) and the single peak 
appeared in the gel permeation chromatograms of the polymers proved that block 
copolymers were successfully synthesized.   The properties of the block copolymers were 
summarized in Table 4.1.   
Table 4.1 Properties of PNIPAAm-b-PLA diblock copolymers synthesized 
Polymers [NIPAAm]/[CTA]/[LA] a Mw Mn Mw/Mn 
1 1:0.01:4 12.9k 7.2k 1.8 
2 1:0.01:5 16.7k 12.1k 1.4 
a. Molar ratio of the monomers and the chain transfer agent (2-hydroethanethiol) 
b. Lower critical solution temperature (LCST): Optical transmittance of aqueous precusor polymer 
solutions (5 mg/mL) at various temperatures was measured at 500 nm.  
c. Mw and Mn of the precursor hydroxyl-terminated poly(N-isopropylacrylamide) polymers was 4.1k and 
3.2k, respectively; LCST of this precusor polymer is 35°C. 
 
 
4.2.2 Fabrication and characterization of BSA-loaded PNIPAAm-b-PLA       
micropsheres 
4.2.2.1 Particle size analysis 
As listed in Table 4.2, the mean diameter of microspheres fabricated under various 
conditions was quite similar, ranging from 29 to 35 µm. The size of microspheres very 
much depends on the viscosity of polymer solution and the concentration of emulsifier in 
the external aqueous phase (Yang and Chung et al., 2001; Yang and Wan et al., 2001). 
For all the formulations studied in this paper, the same concentration of PVA in the 
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external aqueous phase was utilized. In addition, the polymer solutions employed had a 
similar viscosity (Table 4.2). Therefore, the microspheres produced were of similar size.  
 
Table 4.2 Mean size of microspheres fabricated under various conditions and inherent 
viscosity of polymer-DCM solutions 
 
Mean diameter (µm) after 
vacuum dry 








0.26 29 6 
PNIPAAm-b-PLA (1:5, 
0.05%) 
0.35 30 3 
PNIPAAm-b-PLA  (1:5, 
0.2%) 
0.35 34 7 
PLA (0.2%)             0.30 29 4 
 
4.2.2.2 Surface and internal morphologies 
Figure 4.1 shows the surface and internal morphologies of PLA and PNIPAAm-b-PLA 
microspheres fabricated under different conditions. PNIPAAm-b-PLA (1:4) and 
PNIPAAm-b-PLA (1:5) with a higher PVA concentration (0.2%) in the internal aqueous 
phase were porous. In contrast, PNIPAAm-b-PLA (1:5) at a lower PVA concentration 
(0.05%) yielded dense microspheres with a few big pores that were not inter-connected. 
At the lower concentration of PVA, the first emulsion was not stable, and the internal 
water droplets tended to coalesce, forming big pores within the microspheres after water 
was removed by vacuum drying (Chia and Yang et al., 2001). However, the first 
emulsion was more stable at the higher PVA concentration. Therefore, the pores were 
uniformly distributed. Similarly, hydrophobic PLA produced an unstable first emulsion 
as well, leading to a multi-vesicular internal structure with a dense skin layer (Figure 
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4.1). The average pore size and specific surface area of PLA and PNIPAAm-b-PLA (1:5, 
0.2%) microspheres were listed in Table 4.3. It should be mentioned that measured pore 
size only ranges from 3.5 to 2000 Å. Thus, pores bigger than 0.2 µm were not detected. 
The average pore size of PLA microspheres was 593 Å, which was much greater than 
that of PNIPAAm-b-PLA (1:5, 0.2%) (224 Å). However, the specific surface area of 
PNIPAAm-b-PLA (1:5, 0.2%) was larger. These findings well agree with morphological 
observations of the microspheres. 
                                                                      
PNIPAAm-b-PLA (1:4, 0.2%) 
                                        
PNIPAAm-b-PLA (1:5, 0.05%) 
                                            
   PNIPAAm-b-PLA  (1:5, 0.2%) 
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PLA (0.2%) 
Figure 4.1 External and internal morphologies of microspheres fabricated by the double 
emulsion solvent evaporation method. 
 
 
Table 4.3 Average pore size and specific surface area of the microspheres 
Microspheres PNIPAAm-b-PLA (1:5, 0.2%) PLA (0.2%) 










It was reported by Quellec and Peracchia et al. (Quellec et al., 1998; Peracchia et al., 
1997) that PLA-PEG diblock copolymer yielded PEG chains in a “brush-like” 
arrangement on the surface and on the inner surface of aqueous domains of nanospheres 
due to the fact that PEG chains oriented to the external aqueous phase during the 
formation process, which drastically reduced protein adsorption on PEG-PLA 
nanospheres compared to PLA nanospheres. The atomic composition of the microspheres 
surface was analyzed using XPS. The real atomic composition of polymers was 
determined by elemental analysis. The N content of the surface of PNIPAAm-b-PLA (1:5, 
0.2%) microspheres without BSA (5.92%) was similar to that of PNIPAAm-b-PLA (1:5, 
0.2%) microspheres containing BSA (6.34%) (Table 4.4). This indicates that BSA was 
well entrapped within the microspheres. However, The N content of the surface of 
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PNIPAAm-b-PLA (1:5, 0.2%) microspheres without BSA was higher than that of 
PNIPAAm-b-PLA (1:5) polymer (3.91%), resulting from a higher concentration of the 
PNIPAAm block on the surface. Figure 4.2 shows the XPS high-resolution scans of the 
surface of PNIPAAm-b-PLA (1:5, 0.2%) microspheres, which can be curve-fitted with 3 
peaks, with binding energy at 285.0 eV for C-H or C-C, 286.2 eV for O=C-C-H or C-N, 
as well as 288.6 eV for C=O. As listed in Table 4.5, the C=O content of the surface of 
PNIPAAm-b-PLA micropsheres (12.6%) was close to that of PNIPAAm polymer 
(10.0%). On the other hand, from Figure 4.1, much more pores were observed on the 
surface of PNIPAAm-b-PLA (1:5, 0.2%) microspheres compared to PLA microspheres. 
This might be contributed to the hydrophilic PNIPAAm blocks concentrated on the 
surface of the micropsheres. These findings suggest that the surface of PNIPAAm-b-PLA 
microspheres was rich in the hydrophilic PNIPAAm blocks. Since PNIPAAm is water 
soluble during fabrication process, it tended to migrate towards the external aqueous 
phase and inner aqueous phase during the fabrication process.    
Table 4.4 Atomic composition of microsphere surface and polymers 
Sample C (%) N (%) O (%) H (%) 
PNIPAAm-b-PLA (1:5, 0.2%) 
microspheresa 
(without BSA) 
68.11 5.92 25.97  
PNIPAAm-b-PLA (1:5, 0.2%) 
microspheresa 
(with BSA) 
60.34 6.34 24.32  
PNIPAAm-b-PLA (1:5) polymerb 53.92 3.91  7.23 
PLA polymerb 47.17  47.12c 5.31 
PNIPAAm polymerb 61.31 11.66 --d 10.47 
BSAb 45.97 14.28 -- 7.02 
a. Measured by XPS 
b. Measured by elemental analysis 
c. Calculated  
d. Not determined 
 




















Figure 4.2 XPS C 1s high resolution scans of the PNIPAAm-b-PLA (1:5, 0.2%) 
micropsheres surface. 




Table 4.5   Content of C=O in all the carbon bonds on the surface of samples 
 





3.97: 2.94: 1 12.6 
PLA microspheres 
 
1.16: 1.06: 1 31.0 
PNIPAAm polymer 
 
7: 2: 1 10.0 
 
4.2.2.3 Entrapment of BSA 
As listed in Table 4.6, the entrapment efficiency of BSA was higher than 90% except for 
PNIPAAm-b-PLA microspheres fabricated with a PVA concentration of 0.05% in the 
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internal aqueous phase. This was probably due to the fact that the unstable first emulsion 
led to more BSA lost into the external aqueous phase during the fabrication process. The 
CLSM images indicated that PNIPAAm-b-PLA (1:5, 0.2%) (Figure 4.3 b, c, d) yielded 
uniform BSA distribution as well as high BSA encapsulation efficiency.  In contrast, 
PNIPAAm-b-PLA (1:5, 0.05%) showed aggregated BSA distribution (Figure 4.3 a).  The 
CLSM results are agreeable with SEM pictures.  Figure 4.4 shows FT-IR spectra of 
PNIPAAm-b-PLA (1:5) copolymer, BSA and BSA-loaded micropsheres respectively. 
The spectrum of PNIPAAm-b-PLA copolymer shows an ester carbonyl band in the 
lactide unit at 1756.7 cm-1 (a) and an amide carbonyl band in both polymer and BSA at 
1649.8 cm-1 (b). From the spectrum of BSA-loaded PNIPAAm-b-PLA microspheres, it 
can be observed that there were no significant shifts in these two bands. It is suggested 
that there were no strong chemical interactions between BSA and the polymer, and the 
physicochemical integrity of BSA was retained within the micropsheres.   
Table 4.6   Encapsulation efficiencies of BSA (Initial loading: 10% in weight) 
 
PNIPAAm-b-PLA (1:5, 0.2%) PNIPAAm-b-PLA (1:5, 0.05%)         PLA (0.2%) 




                                                                                   Chapter 4   Results and Discussion 1  
 87
                       
 
                        
 
Figure 4.3 Confocal images of the FITC-BSA loaded microspheres (a) PNIPAAm-b-
PLA  (1:5, 0.05%), 20 times; (b) PNIPAAm-b-PLA  (1:5, 0.2%), 20 times; (c) 
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Figure 4.4    FT-IR spectra of BSA (A), PNIPAAm-b-PLA (1:5) copolymer (B), and 
BSA-loaded micropsheres (C). 
 
4.2.3 Microspheres erosion and polymer degradation 
4.2.3.1 Morphologies of the degrading micropsheres 
The SEM pictures of the degrading PLA microspheres over 3 months in vitro are 
illustrated in Figure 4.5. After one month in vitro, the particles still remained spherical. 
However, after two months, it showed an evidently shrunken shape due to extensive bulk 
erosion. After three months, the particles degraded into pieces.  Figure 4.6 shows the 
morphologies of the degrading PNIPAAm-b-PLA (1:5, 0.2%) microspheres. With the 
progression of polymer degradation, the micropsheres were broken and lost their 
spherical shape, indicating a decrease in the mechanical strength. In particular, they were 
broken into pieces after three months in vitro. However, PNIPAAm-b-PLA (1:5, 0.05%) 
microspheres kept their spherical shape even after two months in vitro but lost their 
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spherical shape after three months (pictures not shown). These observations indicate that 
both PLA and PNIPAAm-b-PLA (1:5) microspheres experienced bulk erosion. 
 
 
     
                           1 month                                    2 months                                   3 months 
Figure 4.5  SEM scans of the degrading PLA microspheres. 
 
 
                         
                            1 month                                                              2 months 
                                                                
                                 3 months                                                             4 months 
Figure 4.6 SEM scans of the degrading PNIPAAm-b-PLA (1:5, 0.2%) microspheres.    
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4.2.3.2 NMR analysis 
The NMR experiments were performed to study the degradation mechanism of 
PNIPAAm-b-PLA microspheres. The 1H-NMR spectra of PLA, PNIPAAm-b-PLA and 
the degrading microspheres are illustrated in Figure 4.7. The proton signal at δ 5.2 ppm 
(a, -OCHMeCOO-) was from PLA. However, the proton signal at δ 4.0 ppm (b, -CHMe2) 
was from PNIPAAm. The molar ratio of PLA to PNIPAAm in the degrading micropheres 
was obtained from the integration values of Signals a and b. The mole ratio of PLA to 
PNIPAAm was decreased from 5:1 to 3.5:1 and 0.45:1 after 1 and 4 months in vitro, 
respectively. In particular, Signal a from the PLA block disappeared after 5 months in 
vitro. However, the characteristic peak of PNIPAAm block existed over the entire period 
of in vitro test. This finding proves that PNIPAAm-b-PLA was degradable, and the 
cleavage occurred in the PLA block.    
 
4.2.3.3 FT-IR study 
Figure 4.8 shows the FTIR spectra of the degrading PNIPAAm-b-PLA (1:5, 0.2%) 
micropsheres. The IR spectrum of PNIPAAm-b-PLA (1:5, 0.2%) micropsheres exhibited 
two strong absorptions at 1757.8 cm-1 (νO-C=O, a) and 1089.4 cm-1(νC-O, b) from the PLA 
block. Another two strong absorptions at 1654.6 cm-1 (νHN-C=O, c) and 1550.8 cm-1 (νC-N, 
d) came from the PNIPAAm block. These peaks were evident and strong within the first 
4 weeks.  However, the intensity of peaks at 1757.8 cm-1 (νO-C=O) and 1089.4 cm-1(νC-O ) 
from the PLA block became weaker and weaker with the progression of polymer 
degradation and disappeared after 5 months. However, the peaks from PNIPAAm existed 
through the entire period of in vitro test. The FTIR study supported the results from NMR. 
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The disappearance of ester carbonyl group found in the lactide unit suggests the complete 




Figure 4.7 1H-NMR spectra of PLA and degrading PNIPAAm-b-PLA (1:5, 0.2%) 
microspheres. (A) PLA microspheres before degradation; (B) PNIPAAm-b-PLA (1:5, 
0.2%) microspheres before degradation; (C) PNIPAAm-b-PLA (1:5, 0.2%) microspheres 
after one month in vitro; (D) PNIPAAm-b-PLA (1:5, 0.2%) microspheres after four 
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Figure 4.8 FT-IR spectra of PLA, PNIPAAm and degrading PNIPAAm-b-PLA (1:5, 
0.2%) microspheres. A: PLA; B: hydroxyl-terminated PNIPAAm; C: PNIPAAm-b-PLA 
(1:5, 0.2%) microspheres before degradation; D: PNIPAAm-b-PLA (1:5, 0.2%) 
microspheres after one month in vitro; E: PNIPAAm-b-PLA (1:5, 0.2%) microspheres 
after five months in vitro.  
 
4.2.3.4 Molecular weight and mass loss study 
Based on the NMR, FT-IR and GPC studies, the copolymer degradation occurred in the 
PLA block. Belbella et al. (1996) reported that PLA degradation in aqueous media 
followed two main mechanisms: surface erosion and bulk erosion. In the surface erosion 
process, the total mass of PLA decreased but its molecular weight remained constant. 
However, in the bulk erosion process, the chain cleavage was random, and both mass and 
molecular weight decreased as a function of time. From Figures 4.9 and 4.10, it is 
observed that both molecular weigh and mass of PLA, PNIPAAm-b-PLA (1:5, 0.2%) and 
PNIPAAm-b-PLA (1:5, 0.05%) microspheres decreased as a function of incubation time, 
indicating they experienced the bulk erosion mechanism. Interestingly, the molecular 
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weight of all the formulations did not change very much during the first month. However, 
as degradation proceeded, the matrices experienced faster molecular weight loss probably 
because of self-catalysis by the degradation products of PLA. The degradation of 
PNIPAAm-b-PLA (1:5, 0.2%) microspheres was faster than that of PNIPAAm-b-PLA 
(1:5, 0.05%) microspheres. For instance, after four months in vitro, the mass loss of 
PNIPAAm-b-PLA (1:5, 0.2%) and PNIPAAm-b-PLA (1:5, 0.05%) microspheres was 86 
and 54%, respectively. This is due to the more porous structure of PNIPAAm-b-PLA (1:5, 
0.2%) microspheres. Compared to PNIPAAm-b-PLA (1:5, 0.2%) microspheres, the mass 
loss of PLA microspheres was slower during the first month because of the existence of 
the thick wall (Figure 4.10). However, after one month, the mass loss of PLA increased 
significantly. Initially, degradation products of PLA were difficult to diffuse out of the 
PLA microspheres because of the diffusion barrier presented by the thick wall. Thus, the 
acidic degradation products were accumulated, and thus catalysed the hydrolysis of the 
matrix. These results suggest that the internal structure of micropsheres had a significant 
impact on erosion rate. The more porous the microspheres, the faster they eroded.   
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PNIPAAm-b-PLA (1:5, 0.2%) 
PLA, 0.2% 
 
Figure 4.9 Weight molecular weight changes of the degrading micropsheres as a function 
of incubation time. 


















Figure 4.10 Weight loss of the degrading micropsheres as a function of incubation time. 
 
4.2.4 Water uptake and swelling 
Figure 4.11 shows the water uptake of microspheres after immersed for two days in PBS 
(pH 7.4) at 22 or 37oC. Water uptake is affected by matrix porosity and polymer 
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chemistry. Compared to PLA and PNIPAAm-b-PLA (1:5, 0.05%) micropsheres, 
PNIPAAm-b-PLA (1:5, 0.2%) microspheres yielded much higher water uptake because 
of their more porous structure. However, the difference in water uptake between PLA and 
PNIPAAm-b-PLA (1:5, 0.05%) micropsheres was not significant. From Figure 4.11, it 
can also be seen that the water uptake of both PNIPAA-b-PLA formulations was higher 
at 22ºC (below the LCST) than at 37ºC (above the LCST). This is because PNIPAAm is 
water-soluble and exists in an extended chain form at temperatures below its LCST. This 
allows the microspheres matrix to bind more water molecules, resulting in greater water 
uptake.  
 
Significant swelling was observed for PNIPAAm-b-PLA (1:5, 0.2%) microspheres 
incubated at 22oC (Table 4.7). The mean diameter of the microspheres increased from 34 
to 45 µm after two days incubation. It decreased to 37 µm on the seventh day due to 
polymer degradation. However, the other formulations did not swell. In addition, the 
swelling of PNIPAAm-b-PLA (1:5, 0.2%) microspheres was not obvious at 37oC because 
of its hydrophobicity at temperatures above the LCST. These phenomena are consistent 
with water uptake data. 
























A            B              C              D               E
 
 Figure 4.11 Water uptake of the microspheres after 2 days incubation in PBS (pH 7.4) at 
22ºC and 37 ºC.  A: PNIPAAm-b-PLA (1:5, 0.2%), 37°C; B: PNIPAAm-b-PLA (1:5, 
0.2%), 22°C; C: PNIPAAm-b-PLA (1:5, 0.05%), 37°C; D: PNIPAAm-b-PLA (1:5, 
0.05%), 22°C; E: PLA (0.2%), 37°C.  
 
 
Table 4.7 Mean diameters (µm) of the degrading microspheres 
Day 2 Day 7 Before 
release 
37oC         22oC    37oC         22oC    
Microspheres 
Da S.D.b D S.D. D S.D. D S.D. D S.D. 
PNIPAAm-b- 
PLA (1:5, 0.2%) 
34 7 34 5 45 8 38 7 37 5 
PNIPAAm-b-PLA 
(1:5, 0.05%) 
30 3 28 6 32 5 28 5 31 9 
PLA (0.2%) 29 4 30 3 - 31    6 - 
a. Mean diameter 
b.    Standard deviation 
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4.2.5 In vitro release kinetics of BSA 
As shown in Figure 4.12, BSA release from PLA microspheres was characterized with an 
initial burst followed by a non-release phase. This finding is consistent with the results 
reported previously (Crotts and Park, 1997; Puri and Jones et al., 2000). The initial 
release of BSA from PLA microspheres was due to the release of BSA molecules loaded 
near the surfaces of the microspheres. As described earlier, PLA microspheres were 
wrapped with a dense skin layer, which prevented water penetration and BSA diffusion, 
and thus led to slow initial release. The non-release phase of proteins was often found in 
PLA and PLGA microspheres. This was caused by protein aggregation or non-specific 
adsorption (Boury et al., 1997). The acidic microclimate resulting from the degradation 
products of PLA within the microspheres led to the instability and aggregation of BSA. 
The residual BSA remaining in micropsheres after release had become water-insoluble 
non-covalent aggregates in the residue (Jiang and Schwendeman, 2001).  The adsorption 
of proteins onto hydrophobic polymer surface might also cause the instability and 
aggregation of BSA. XPS analysis shows that the N content of BSA-loaded PLA 
microspheres increased from 0% to 2.2% and 2.8% after one and two months in vitro 
respectively, indicating the aggregation or adsorption of proteins. The total amount of 
BSA released over one month in vitro was only about 20%.    
 
Like PLA, the PNIPAAm-b-PLA (1:5, 0.05%) microspheres shared a similar release 
pattern (Figure 4.12). The presence of dense wall and disconnected porous structure 
limited water penetration and BSA diffusion prior to a significant degradation of the 
polymer. Consequently, BSA release was mainly controlled by erosion of the matrix. 
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However, it can be seen from Figure 4.12 that only 17% mass loss was detected during 
the first one month in vitro. The initial release of BSA was slightly higher at 22°C than at 
37°C. This is because of the more hydrophilic nature of the PNIPAAm block at 22°C 
(below the LCST). For PNIPAAm-b-PLA (1:5, 0.05%) microspheres, the non-release 
phase of BSA might be caused by slow polymer degradation, protein aggregation or non-
specific adsorption.    
 
In contrast, BSA release from PNIPAAm-b-PLA (1:5, 0.2%) microspheres was more 
sustained, which lasted more than three weeks (Figure 4.12). More BSA molecules were 
released out from the microspheres. As reported in the previous paragraphs, the 
PNIPAAm-b-PLA (1:5, 0.2%) microspheres had an inter-connected porous structure and 
greater surface area, which would allow the degradation products of polymer to easily 
diffuse into the in vitro release medium, providing a mild environment for BSA release. 
In addition, the diffusion of BSA molecules was easier through the more porous matrix. 
On the other hand, the PNIPAAm block was the dominant component of the surface of 
PNIPAAm-b-PLA microspheres, which prevented non-specific adsorption of BSA 
molecules, leading to more BSA release. From Figure 4.12, it can also be seen that BSA 
release was faster at 22oC than at 37oC at the initial stage of in vitro test. However, after 
about 10 days, BSA release rate became higher at 37oC. Since the microspheres were 
more hydrophilic at 22oC and underwent significant swelling, water molecules were 
easier to penetrate into the matrix, leading to faster BSA release. After a certain period of 
time when the whole matrix was wetted, the diffusion of BSA molecules was the 
dominant factor. Faster BSA diffusion at 37oC yielded higher BSA release rate. BSA 
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release from PNIPAAm-b-PLA (1:5, 0.2%) microspheres was mainly based on diffusion, 
swelling as well as polymer degradation. 
 
BSA release from PNIPAAm-b-PLA (1:4, 0.2%) microspheres was characterized with a 
very high initial burst followed by a slow release over about two weeks (Figure 4.13). 
This is because of their highly porous structure. It was also observed that the initial burst 
of BSA was higher at 22ºC than at 37ºC. In addition, compared to PNIPAAm-b-PLA (1:5, 
0.2%) microspheres, PNIPAAm-b-PLA (1:4, 0.2%) microspheres provided much faster 
initial release because of their more porous structure and greater portion of hydrophilic 

















      
Figure 4.12 Release profiles of BSA from PLA, PNIPAAm-b-PLA (1:5, 0.2%) and 
PNIPAAm-b-PLA (1:5, 0.05%) microspheres incubated at different temperatures. (A): 
PNIPAAm-b-PLA (1:5, 0.2%), 37°C; (B) PNIPAAm-b-PLA (1:5, 0.2%), 22°C;(C): 
































Figure 4.13 Release profiles of BSA from PNIPAAm-b-PLA (1:4, 0.2%) microspheres 
incubated at different temperatures. (A): PNIPAAm-b-PLA (1:4, 0.2%), 37°C; (B) 
PNIPAAm-b-PLA (1:4, 0.2%), 22°C. 
 
4.3 Conclusions 
Temperature-sensitive microspheres were synthesized using PNIPAAm-b-PLA diblock 
copolymers. PNIPAAm was a dominant component of the microspheres surface. The 
microspheres were erodible in the in vitro medium, and polymer degradation occurred in 
the PLA block. The erosion of microspheres was dependent upon their morphology. The 
more porous the microspheres, the faster erosion they experienced. Under the optimized 
fabrication conditions, more than 90% encapsulation efficiency of BSA was achieved. 
BSA release from the microspheres was sensitive to the external temperature. BSA 
release was faster at the temperature below the LCST. The microspheres fabricated with 
PNIPAAm-b-PLA having 1:5 molar ratio of PNIPAAm to PLA and a PVA concentration 
of 0.2% (w/v) in the internal aqueous phase were able to provide a sustained release of 
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5.1 Introduction 
As discussed in Chapter 2 and Chapter 4, thermo-responsive microspheres may be a good 
carrier for protein delivery. For anticancer drug delivery, polymeric micelles are a 
promising approach (Torchilin, 2001). Polymeric micelles structured from amphiphilic 
copolymers are regarded as one of the most promising carriers for drug delivery (Kwon 
and Kataoka, 1995). Polymeric micelles have a small size (<200 nm) and can solubilize 
hydrophobic drugs in their inner cores, while exposing their hydrophilic shells to the 
external environment. This enables them to exhibit prolonged activity in the systemic 
circulation by avoiding the scavenging of the reticuloendothelial systems (RES). 
Poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) are often used as 
hydrophobic core-forming segments for fabrication of micelles because of their superior 
biocompatibility and biodegradability (Yasugi et al., 1998; Jeong and Park, 2001).  On 
the other hand, by changing the composition of PLGA, the hydrophobicity of core-
forming segment can be easily modulated to design micelles with desirable properties. 
Poly(N-isopropylacrylamide) (PNIPAAm) is a well-known thermosensitive polymer and 
exhibits a lower critical solution temperature (LCST) of about 32ºC. It has been utilized 
as a hydrophilic shell-forming segment together with various kinds of hydrophobic 
moieties to make thermosensitive micelles (Chung et al., 1997; Chung et al., 2000; Chaw 
et al., 2004). With micelles having PNIPAAm or its copolymer as the shell, both passive 
and active targeting to tumors can be achieved through an enhanced permeability and 
retention effect (EPR effect) (Kohori et al., 1999) and external temperature changes. It is 
expected that selective anticancer drug release from the micelles accumulated in tumors 
through the EPR effect may be triggered by local heating at a temperature slightly higher 
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than the LCST. However, Most of the hydrophobic moieties reported in the literature 
such as polystyrene, poly(butyl methacrylate) and alkyl are not degradable (Chung et al., 
1997; Chung et al., 2000).  In this study, we synthesized temperature-sensitive block 
copolymers, P(NIPAAm-co-DMAAm)-b-PLGA with different compositions and lengths 
of PLGA to modulate the hydrophobicity of the core-forming block. The micelles self-
assembled from the polymers would be more readily degraded compared to the micelles 
fabricated from P(NIPAAm-co-DMAAm)-b-PLA (Burersroda et al., 2002). The 
important parameters of micelles, such as LCST, critical association concentration (CAC), 
particle size, zeta potential and morphology in the phosphate buffered-saline (PBS, pH7.4) 
or PBS buffer containing serum, were investigated. DOX (amphiphilic) and paclitaxel 
(hydrophobic), as model anticancer drugs, were encapsulated into the micelles by a 
membrane dialysis method and presented in 5.2 and 5.3, respectively. The dialysis 
parameters were optimized to achieve higher encapsulation efficiency (EE) and drug 
loading level. The micelles were characterized by DLS, TEM, AFM, NMR, DSC, 
WAXRD. The effect of the composition and length of PLGA on drug loading and in vitro 
drug release were examined. Cellular uptake and cytotoxicity of the polymers, free drugs, 
and drug-loaded micelles were also studied and compared. 
 
5.2 DOX-loaded polymer micelles 
5.2.1 Synthesis of P(NIPAAm-co-DMAAm)-b-PLGA 
Hydroxy-terminated P(NIPAAm-co-DMAAm) precursor polymer was prepared by the 
radical copolymerization, where hydroxy group was introduced to the end of the 
copolymer by telomerization using hydroxyethanethiol (chain transfer agent, CTA). As 
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listed in Table 5.1, the weight average molecular weight (Mw) and polydispersity index of 
polymer decreased when the content of CTA increased from 0.75 to 1.5% of the 
monomers (NIPAAm and DMAAm). In addition, the LCST of polymer increased with 
increasing CTA content. This is because the portion of hydroxy groups in each polymer 
chain increased as the molecular weight of the polymer decreased. An ideal LCST would 
be slightly higher than the normal human body temperature so that a small temperature 
increase by local heating could induce the deformation of the micelles to trigger the 
release of enclosed drug molecules. Therefore, hydroxy-terminated P(NIPAAm-co-
DMAAm) polymer synthesized with a CTA content of 1.0% was chosen as the precursor 
for the block copolymer in the following studies. P(NIPAAm-co-DMAAm)-b-PLGA 
block copolymers were synthesized by ring opening esterification polymerization of D,L-
lactide and glycolide with the hydroxy-terminated precursor in toluene. Five P(NIPAAm-
co-DMAAm)-b-PLGA block copolymers with various compositions and lengths of 
PLGA were obtained. The yield ranged from 65 to 76%.  The 1H NMR spectra of all the 
five polymers shared a similar pattern. Figure 5.1 shows a typical 1H-NMR spectrum of 
Polymer E. The peak at δ 4.1 (Signal a) was contributed to the protons of -NHCHMe2 
moieties. The broad peak at δ 2.9-3.1 (Signal b) was from -NMe2 groups in the DMAAm 
moieties. The broad peak at δ 5.1-5.3 (Signal c) was from –CHMeO- groups in the lactide 
moieties. Signal d at δ 4.6-4.9 was from -CH2O- groups in the glycolide moieties. The 
molar ratio of the monomers was obtained from the integration values of Signals a, b, c 
and d. The increase in molecular weight after polymerization and the single peak 
appeared in the gel permeation chromatograms of the polymers further proved that block 
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copolymers were successfully synthesized. The properties of the block copolymers were 
summarized in Table 5.2.   
Table 5.1   Properties of the precursor copolymers. 
Samples a CTA/Monomer 





b Polydispersity LCST in  













1.5 6.8 6.0 1.1 47.6 
a CTA: chain transfer agent 
b Polydispersity: Mw/Mn 
The feed molar ratio of NIPAAm to DMAAm was 4:1, the final molar ratio estimated by 
NMR was 3:1.    
 
Table 5.2   Properties of the block copolymers. 
Polymer 
samples 















A 0.25 1:0 13.0 8.9 1.5 39.1 
B 0.28 10:1 13.3 9.6 1.4 39.1 
C 0.30 85:15 13.9 9.5 1.5 39.0 
D 0.60 85:15 16.1 11.2 1.4 39.0 
E 0.72 70:30 17.9 12.0 1.5 38.9 
a,b Estimated from 1H-NMR spectra 
 
 






















Figure 5.1 A typical 1H-NMR spectrum of Polymer E in CDCl3. 
 
5.2.2 Critical association concentration (CAC) determination 
The amphiphilic polymers consisting of hydrophilic segment and hydrophobic segment 
can self-associate to form micellar structure in aqueous solutions. The formation of 
micelles with P(NIPAAm-co-DMAAm)-b-PLGA was examined by the detection of CAC 
using a fluorescence technique, where pyrene was chosen as a fluorescent probe. The 
gradual shift of the third peak in the excitation spectra of pyrene from 334.5 nm to 336.5 
nm was observed (Figure 5.2), indicating the change in vibration structure of pyrene 
emission (Kim and Lee, 2000). The peak intensity increased markedly when the polymer 
concentration was above 1 mg/L. At low concentrations, the intensity ratio of I336.5 to 
I334.5 changed slightly. However, as polymer concentration increased, the intensity ratio 
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micelles. Table 5.3 lists the CAC values of the polymers in DI water, ranging from 4.0 to 
25.0 mg/L. The low CAC values indicate that the micelles can be formed at low 
concentrations, allowing their use in very dilute medium such as body fluids. An 
increased length of PLGA block yielded lower CAC. This finding is consistent with the 
results obtained from poly(propylene oxide)-b-poly(ethylene oxide)-b-poly(propylene 
oxide) polymers reported by Gadelle et al. (1995).  The CAC value of Polymer D in PBS 
buffer was also obtained, similar to that in DI water (6.5 and 5.0 mg/L respectively). This 
is due to the non-ionic nature of the block copolymer, and the presence of salts did not 
affect its CAC significantly.  
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Figure 5.3 Plot of intensity ratio of I336.5/I334.5 as a function of log C for Polymer D in DI 
water (a) and PBS buffer (b). 
 
5.2.3 Inner core deformation 
Pyrene was used as a fluorescence probe to study the changes in the polarity of the core 
of the micelles at different temperatures. The I336.5/I334.5 ratio obtained from pyrene 
excitation spectra was monitored as a function of temperature at a polymer concentration 
above the CAC (Figure 5.4). At temperatures below the LCST, the ratio was high and 
relatively constant, indicating a low polar microenvironment (Kim and Lee, 2000). This 
is because pyrene was in the hydrophobic core of the micelles. However, as the 
temperature increased above the LCST, the intensity ratio decreased rapidly, indicating 
pyrene molecules were exposed to a more polar environment. At the temperatures above 
the LCST, the hydrophilic shell of the micelles became hydrophobic, inducing 
deformation of the core-shell structure of the micelles. This deformation allowed pyrene 
to be exposed to the external aqueous phase, increasing the polarity of its 
microenvironment. The reversibility of the change of pyrene microenvironment in 
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found that the pyrene polarity reduced to its initial level when the solution was cooled to 
the temperatures below the LCST, suggesting that the shell of the micelles became 
hydrated and the core-shell structure of the micelles reformed. These data were in 
agreement with dynamic light scattering measurements. The size of the micelles was 
temperature-dependent, as shown later.  
 
 
Figure 5.4   Plots of the I336.5/I334.5 ratio from the excitation spectra of pyrene in Polymer 
D/PBS solution as a function of temperature. (a) heating; (b) cooling (λem = 395 nm; 
heating rate: 1°C/min; pyrene concentration: 6.17×10-7 M; polymer concentration: 1.0 
g/l). 
 
5.2.4 Characterization of blank and DOX-loaded micelles 
5.2.4.1 Particle size and zeta potential analyses 
The particle size and size distribution of the micelles in PBS buffer are shown in Table 
5.3. The average diameters of the blank and drug-loaded micelles except for the drug-
loaded micelles made from Polymer E were less than 200 nm, making them less 
susceptible to clearance by the reticuloendothelial systems (RES) (Nagarajan and 
Ganesh, 1989). The polydispersity indices of blank and drug-loaded micelles were below 
0.30, indicating that the micelles had a relatively narrow size distribution. Compared to 













                                                                                Chapter 5   Results and Discussion 2A  
 110
was loosely packed due to smaller ratio of its hydrophobic chain to hydrophilic chain 
(Lee and Jung, 2004). However, further increasing PLGA chain length led to an increased 
particle size (e.g. Micelles D and Micelles E). This may be because the micelles made 
from the polymers with longer hydrophobic chain had greater aggregation number per 
micelle (Shuai and Ai et al., 2004; Allen and Maysinger et al., 1999). In addition, 
compared to the blank micelles, the corresponding drug-loaded micelles were bigger, 
contributed by the encapsulated drug molecules. Figure 5.5 shows TEM pictures of blank 
and DOX-loaded micelles made from different polymers. All the micelles were spherical, 
and drug loading as well as the presence of salts in PBS did not change the morphology 
of the micelles (Figure 5.5 f). The particle size estimated from the TEM pictures was in 
agreement with that obtained from dynamic light scattering analyses (Table 5.3). The size 
of the micelles was temperature-dependent. At 37°C in PBS, the micelles were stable, 
having a size in the range of 60 to 130 nm. However, when heated to 39.5°C, the size of 
the micelles increased to 250 nm and 600 nm respectively because the shell of the 
micelles became hydrophobic at the temperature above the LCST, leading to 
intermicellar hydrophobic association. Interestingly, this size change was reversible. This 
finding was consistent with that reported by Kohori et al. (1998).  The surface charges of 
both the blank and DOX-loaded micelles in PBS buffer are also listed in Table 5.3. All 
the micelle formulations had negative surface charges at room temperature. The negative 
surface charge of micelles can be explained as follows. Firstly, hydrogen bonds were 
formed between amide group of P(NIPAAm-co-DMAAm) and water molecules. Oxygen 
atom from water molecules was exposed externally and hence micelles were surrounded 
by electron cloud, making the surface of micelles negatively charged.  The more negative 
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the zeta potential, the more stable the micelles. This was due to the electrostatic repulsive 
interactions among the charged micelles. The micelles did not aggregate in the presence 
of FBS (data not shown), which was attributed to the hydrophilic nature and negative 
surface charge of the micelles.  These properties can reduce the adsorption of various 
proteins to the surface of micelles. 
Table  5. 3   Properties of blank and DOX-loaded micelles. 













A 25.0 77.2 ± 0.9 0.29 ± 0.01 -16.2± 6.1 113.6± 1.6 0.29± 0.01 -14.6±1.5 
B 20.0 52.6± 0.5 0.18± 0.01 -16.9± 3.1 76.0±0.2 0.23± 0.01 -14.9±1.1 
C 
 
7.9 52.5± 0.5 0.23± 0.00 -18.2± 2.2 74.9±0.4 0.23± 0.00 -15.8±0.5 
D 
 
5.0 104.5±0.9 0.15± 0.02 -25.4± 2.2 122.7± 1.7 0.12± 0.01 -25.3±2.4 
E 
 
4.0 133.5±1.5 0.09±0.01 -28.2±1.3 242.9±9.5 0.19±0.01 
 
-20.6±1.7 
E.D.: Effective diameter 
P.D.: Polydispersity   
 
                   
                                            a                                                            b 
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                                           c                                                            d 
                 
       e                                                            f 
                 
        g                                                            h 
 
Figure 5.5 TEM pictures, blank micelles made from Polymer A in DI water (a) and 
DOX-loaded micelles in DI water (b); DOX-loaded micelles made from Polymer B in DI 
water (c); blank micelles made from Polymer C in DI water (d, e); blank micelles made 
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from Polymer C in PBS (f); Polymer D micelles in DI water (g) and DOX-loaded 
micelles in DI water (h). 
 
5.2.4.2 Core-shell structure     
The core-shell structure of the micelles was studied by NMR analyses (Kim and Lee, 
2000). Figure 5.6 shows 1H-NMR spectra of the micelles in D2O and CDCl3. In the 
spectrum of the micelles in D2O, the peak at δ 3.8 (Signal a) was contributed by the 
protons of -NHCHMe2 groups in the NIPAAm moieties. The broad peak at δ 2.8-3.0 
(Signal b) was from -NMe2 groups in the DMAAm moieties. The characteristic peaks of 
PLGA blocks were not found in the spectrum. This result indicated the formation of the 
well-defined core-shell structure of the block polymer in aqueous solution, which 
exhibited a shell of P(NIPAAm-co-DMAAm) and a core of PLGA. On the other hand, 
the micelles had a spectrum similar to that of the block copolymers (Figure 5.6) after 
dissolved in CDCl3, in which the characteristic peaks of NIPAAm, DMAAm and PLGA 
were observed. This is due to the fact that the core-shell structure disappeared in the 





















Figure 5.6   1H-NMR spectra of the micelles made of Polymer D dissolved in (A) D2O 
and (B) CDCl3. 
 
5.2.4.3 LCST of precursor polymers and micelles in PBS buffer 
PNIPAAm exhibits a LCST of 32oC in water. The LCST can be modulated via 
introducing hydrophobic or hydrophilic monomers (Chen and Hoffman, 1995). In this 
study, a hydrophilic comonomer N, N-dimethylacrylamide (DMAAm) was employed to 
adjust the LCST of the precursor copolymer. As shown in Table 5.1, the LCST increased 
by the incorporation of DMAAm. As discussed earlier, hydroxy-terminated P(NIPAAm-
co-DMAAm) polymer synthesized with a CTA content of 1.0% was chosen as the 
precursor for the synthesis of the block copolymer, which had a LCST of 42.0°C in PBS 
buffer. The micelles made from all the P(NIPAAm-co-DMAAm)-b-PLGA block 
copolymers had  a LCST ranging from 38.9 to 39.1ºC (Table 5.2), which is lower than 
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formation of the block copolymers. The block copolymers formed core-shell micellar 
structures with completely isolated hydrophobic inner cores from an aqueous phase. 
Therefore, the composition of the shell determined the LCST of the micelles regardless of 
the length of PLGA used, leading to the similarity in the LCST among all types of 
micelles. More importantly, the LCST of the micelles did not change significantly after 
dispersed in a simulated physiological condition (PBS containing 10% serum in volume) 























Figure 5.7 Transmittance changes as a function of temperature. (a) Selected precursor 
polymer in PBS buffer; (b) Polymer C micelles in PBS buffer; (c) Polymer C micelles in 
PBS buffer containing 10% FBS. (Polymer concentration: 5 mg/mL, at 500 nm). 
 
5.2.4.4 Yield of micelles and drug loading level  
Hydrophobic drugs can be incorporated in micelles by physical entrapment through a 
membrane dialysis method. The formation of micelles and drug loading during the 
dialysis process were affected by various parameters including the nature of solvents, 
polymers and drugs, dialysis temperature and  medium used, solvent exchange rate, and 
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initial drug loading (Lee and Na et al., 2003). The fabrication parameters described in 
Chapter 3 were the optimized ones, under which the DOX-loaded micelles solution 
obtained was transparent and exhibited the original color of DOX in aqueous solution. As 
shown in Table 5.4, the yield of the micelles ranged from 15.2 to 41.3%, and the drug 
loading level was from 2.1 to 8.0%. The yield of micelles fabricated from Polymers A, B, 
C and D was similar. In addition, from Polymer A to Polymer D, an increased length of 
the core-forming block PLGA yielded a higher drug loading level. Physical entrapment 
of drugs in polymeric micelles is driven by the hydrophobic interactions between the 
drug and hydrophobic block of polymers. Strong polymer-drug interactions enhance drug 
loading (Allen and Maysinger et al., 1999). An increased length of PLGA chain may 
enhance the polymer-drug interactions, resulting in higher drug loading level. However, 
comparing Polymer B with Polymer C, it seems that the composition change of PLGA 
block did not affect drug loading level significantly. In addition, Polymer E, with the 
longest PLGA block, produced the smallest amount of micelles and the lowest drug 
loading level because of the precipitation of drug and polymer during the fabrication 
process. This indicates that there is an optimized length of PLGA block for achieving 
high drug loading level and great yield of micelles. 
 
Table 5.4   Yield of micelles and drug loading level. 
Samples A B C D E 
Yield (%) 37.5 38.3 41.3 40.5 15.2 
Loading level (% in weight) 5.6 6.0 6.2 8.0 2.1 
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5.2.5 Polymer degradation 
The degradation of P(NIPAAm-co-DMAAm)-b-PLA (Polymer A) and P(NIPAAm-co-
DMAAm)-b-PLGA block copolymers (Polymer C) in PBS was examined and compared 
by mass loss and Mw change as a function of time (Figures 5.8). Both Mw and mass of the 
degrading polymers decreased as a function of incubation time. Compared to Polymer A, 
Polymer C underwent faster weight loss and molecular weight decrease. For instance, the 
weight loss of Polymer A and Polymer C after six weeks was 65% and 98%, respectively. 
The molecular weight of Polymer C residues was not detectable after 6 weeks, while the 
residues of Polymer A still had a molecular weight of 4.8 kDa. It is well known that PLA 
and PLGA degraded in a random scission of ester linkage in the polymer chain, resulting 
in water-soluble oligomers with carboxylic acid at the chain end. According to Jiang et al. 
(2001), few acidic species were produced during early incubation for Polymer A due to 
slow degradation of PLA. In contrast, the amount of oligomers produced by PLGA was 
much higher than that produced by PLA (Giunchedi and Conti, 1998).  Therefore, the 
degradation of Polymer C was accelerated in the acidic environment created by the 
degradation products. It should be noted that although the hydrophilic block of the 
polymer is non-degradable, it is water-soluble after the disappearance or extensive 
degradation of PLA or PLGA block because the in vitro temperature is lower than the 
LCST.  





























Figure 5.8 Mass loss (a, b) and molecular weight changes (c, d) of the degrading polymer 
as a function of incubation time. (a) and (c), Polymer A; (b) and (d), Polymer C. 
 
 
5.2.6 In vitro drug release 
In vitro DOX release from the micelles was studied in PBS buffer at 37ºC (below the 
LCST) and 39.5ºC (above the LCST). As shown in Figure 5.9, DOX release from the 
micelles at 37ºC was characterized with an initial burst followed by a non-release phase. 
The initial burst release of DOX was attributed to DOX molecules located within the 
corona or at the interface between the micelle core and corona (Allen and Maysinger, 
1999). Polymer A micelles yielded the fastest initial burst release of DOX, reaching 
45.0% within the first eight hours. However, the initial burst release of DOX from 
Polymer D micelles was the slowest. In contrast, at 39.5ºC, DOX release from the 
micelles was much faster. Within the first eight hours, more than 80% DOX was 
released. The results show that drug release well responded to the environmental 
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temperature change. When the temperature was below the LCST, the core-shell structure 
was stable, and DOX diffusion was slow. However, when the temperature increased to a 
value above the LCST, the outer shell collapsed. The collapsed shell might induce the 
deformation of the core-shell structure (Chung and Yokoyama, 2000), exposing DOX 
molecules to the external in vitro release medium and thus accelerating drug release. An 
increased length of PLGA block (i.e. the core-forming block) yielded slower drug 
release. The increased length of PLGA block caused greater polymer aggregation number 
per micelle, resulting in stronger PLGA-DOX interactions and thus hampering drug 
release. These findings indicate that drug release from the micelles could be tailored by 



































Figure 5.9 Release profiles of DOX from DOX-loaded micelles incubated at different 
temperatures. (a) Polymer A micelles incubated at 37°C; (b) Polymer A micelles 
incubated at 39.5°C; (c) Polymer C micelles incubated at 37°C; (d) Polymer C micelles 
incubated at 39.5°C; (e) Polymer D micelles incubated at 37°C; (f) Polymer D micelles 
incubated at 39.5°C. 
 
5.2.7 Cellular uptake and cytotoxicity study 
In order to examine the cellular uptake and in vitro cytotoxicity of DOX-loaded micelles 
against different cells, 4T1 cells and MDA-MB-435S cells were employed in this study. 
As shown in Figure 5.10, after 4 h of 4T1 cell incubation with free DOX, strong 
fluorescence was observed in cell nuclei with no signal in cytoplasm.  In contrast, DOX 
fluorescence was observed only in the cytoplasm instead of the cell nuclei for DOX-
loaded Polymer D micelles incubated at 37ºC (below the LCST), suggesting that DOX-
loaded micelles may be internalized through an endocytosis pathway. This finding is 
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consistent with the results reported Savic et al. (2003). In contrast, the cells incubated at 
39.5°C (above the LCST) gave strong fluorescence in cytoplasm and fluorescence was 
also seen in the nuclei. This may be attributed to the fact that drug release from micelles 
was much faster at a temperature above the LCST (Figure 5.9).    
 
Figure 5.11 compared cytotoxic effects of free DOX, DOX-loaded Polymer D micelles 
against 4T1 cells incubated at different temperatures. There was no significant 
cytotoxicity observed up to 600 mg/L of blank Polymer D micelles for 48 h regardless of 
the environmental temperature (data not shown).  Although the monomer and oligomers 
of PNIPAAm and PDMAAm are toxic, but the polymers used in this study would not 
degrade to low molecular weight oligomers.  Additionally, cytotoxicity assay for blank 
polymer A-D were performed against 4T1 and L929 cell line.  There was no significant 
cytotoxicity observed up to 600 mg/L of blank Polymer A-D micelles for 48 h regardless 
of the environmental temperature (data not shown), indicating that polymers used in this 
study were biocompatible. However, DOX-loaded micelles presented cytotoxicity in a 
temperature dependent manner. The DOX-loaded micelles exhibited great superior 
cytotoxic activities at a temperature above the LCST (IC50 = 3.1 mg/L) as compared to 
those below the LCST (IC50 = 7.9 mg/L).  On the other hand, IC50 value of free DOX at 
37°C (3.2 mg/L) was similar to that of at 39.5°C (2.4 mg/L).  Therefore, the temperature-
dependent cytotoxicity was caused by the difference in the release rate of DOX at 
different temperatures.    
 
 














Figure 5.10  Confocal microscopic images of 4T1 cells incubated with (a) free DOX, (b) 
DOX-loaded Polymer D micelles at 37°C and (c) DOX-loaded Polymer D micelles at 

























Figure 5.11 Viability of 4T1 cells incubated with free DOX and DOX-loaded polymer D 
micelles for 48 h at 37°C and 39.5°C respectively. (A) free DOX at 37°C; (b) free DOX 
at 39.5°C; (C) DOX-loaded Polymer D micelles at 37°C and (D) DOX-loaded Polymer D 
micelles at 39.5°C 
 
Similarly, MDA-MB-435S cells were incubated with free doxorubicin or doxorubicin-
loaded Polymer D micelles for 4 hours. In the case of free DOX molecules, they were 
a b c
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mainly present within the nucleus, but the signal was weak (Figure 5.12 a). This is 
because free doxorubicin molecules were transported into the cell via a passive diffusion 
pathway, and some doxorubicin molecules might be pumped out of the cells due to a 
multi-drug resistance effect (Yoo and Park, 2004). In contrast, the fluorescence was 
found in both the nucleus and the cytoplasm for the doxorubicin-loaded micelles 
incubated at 37ºC (Figure 5.12 b), indicating that the doxorubicin-loaded micelles were 
internalized by the cells through non-specific endocytosis. A similar phenomenon was 
also observed by Luo and Tam (2002) for poly(ethylene oxide)-b-poly(ε-caprolactone)  
micelles. The fluorescence intensity in the nucleus was attributed to free doxorubicin 
released from the micelles. On the other hand, greater fluorescence intensity was 
observed in the nucleus when the cells were incubated with doxorubicin-loaded micelles 
at 39.5ºC (Figure 5.12 c). This is due to the fact that at the temperature above the LCST, 
the core-shell structure of doxorubicin-loaded micelles deformed, accelerating 
doxorubicin release. For example, 64% of doxorubicin was released from the micelles 
within the first 4 hours at 39.5ºC whereas only 30% of doxorubicin was released during 







Figure 5.12 Confocal images of MDA-MB-435S cells incubated with (a) free 
doxorubicin, (b) doxorubicin-loaded Polymer D micelles at 37°C and (c) doxorubicin-
a b c 
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loaded Polymer D micelles at 39.5°C. (doxorubicin concentration = 10 mg/L; incubation 
time: 4 hours)  
 
The in vitro cytotoxicity of free drugs (DOX versus paclitaxel) and drug-loaded micelles 
to MDA-MB-435S cells was analyzed and compared. As seen in Figure 5.13, there was 
no significant difference in the cytotoxicity of DOX at different incubation temperatures 
(IC50 = 1.0 mg/L at 39.5°C vs IC50 = 1.1 mg/L at 37°C). However, DOX-loaded  micelles 
incubated at 39.5°C ( IC50 = 0.30 mg/L) showed noticeable enhanced cytotoxicity than 
those incubated at 37.0°C ( IC50 = 0.75mg/L).  Cytotoxicity of blank micelles was also 
tested. The results showed that blank micelles had no cytotoxicity at both incubation 
temperatures.  As stated before, the pronounced cytotoxicity of DOX-loaded micelles at 
























Figure 5.13 Viability of MDA-MB-435S cells incubated with (a1) DOX-loaded polymer 
D micelles at 37°C and (a2) DOX-loaded Polymer D micelles at 39.5°C. (b1) free DOX 
37°C; (b2) free DOX 39.5°C.  
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5.3 Paclitaxel-loaded micelles 
5.3.1 Size and morphology of blank and paclitaxel-loaded micelles 
P(NIPAAm-co-DMAAm)-b-PLGA block copolymers with two different PLGA contents 
(Polymer C and Polymer D) were synthesized. The CAC values of polymers were 7.9 and 
5.0 mg/L respectively (Table 5.3). The size and size distribution of blank and paclitaxel-
loaded micelles in DI water are listed in Table 5.5.   The average effective diameters of 
the blank and drug-loaded micelles were in the range of 60 to 120 nm with a relatively 
narrow size distribution (polydispersity < 0.3), making them less susceptible to clearance 
by the reticuloendothelial system. The micelles made from Polymer D were bigger than 
those fabricated from Polymer C because of its longer core-forming block (Shuai and Ai 
et al., 2004). After loading of paclitaxel, the size of the micelles increased. TEM and 
AFM images show that the blank and paclitaxel-loaded micelles made from the two 
polymers were spherical in shape (Figure 5.14 and Figure 5.15). The size of the micelles 
measured by dynamic light scattering (Table 5.5) is consistent with that visualized by 
TEM and AFM images. Furthermore, it was observed that the size and morphology of the 
micelles remained unchanged after freeze-drying. This is an important property for 
storage and transportation of the end products. It was frequently reported that freeze-
dried polymeric micelles did not re-dissolve in aqueous media (Huh and Lee, 2005). The 
surface charges of both the blank and paclitaxel-loaded micelles are also listed in Table 
5.5. All the micelles formulations had negative surface charges at room temperature in DI 
water. The micelles did not aggregate in the presence of FBS (fetal bovine serum), which 
was attributed to the hydrophilic nature and negative surface charge of the micelles. The 
LCST of both Polymer C and Polymer D micelles was 39.0°C (Table 5.2).  
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Table 5.5   Properties of blank and paclitaxel-loaded micelles. 















7.9 66.3± 1.0 0.23± 0.00 -14.4± 3.2 85.7±3.8 0.23±0.01 -11.8±1.0 
D 
 
5.0 104.5±0.9 0.15± 0.02 -19.0±5.5 119.5±0.7 0.20±0.01 -17.2±3.0 
aCAC: Critical aggregation concentration determined from I336.5/I334.5 ratios as a function 
of polymer concentration 
bE. D.: Effective diameter 














































































Figure 5.14 TEM images. (a) blank Polymer C micelles; (b) paclitaxel-loaded Polymer C 










Figure 5.15 AFM images of blank Polymer C micelles.  
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5.3.2 Drug encapsulation 
The loading level and encapsulation efficiency of drug-loaded polymeric micelles are 
affected by various parameters including fabrication temperature, polymer concentration 
and initial drug loading (Jones and Leroux, 1999). As reported in our previous study 
(Chaw et al., 2004), higher polymer concentrations yielded greater higher encapsulation 
efficiency and drug loading level. However, the particle size also increased.  In this study, 
polymer concentration was fixed at 0.50 (w/v) % to maintain a small size. As shown in 
Figure 5.16, when the initial paclitaxel loading increased from 9.1% to 20.0%, the 
encapsulation efficiency of paclitaxel decreased from 50% to 27%, while the actual 
paclitaxel loading level increased and reached the maximum of 8.2% at the initial loading 
of 16.7%. Further increasing the initial drug loading level to 20.0% did not lead to greater 
actual drug loading level and paclitaxel precipitates were found inside the dialysis 
membrane tube possibly because the initial paclitaxel loading reached the maximum 
loading capacity of the micelles.    
 
As shown in Figure 5.17, fabrication temperature was another factor influencing the 
loading level and encapsulation efficiency of paclitaxel. An increased temperature from 4 
to 20°C yielded higher encapsulation efficiency and loading level of paclitaxel. However, 
further increasing the temperature did not lead to any improvement of encapsulation 
efficiency and loading level. It was observed that at low temperatures such as 4, 10 and 
15°C, precipitates were observed inside the dialysis membrane tube probably because of 
limited water solubility of paclitaxel at these temperatures, leading to lower encapsulation 
efficiency and drug loading level. However, at a higher temperature such as 25°C, solvent 
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removal rate increased, leading to faster solidification of the PLGA core before the 
incorporation of paclitaxel. Therefore, there is an optimized fabrication temperature to 
achieve high encapsulation efficiency and loading level of paclitaxel. In the following in 
vitro release, cellular uptake and cytotoxicty studies, the paclitaxel-loaded micelles were 
fabricated at 20°C.  
 
Figure 5.17 also shows that Polymer D with the longer hydrophobic segment of PLGA 
yielded greater encapsulation efficiency and loading level of paclitaxel. For instance, the 
encapsulation efficiency and loading level of paclitaxel was 34.6% and 8.2% respectively 
for Polymer C micelles, and 46.8% as well as 11.5% respectively for Polymer D micelles. 
This may be because longer hydrophobic block resulted in a big core and thus offered 
greater capacity for drug loading (Allen and Maysinger, 1999). It is also possible to 
assume that the hydrophobic interaction between the drug and the core increased with a 
longer core-forming length, resulting in higher loading capacity.   
 
5.3.3 Core-shell structure of micelles and drug distribution 
The core-shell structure of paclitaxel-loaded micelles and distribution of paclitaxel in the 
micelles were studied by comparing 1H-NMR spectrum of paclitaxel-loaded micelles in 
D2O with that in CDCl3. Figure 5.18 shows the typical spectra of paclitaxel-loaded 
Polymer C micelles in D2O with that in CDCl3. In D2O, only the peaks of the precursor 
copolymer P(NIPAAm-co-DMAAm) existed (i.e. -CH3 at δ 1.0; -CH-C=O-NH at δ 1.5; -
CH2-CH at δ 2.0;    -NHCHMe2 at δ 3.8; -NMe2 at δ 2.8-3.0) but  the  characteristic peaks 
of  PLGA block  and drug  were not found. However, in CDCl3, the characteristic peaks 
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of paclitaxel were observed at δ 4.2-5.0, δ 5.6-6.3 and δ 7.4-8.2 in addition to those of 
PLGA (i.e. –CHMeO- at δ 5.1-5.3 and -CH2O- at δ 4.6-4.9) and P(NIPAAm-co-
DMAAm). These results suggested that the paclitaxel-loaded micelles had a well-defined 
core-shell structure having a core of PLGA and a shell of P(NIPAAm-co-DMAAm), and 
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Figure 5.16 Effect of initial paclitaxel loading level on encapsulation efficiency and 





















































Figure 5.17 Effect of fabrication temperature on encapsulation efficiency and actual 
loading level of paclitaxel. (a1, a2: Polymer C micelles; b1, b2: Polymer D micelles; 
initial paclitaxel loading: 16.7% in weight) 
 
The physical status of paclitaxel inside the micelles was further studied by thermal 
analysis. From Table 5.6, pure paclitaxel exhibited a melting point of 224°C. However, it 
was not observed in the paclitaxel-loaded micelles, indicating that paclitaxel molecules 
were in an amorphous phase. In addition, Polymer D micelles had two glass transition 
temperatures, which were 131°C from P(NIPAAm-co-DMAAm) block and 46°C from 
PLGA block. After loading of paclitaxel, Tg of PLGA block increased to 51°C but Tg of 
P(NIPAAm-co-DMAAm) block remained unchanged. This finding further confirmed 
that paclitaxel molecules were located in the core of the micelles. The increase in Tg of 
PLGA block was possibly because the rigid paclitaxel molecules block the movement of 
the PLGA block. Figure 5.19 shows WAXRD spectra of pure paclitaxel and paclitaxel-
loaded micelles. The X-ray diffraction spectrum of paclitaxel exhibited a number of sharp 
peaks, indicating a highly crystallized structure of paclitaxel. After encapsulated into the 
micelles, the crystalline structure disappeared. Thus the Tm of paclitaxel was not 
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observed in the DSC curves. This finding further confirmed that paclitaxel molecules 















Figure 5.18 1H-NMR spectra of the paclitaxel-loaded Polymer D micelles dissolved in  
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Table 5.6 Glass transition temperatures (Tg) and melting points (Tm) of paclitaxel, blank 
micelles and paclitaxel-loaded micelles. 
 
 Tg  (°C) 
of P(NIPAAm-co-DMAAm) 
block 
Tg  (°C)  
of PLGA block 
Tm 
(°C) 
Paclitaxel  - - 224 
Polymer D micelles 131 46 - 
Paclitaxel-loaded 
Polymer D micelles 
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Figure 5.19 WAXRD spectra of paclitaxel-loaded Polymer D micelles (a) and free 
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5.3.4 In vitro release of paclitaxel 
Figure 5.20 shows the cumulative release of paclitaxel from the micelles incubated in 
PBS buffer at 37ºC (below the LCST) and 39.5ºC (above the LCST). A sustained release 
of paclitaxel was achieved from all the formulations. The paclitaxel release was 
accelerated at the temperature above the LCST. For instance, more than 80% of 
paclitaxel was released within three days from Polymer C micelles at 39.5ºC whereas less 
than 30% of paclitaxel was released within the same period of time at 37ºC. The results 
show that paclitaxel release was in response to the external temperature change. When 
the temperature was below the LCST, the core-shell structure was stable, and paclitaxel 
release depended on its slow diffusion. However, when the temperature increased to a 
value above the LCST, the outer shell collapsed. The collapsed shell induced the 
deformation of the core-shell structure, exposing paclitaxel molecules to the external in 
vitro release medium and thus accelerating paclitaxel release.  
Comparing Polymer C micelles with Polymer D micelles, paclitaxel release from 
Polymer C micelles was faster. The increased length of PLGA block caused greater 
polymer aggregation number per micelle, resulting in stronger PLGA-paclitaxel 
hydrophobic interactions and thus hampering paclitaxel release. On the other hand, the 
increased length of PLGA block led to larger core of the micelles, providing a longer 
distance for paclitaxel molecules to diffuse into the external in vitro release medium and 
thus decreasing paclitaxel release rate.  
 
 






























Figure 5.20 Release profiles of paclitaxel from Polymer C micelles incubated at 39.5°C 
(a) and 37°C (b); Polymer D micelles incubated at 39.5°C (c) and 37°C (d). 
 
 
5.3.5 Cytotoxicity study 
The in vitro cytotoxicity tests of blank micelles, free paclitaxel and paclitaxel-loaded 
Polymer D micelles were performed against MDA-MB-435S cells at different 
temperatures. As shown in Figure 5.21, there was no significant effect of incubation 
temperature on the cytotoxicity of free paclitaxel (IC50 = 0.063 mg/L at 39.5°C vs IC50 = 
0.082 mg/L at 37°C). However, paclitaxel-loaded micelles showed much greater 
cytotoxicity at 39.5°C than at 37ºC (IC50 = 0.0061 mg/L at 39.5°C vs IC50 = 0.048 mg/L 
at 37°C). It should be mentioned that no obvious cytotoxcicity (over 90% cell viability) 
of blank micelles (up to 500 ppm) at 37ºC or 39.5°C (data not shown). The pronounced 
cytotoxicity of paclitaxel-loaded micelles at 39.5°C was attributed to the enhanced 
release of paclitaxel (Figure 5.20). Free paclitaxel showed less cytotoxicity as compared 
to paclitaxel-loaded micelles, possibly due to multi-drug resistance effect. 
























Figure 5.21 Viability of MDA-MB-435S cells incubated with (a1) free paclitaxel at 
39.5°C; (a2) free paclitaxel at 37°C; (b1) paclitaxel-loaded Polymer D micelles at 39.5°C 
and (b2) paclitaxel-loaded Polymer D micelles at 37°C. 
 
 
5.4 A comparison between DOX-loaded polymer micelles and paclitaxel-loaded 
polymer micelles 
DOX and paclitaxel were employed as model anticancer drugs and loaded into polymer 
micelles.  As discussed earlier, micelles properties are affected by various parameters 
such as polymer composition and fabrication process.  Furthermore, drug 
physicochemical properties, biological properties and disease properties are critical to 
designing micelles. 
 
5.4.1 Effect of physicochemical properties on encapsulation efficiency 
In addition to other factors presented in the previous paragraphs, drug physicochemical 
properties greatly affected drug incorporation into polymer micelles. As shown in Table 
5.7, under the optimized fabrication condition, encapsulation efficiencies of paclitaxel-
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loaded micelles were much higher than those of DOX-loaded micelles.  For example, 
encapsulation efficiency yielded by Polymer D micelles was 9.7% and 46.8% for DOX-
loaded micelles and paclitaxel-loaded micelles, respectively. The physicochemical 
properties of drugs such as polarity, hydrophobicity, charge and degree of ionization have 
been found to greatly influence the incorporation. Among these factors, hydrophobicity 
plays a key role in drug loading for physical entrapment of drugs. Unlike paclitaxel, 
deprotonated DOX (after treatment with TEA) is less hydrophobic because of its polar 
hydroxyl and amino groups (Shuai and Ai et al., 2004). However, loading level was 
similar.  This may be because the core space is limited for a specific core-forming block.    
 
Table 5.7 Comparison of drug loading between DOX-loaded and paclitaxel-loaded 
micelles.  
 
DOX Paclitaxel Samples 
Loading level Encapsulation 
efficiency 




6.2 7.6 8.2 34.6 
Polymer D 
 
8.0 9.7 11.5 46.8 
 
 
5.4.2 Effect of physicochemical properties on drug release 
As shown in Figure 5.9 and Figure 5.20, similar to DOX release, paclitaxel release from 
pacltaxel-loaded micelles was accelerated when the environmental temperature was 
raised slightly above the LCST.  However, a more sustained release of paclitaxel was 
achieved from the paclitaxel-laoded micelles compared to DOX release.  For instance, 
complete doxorubicin release from the micelles was achieved within the first 10 hours at 
39.5ºC (Figure 5.9) whereas complete paclitaxel release was achieved after 3 days 
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incubation at 39.5ºC (Figure 5.20).   It is known that drug release is a complicated 
process.  Several mechanisms of drug release from biodegradable polymeric micelles 
have been proposed: drug release by polymer erosion, diffusion, drug dissolution and 
micelles stability (Allen and Maysinger, 1999).  It is difficult to predict a drug release 
profile because it is governed by two or more mechanisms listed.   A lot of studies have 
reported that polymer erosion had a great effect on drug release (Potineni and Lynn, 
2003).  However, in this study, the time required for complete degradation was more than 
one month (Section 5.2.5).  Therefore, it seems that drug release from micelles was 
affected mainly by diffusion, drug dissolution and micelles stability.  Furthermore, 
diffusion is affected by various factors such as the strength of the interactions between 
the drug and the core-forming block. Paclitaxel is more hydrophobic than DOX, the 
interaction between paclitaxel and core-forming block is thus stronger than that between 
DOX and, resulting in slow drug release.  Besides, the water solubility of DOX is much 
higher than that of paclitaxel, leading faster release.  
 
5.4.3 Effects of biological properties on cytotoxicity 
The in vitro cytotoxicity of free drugs (DOX versus paclitaxel) and drug-loaded micelles 
against various cells was analyzed and compared (Table 5.8). Similar to paclitaxel loaded 
micelles, IC50 values of DOX-loaded micelles for MDA-MB-435S cells were lower than 
those of free DOX.  This may be because of increased cellular uptake of DOX-loaded 
micelles.  However, IC50 values of both free DOX and DOX-loaded micelles for MDA-
MB-435S cells were higher than those of paclitaxel, indicating DOX was less toxic than 
paclitaxel.  On the other hand, it was found paclitaxel (IC50 > 50 ppm) was not as efficient 
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as DOX (IC50 = 3.2 ppm) for in vitro cytotoxicity against 4T1 cells and MCF-7 cells.  As 
described in Chapter 2, DOX exerts its effects on cancer cells via inhibiting the synthesis 
of DNA as well as DNA transcription. However, paclitaxel is a unique antimicrotubule 
agent which binds and stabilizes microtubululin during the later G2 mitotic phase of the 
cell cycle. It is possibly to assume that the different effect of drugs on in vitro 
cytotoxicity was attributed to the different extent of damage caused by drugs involved in 
different cells. Therefore, formulation should be well designed in order to achieve a 
desired effect of chemotherapy. 
 
Table 5.8 Comparison of IC50 of free drug and drug-loaded micelles against various 
cells.  
4T1 cells MDA-MB-435S MCF-7 IC50 (mg/L) 
(drug concentration) 37°C 39.5°C 37°C 39.5°C 37°C 39.5°C 
Free DOX 
 
3.2 2.4 1.1 1.0 0.055 0.047 
DOX loaded polymer D micelles 
 
7.9 3.1 0.75 0.3 0.16 0.062 
Free paclitaxel 
 
59.2 57.3 0.082 0.063 26.1 24.8 
Paclitaxel loaded polymer D 
micelles 
48.9 35.4 0.048 0.0061 28.5 15.2 
 
5.5 Conclusions 
Thermally sensitive block copolymers, P(NIPAAm-co-DMAAm)-b-PLGA with various 
compositions and lengths of PLGA block were successfully synthesized to incorporate 
doxorubicin and paclitaxel into micelles. The block copolymers were degradable, and the 
degradation of PLGA-based block copolymer was faster than that of PLA-based block 
copolymer. The block copolymers had a low CAC value in both DI water and PBS 
buffer. The micelles made from the block copolymers were spherical. The LCST of the 
micelles in PBS buffer was slightly higher than the normal body temperature, desirable 
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for in vivo applications. The micelles were stable in PBS buffer at 37ºC. An increased 
length of PLGA block led to a slight increase in drug loading capacity. Polymer D 
provided a favorable balance of hydrophilicity and hydrophobicity for drug loading. Fast 
drug release was achieved at a temperature higher than the LCST. Drug-loaded micelles 
were internalized through an endocytosis pathway. Drug-loaded micelles showed higher 
cytotoxicity against cells at a temperature above the LCST. In addition, drug 
encapsulation efficiency, in vitro drug release and in vitro cytotoxicity of micelles were 
affected by drug properties.  In vitro cytotoxicity of drug loaded micelles were also 
affected by cell biological properties. The micelles made from P(NIPAAm-co-DMAAm)-
b-PLGA with an optimized PLGA block may be employed for anticancer drug delivery.  
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6.1 Introduction 
Micelles self-assembled from poly (N-isopropylacrylamide-co-N, N-
dimethylacrylamide)-based amphiphilic copolymers have also been studied for delivery 
of other therapeutics (Chaw and Chooi et al., 2004). However, a major disadvantage of 
such systems is that their application is limited to surface organ or tumors (Soppimath et 
al., 2005).  An alternative approach to targeting drugs to tumor tissues is to use pH-
sensitive polymeric micelles.  The pH value of disease site such as tumor tissue is 
significantly lower than that under normal physiological conditions (pH 7.0 versus pH 
7.4) (Haag, 2004).  The pH-sensitive drug carriers remained intact until they have 
reached tumor tissue or subsequently been taken up by a cell but deformed and drug 
release was triggered under low pH conditions (Bae and Fukushima et al., 2003). In 
addition, active targeting could be further improved by introducing recognition signals 
such as folic acid onto the surface of the nanoparticles.  The choice of folic acid is 
because its corresponding receptor is abundantly distributed on the surface of most cancer 
cell types.  Based on these concepts, we have developed temperature and pH-sensitive 
folate-conjugated poly(N-isopropylacrylamide-co- N, N-dimethylacrylamid-co-
methacrylate)-b-PUA (FA conjugated Poly(NIPAAm-co-DMAAm-co-MAm)-b-PUA) 
micelles for DOX delivery.  The novelty of this system is the ability to target drugs to 
deep tissues or organs without external heating. In this study, DOX-load micelles were 
fabricated by a membrane dialysis method. DOX release was responsive to 
environmental pH changes.  In vitro cytotoxicity of blank micelles, free DOX and DOX-
loaded micelles against 4T1 cells were investigated and compared. Mouse breast cancer 
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model induced by 4T1 cells was employed to study biodistribution of DOX and its blood 
concentration as a function of time. 
 
6.2   Results and discussion 
6.2.1 Synthesis of folate- conjugated Poly(NIPAAm-co-DMAAm-co-MAm)-b-PUA  
The folate(FA)-conjugated copolymer was synthesized by multiple steps.  Firstly, 
carboxylic acid-terminated poly(NIPAAm-co-DMAAm-co-MAm) was prepared by the 
radical copolymerization using benzoyl peroxide (BPO) as an initiator and 3-
mercaptopropionic acid as a chain transfer agent (Figure 3.2).  MAm monomer was 
introduced due to the presence of amine group for further conjugation of folic acid. The 
precursor polymer was obtained after purification by a liquid-liquid diffusion method 
(THF/Et2O), followed by dialysis against DI water. The molecular weight of this polymer 
is 6.8 kDa, having a polydispersity of 1.7 (Table 6.1).  Subsequently, activated folic acid 
was conjugated to the amine group of carboxylic acid-terminated poly(NIPAAm-co-
DMAAm-co-MAm).  Although folic acid has α- and γ--carboxylic acid, γ--carboxylic 
acid was primarily activated in the DCC/NHS reaction (Figure 3.3 (a). Therefore, γ--
carboxylic acid was conjugated to precursor polymer due to its higher reactivity (Figure 
3.3(b)).  The resulting solution was centrifuged to discard the pellets, followed by dialysis 
against DI water.  Pale-yellow polymer was obtained after freeze-dry.  The molecular 
weight of this polymer was 7.1 kDa, having a polydispersity of 1.8.   Thirdly, amine 
group-terminated PUA polymer was prepared by the radical copolymerization using the 
redox agent ammonium persulfate (APS) as an initiator and 2-aminoethanethiol as a 
chain transfer agent (Figure 3.4).  The success of the polymerization of UA monomer in 
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the presence of chain transfer agent was evidenced by the absence of vinylic proton 
signals at δ 4.8-5.0 (CH2 = CHCH2) and δ 5.7-5.9 (CH2 = CHCH2) (Figure 6.1 A).  The 
peaks at δ 1.3, 1.5 and 2.2 were assigned to CH2CH2 (Signal a), HOOCCH2CH2 (Signal 
b) and HOOCCH2 (Signal c), respectively (Figure 6.1 B). The lack of absorption at 3084 
cm-1 and 911 cm-1 in the FT-IR spectrum of PUA further proved the successful 
polymerization of UA monomer (Figure 6.2, A). The spectrum of PUA-NH2 showed an 
carbonyl band ((νO-C=O, a) in the COOH at 1712.3 cm-1 (Figure 6.2, A).   Finally, the 
carboxylic acid group of folate-conjugated poly(NIPAAm-co-DMAAm-co-MAm)-
COOH was activated using DCC/NHS in DCM, followed by precipitation two times 
using ether and vacuum drying.   The activated folate-conjugated poly(NIPAAm-co-
DMAAm-co-MAm)-COOH was dissolved in DMSO, and reacted with an excess amount 
of poly(10-undecenoic acid)-NH2 (Figure 3.5).  The resulting solution was purified by 
dialysis.  The final pale-yellowish product was obtained by freeze-drying, and 
characterized by GPC, NMR, FTIR and titration. The NMR spectra of the final product 
shared a similar pattern to that of folate-conjugated poly(NIPAAm-co-DMAAm-co-
MAm)-COOH.  As shown in Figure 6.3, the peak at δ 3.8 (Signal a) was contributed to 
the protons of -NHCHMe2 moieties, the broad peak at δ 2.7-3.0 (Signal b) was from -
NMe2 groups in the DMAAm moieties, the weak peaks at δ 6.6 (Signal c), δ 7.7 (Signal 
d) and δ 8.7 (Signal e) were from folic acid moieties.  The FTIR spectrum showed two 
strong absorptions at 1647.1 cm-1 (νHN-C=O) and 1547.8 cm-1 (νC-N) caming from the 
poly(NIPAAm-co-DMAAm-co-MAm) block.  Another weak absorption at 1720 cm-1 
(νO-C=O, b) was from the PUA-NH2 block and folate moieties (Figure 6.2 B).  Mw of the 
final product was 7.7 kDa with a polydispersity of 1.5.  The increase of Mw indicated 
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that PUA-NH2 was successfully conjugated to folate-conjugated poly(NIPAAm-co-
DMAAm-co-MAm)-COOH (Table 6.1).  The COOH content was estimated to be 18.4 
mg per gram of polymer.  
 








6.8 4.1 1.7 
Folate-conjugated Poly(NIPAAm-co-
DMAAm-co-MAm)-COOH 
7.1 3.9 1.8 
Folate-conjugated Poly(NIPAAm-co-
DMAAm-co-MAm)-b-PUA 
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6.2.2 LCST of micelles and effect of pH 
PNIPAAm exhibits an LCST of 32ºC in water. The LCST can be modulated via 
introducing hydrophobic or hydrophilic monomers. In this study, poly(10-undecenoic 
acid) was used as the hydrophobic block. The carboxylic group in the hydrophobic block  
could influence the hydrophobicity of the polymer.  Figure 6.4 shows the LCST of 
precursor polymer and final micelles measured in buffer solutions of different pH.  The 
LCST of the precursor polymer was found to be 39.5°C and 38.4°C at pH 7.4 and pH 6.6, 
respectively.  This may be due to the protonation effect of the carboxylic acid group of 
folic acid and that of carboxylic acid-containing chain transfer agent. With the 
incorporation of a terminal hydrophobic group of PUA, the LCST of micelles at pH 7.4 
decreased to 38.0°C.  The LCST of micelles at pH 6.6 was 36.2°C. The results indicated 
that the LCST values of micelles are pH dependent.  This is because with the decrease of 
pH, the carboxylic acid groups in the 10-undecenoic acid segment (pKa of 10- 
undecenoic acid = 6.8) protonated.  The hydrophobicity of polymer thus increased.  Since 
the LCST of the micelles is higher than the normal body temperature in the physiological 
environment (pH 7.4) but lower than the normal body temperature in acidic environments 
(e.g. pH 6.6), these micelles can be used for intracellular drug delivery.  In the endosomes 
or lysosomes (pH 5.0-7.0 in endosomes and pH 4-5 in lysosomes), the micelles can 
adsorb protons and the shell of the micelles becomes hydrophobic due to the decrease in 
the LCST. These may help to break down the endosome or lysosome membrane, 
releasing the enclosed drug molecules into cytoplasm.    




















Figure 6.4 Plot of transmittance of polymer solutions as a function of temperature at 
varying pH at 500 nm.  (a) precursor polymer in PBS (pH 7.4); (b) precursor polymer at 
pH 6.6; (c) micelles in PBS (pH 7.4); (d) micelles at pH 6.6. 
 
6.2.3 CAC determination 
The formation of micelles from the polymer was investigated by the detection of CAC 
using a fluorescence technique.  The excitation spectra of pyrene are illustrated in Figure 
6.5.  As polymer concentration increased, the fluorescence intensity increased and the 
third peak shifted from 334.0 nm to 335.5 nm.  The red shift of the third peak indicated 
that pyrene molecules transferred to less polar domains of the core of micelles. Figure 6.6 
shows the change of ratio of I334.0 to I335.5 against polymer concentrations at DI water.  
The CAC value was determined from the intersection of the tangent curve to the curve at 
the inflection with the horizontal tangent through the points at low polymer 
concentrations. The CAC of polymer at DI water was 17.8 mg/L.  The low CAC value 
indicates that such micelles would remain stable under conditions of extreme dilution, as 
would be the case in the physiological environment, after administration.  
 



















Figure 6.5 Excitation spectra of pyrene as a function of polymer concentration in DI 
water.  
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6.2.4 pH effect on structural changes of micelles 
To study the effect of pH on the structural change of micelles, the change of the intensity 
ratio (I335.5/I334.0) of pyrene at 37°C in the presence of micelles prepared in buffers of 
different pH was investigated (ionic strength = 154 mM).  As shown in Figure 6.7, for 
micelles at pH 7.4 and pH 7.2, the ratio of I 335.5 nm to I 334.0 nm was high and 
relatively constant, indicating that pyrene molecules were in a low polar 
microenvironment.  However, the intensity ratio sharply decreased as the pH decreased 
from pH 7.0, indicating pyrene molecules were exposed to a more polar environment 
(aqueous medium) as the pH decreased.  As stated earlier, carboxylic acid group in the 
micelles deionized below pH 6.8, leading to a lower LCST.  Internal structure of micelles 
was thus perturbed due to the dehydration of micelles at 37°C.   
 









6 6.3 6.6 6.9 7.2 7.5 7.8
pH
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6.2.5   Size and morphology of the micelles 
Table 6.2 lists the size and size distribution of the micelles fabricated in DI water. It was 
found that micelles have a relatively narrow size distribution and the average effective 
diameter of blank micelles was 92.8 nm.   The effective diameter of the DOX-loaded 
micelles was 98.5 nm, indicating that micelles size was slightly affected by drug loading.  
The morphologies of the micelles are spherical (Figure 6.8). The particle size observed 
from the TEM picture is in good agreement with that measured by dynamic light 
scattering.  Physical stability of the micelles is another important aspect to be considered 
for clinical applications because the aggregation of micelles may cause blood vessel 
occlusion and make them more susceptible to clearance by the RES.   It is found that the 
diameter remained little difference in PBS medium over 1 week at room temperature 
(87nm-97nm), suggesting that particles are stable in the PBS.   On the other hand, the 
particle size does not change for diluted micelles (87.0nm vs. 92.1nm) (5 times dilution).   
This is crucial since dissociation of micelles after administration will lead to rapid release 
of the drug, resulting in side effects in vivo.  Furthermore, the particle size of the blank 
micelles did not change significantly in PBS buffer containing 10% BSA, indicating that 
the interactions between particles and protein are weak.  This can be attributed to the 
negative surface charge (Table 6.2).   It is expected that the micelles would have good 
physical stability in vivo.  The size of micelles in buffer solutions of different pH was 
studied.  It was observed that the effective diameter of micelles was pH dependent (117.2 
nm in pH7.4 vs. 612.6 nm in pH 6.6 at 37°C).   The increase of particle size was due to 
the aggregation of micelles in pH 6.6.  Furthermore, the particle size was also 
temperature dependent.  For instance, the particle size was about 117.2 nm at 37°C in 
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PBS, the size increased to 740.0 nm at 40°C due to the aggregation of micelles above the 
LCST.  These results indicate that the micelles were both temperature and pH sensitive. 
In particular, the change in particle size was reversible.   
 




Polydispersity Zeta potential 
(mV) 
Blank micelles 92.8±0.1 0.27±0.01 -14.6±3.0 
DOX-loaded micelles 98.5±2.1 0.28±0.01 -11.2±1.0 
 
       
                                        (a)                                               (b) 
 
         
                                        (c)                                                   (d) 
Figure 6.8 TEM images. (a, b) blank micelles; (c, d) DOX-loaded micelles. 
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6.2.6 Drug encapsulation and in vitro drug release  
The incorporation of DOX into micelles was carried out under the conditions stated in 
Section 3.3. The actual loading level of DOX in the micelles was about 2.5 % in weight.  
Unlike the polymer D micelles stated in Section 5.2, in which the actual loading level 
was about 8.0%, this relatively low loading level in this pH sensitive micelles was 
because of the less hydrophobic core. Figure 6.9 shows in vitro DOX release from the 
micelles under a physiological condition (PBS, pH 7.4) and in an acidic environment (pH 
6.6). DOX release was accelerated for micelles incubated at pH 6.6 and 37°C, with 
approximately 85% of the drug released within 24 h.  However, DOX release from the 
micelles in pH 7.4 at 37ºC was much slower, with 40% released over 24 h.  As discussed 
in Section 6.2.2, at pH 6.6, the LCST of the micelles decreased to 36.2ºC, leading to 
hydrophobic shells of the micelles. The loss of hydrophilicity/hydrophobicity balance of 
the micelles led to the deformation of the core-shell structure, releasing the enclosed drug 



























Figure 6.9 Release profiles of DOX from the micelles incubated at 37°C (a) pH 7.4; (b) 
pH 6.6. 
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6.2.7 Cellular uptake and in vitro cytotoxicity 
            Cellular uptake of free DOX, DOX-loaded micelles by 4T1 cells was examined and 
results are shown in Figure 6.10.   When free DOX was incubated with 4T1 cells, free 
doxorubicin molecules are transported into the cell via a passive diffusion pathway, 
doxorubicin molecules are only accumulated in the nucleus. However, strong 
fluorescence was observed in the cytoplasm as well as nucleus for the cells incubated 
with DOX-loaded micelles. It is known that endosomes are acidic (Haag, 2004). Due to 
their acidity, endosomes can alter the LCST of micelles (from a value higher than the 
normal body temperature to a value lower than the normal body temperature), breaking 
down the endosome membrane. Therefore, intracellular drug delivery into the cells can 
be achieved. This indicates that the DOX-loaded micelles were internalized by the cells 
through endocytosis, and then escaped from the endosome and lysosome to enter the 
cytoplasm. In addition, it was also found that cellular uptake of DOX-loaded micelles 
was higher than that of DOX-loaded Polymer D micelles (Figure 5.10).  This may be 
because DOX-loaded micelles were taken up by folate-receptor-mediated endocytosis.  
The strong signals appeared in the nucleus of the cells were attributed to the doxorubicin 















Figure 6.10 Confocal microscopic images of 4T1 cells incubated at 37°C with (a) free 
























Figure 6.11 Viability of 4T1 cells incubated at 37°C with (a) free DOX; (b) DOX-loaded 
micelles.  
 
Cell cytotoxicity of free DOX and DOX-loaded micelles against 4T1 cells was 
investigated. DOX-loaded micelles showed a comparable cytotoxicity when compared to 
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free DOX (IC50: 3.8 mg/L versus 3.0 mg/L), suggesting that DOX released from the 
micelles remained bioactive.  DOX-loaded folate-conjugated micelles were found to be 
more cytotoxic than DOX-loaded Polymer D micelles discussed in Section 5.2 (IC50: 3.8 
mg/L versus 7.9 mg/L).  This is because of the increased cellular uptake of DOX-loaded 
micelles due to folate-mediated endocytosis as well as enhanced drug release in 
endosomes and lysosomes (Figure 6.10). It should be mentioned that no cytotoxcicity 
was observed for blank micelles at a concentration of up to 500 mg/L. 
 
6.2.8 Biodistribution 
The biodistribution of free DOX and DOX-loaded micelles (DOX micelles) was 
evaluated and compared in mice bearing 4T1 cells-induced breast cancer. As shown in 
Figure 6.12, the levels of free DOX in the blood were 10.8 µg/g at 10 min, 5.2 µg/g at 30 
min, and decreased to 1.2 µg/g at 240 min.  Although the biodistribution of free DOX and 
the DOX micelles in blood showed similar pattern, DOX administrated in the micelles 
formulation exhibited a longer circulation time, which is consistent with previous studies 
(Crowns and Creaven et al., 1993).  For example, the levels of DOX administrated in the 
micelles in the blood were 11.8 µg/g at 10 min, 9.1 µg/g at 30 min and 3.5 µg/g at 240 
min (Figure 6.13).  The t1/2 of DOX micelles in the blood was found to be about 140 min, 
while the t1/2 of free DOX was approximately 30 min.  This enhanced circulation may be 
due to slower release in the blood and thus slower elimination of DOX. 
 
The DOX levels in tissues including spleen, kidney, heart, liver and lung after 
administration of free DOX or DOX micelles are shown in Figure 6.12 and Figure 6.13, 
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respectively.   It was found that free DOX had a wide tissue distribution, accumulating 
uniformly in heart, lung and liver. However, when administrated in the micelles, a 
significant reduce in DOX level was found in heart, indicating that the micelles might 
reduce the cardiotoxicity of DOX considerably. This reduced accumulation in the heart 
might be due to the selective localization of DOX in the tumor. It was also found that 
DOX administrated in micelles preferentially accumulated in organs containing the 
macrophages of the RES, such as liver and spleen.  This higher accumulation amount in 
the liver was possibly attributed to the non-specific uptake of the micelles by the RES.  
This could be minimized by further modifying the surface and/or particle size of the 
micelles. 
 
The amount of DOX in tumor tissue was also examined (Figure 6.14).   It was observed 
that the DOX level of free drug reached a peak level of 2.9µg/g at 30 min, and decreased 
to 1.4µg/g at 120 min, further dropped to 1.0 µg/g at 240 min.  However, the level of 
DOX administrated in the micelles reached 5.0 µg/g at 30 min, increased to 5.8 µg/g at 
120 min, and then decreased to 3.8 µg/g at 240 min.  These results indicate that higher 
accumulation of DOX micelles in tumor tissues may be due to EPR effect (Shiah and 
Dvorak et al., 2001; Shiah and Sun et al., 2000) as well as the folate receptor mediated 
endocytosis (Yoo and Park, 2004).  
 




















































































Figure 6.14 DOX concentrations in the tumor for free DOX and DOX-loaded micelles.   
 
6.3 Conclusions 
Folate-conjugated poly(N-isopropylacrylamide-co- N, N-dimethylacrylamid-co-
methacrylate)-b-polyfatty acid  was successfully synthesized and utilized to fabricate 
micelles for targeted delivery of DOX.  The morphologies of the nanoparticles were 
spherical and the mean diameters of the micelles were less than 100 nm. The lower 
critical solution temperature (LCST) of the micelles was pH-dependent.  In PBS (pH 7.4), 
it was 38.0ºC, while it was 36.2ºC in pH 6.6.  Particle size and dug release from micelles 
were pH-dependent.  The micelles were stable in PBS (pH 7.4) at 37°C, but deformed in 
an acidic environment, leading to fast release. DOX-loaded folate-conjugated micelles 
perhaps were taken up rapidly by cells via endocytosis. The in vitro studies have proved 
that the DOX-loaded micelles killed cancer cells efficiently. The DOX-loaded micelles 
had a longer circulation time in the blood, and yielded greater concentration in the tumors 
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when compared to free DOX.  The enhanced accumulation of DOX in the tumors using 


































CONCLUSIONS AND RECOMMENDATIONS 






















In this study, poly(N-isopropylacrylamide) (PNIPAAm) was blocked with PLA or PLGA 
or polyfatty acid to form amphiphilic block copolymers.  These block copolymers were 
utilized to make thermo-responsive microspheres and micelles for controlled delivery of 
proteins and anticancer drugs.   
 
Firstly, PNIPAAm-b-PLA microspheres containing bovine serum albumin (BSA, as a 
model protein) were fabricated and investigated.  It was found that BSA was well 
entrapped within the PNIPAAm-b-PLA microspheres. Under the optimized fabrication 
conditions, more than 90% encapsulation efficiency of BSA was achieved. The 
microspheres were erodible in the in vitro medium, and polymer degradation occurred in 
the PLA block. The erosion of microspheres was dependent on their morphology. The 
more porous the microspheres, the faster was the erosion.  A PVA concentration of 0.2% 
(w/v) in the internal aqueous phase yielded microspheres with an inter-connected porous 
structure, resulting in fast matrix erosion and sustained BSA release. This is mainly 
because a higher PVA concentration made the first emulsion more stable, leading to 
higher encapsulation efficiency and a more porous internal structure.  The microspheres 
made from PNIPAAm-b-PLA with a higher portion of PNIPAAm provided faster BSA 
release. In addition, BSA release was slower at 37oC (above the LCST) than at a 
temperature below the LCST.  One reasonable explanation is that microspheres were 
more hydrophilic below the LCST and underwent significant swelling.  Thus, water 
molecules diffused into micropsheres more easily, leading to faster BSA release below 
the LCST. The results indicate that the PNIPAAm-b-PLA microsppheres not only 
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provided a mild environment for BSA but also improved protein release pattern 
compared to unmodified PNIPAAm or PLA microspheres.  
 
However, a major problem with such microspheres is the non-specific uptake by the 
reticuloendothelial system (RES) (Kwon and Kataoka, 1995). Temperature sensitive 
polymeric micelles were developed in this study to overcome this problem. Temperature 
sensitive block copolymers with different compositions and lengths of PLGA block were 
synthesized, and used to develop thermo-responsive polymer micelles that had enhanced 
vascular permeability and retention in tumor tissues compared to healthy tissue. The 
micelles prepared from the block copolymer had a very low CAC value ranging from 25 
mg/L to 4 mg/L.  In addition, the CAC value was similar in both aqueous solution and 
PBS buffer.  DOX and paclitaxel were encapsulated into the micelles by a membrane 
dialysis method.  The Polymer D provided a favorable hydrophilic/hydrophobic balance 
for high drug loading.  The TEM morphologies showed that micelles were spherical and 
had a uniform distribution, which is consistent with the particle size analysis.  The LCST 
of the micelles in PBS was 39.0ºC.  In particular, it was determined by the shell instead 
of the core.  The micelles were stable in both PBS and PBS containing 10% fetal bovine 
serum at 37ºC.  Moreover, the hydration-dehydration process was reversible. Drug 
release from micelles was responsive to external temperature changes. Drug release was 
much faster above the LCST than at body temperature. This is because the hydrophilic 
shell became aggregated above the LCST.  The aggregated shell could induce the 
deformation of the inner core structure, resulting in fast drug release.  However, when the 
temperature is below the LCST, the hydrated shell stabilizes the drug loaded in the core. 
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Therefore, only a small amount of the drug was released. The polymers did not cause 
significant cytotoxicity against the cells, indicating that they are biocompatible.  Drug-
loaded micelles were internalized through an endocytosis pathway.  Drug-loaded micelles 
showed higher cytotoxicity against cells at a temperature above the LCST.  The IC50 of 
drug-loaded micelles also depends on drugs and cells. The results indicate that reversible 
and thermo-responsive micelles can be used to deliver anticancer drugs timely to surface 
cancers by modulating local temperature at cancers. 
 
Since deep organs or tumors may not be easily accessible to temperature sensitive 
micelles (Soppimath et al., 2005), another strategy to targeting drugs to tumor tissues is 
to use pH-triggered temperature sensitive carriers.  A new polymer, folate-conjugated 
poly(N-isopropylacrylamide-co- N, N-dimethylacrylamid-co-methacrylate)-b-PUA was 
synthesized and utilized to fabricate core-shell micelles for targeted delivery of DOX.  
DOX was loaded into the micelles by a membrane dialysis method with actual drug 
loading level of 2.5%. The morphologies of the micelles are spherical (examined by 
TEM). The mean diameters of the empty and DOX-loaded micelles were 92.8 nm and 
98.5 nm respectively. The lower critical solution temperature (LCST) of the micelles was 
pH-dependent, being 38.0ºC in PBS (pH 7.4) but 36.2ºC in pH 6.6. Particle size and dug 
release from micelles were pH-dependent.  It was found that the micelles were stable in 
PBS (pH 7.4) at 37°C, but deformed in an acidic environment, triggering the release of 
enclosed drug molecules. Confocal images showed that DOX-loaded folate-conjugated 
micelles were taken up rapidly by cells via endocytosis. The in vitro studies have proved 
that the DOX-loaded micelles killed cancer cells more efficiently.  The in vivo studies 
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showed increased circulation time of DOX administrated in the micelles.  This is possibly 
due to slower release in the blood and thus slower elimination of DOX.  DOX micelles 
also led to less distribution in heart and lung, decreasing the cardiotoxicity of DOX.  In 
particular, the enhanced accumulation in tumors and longer circulation of DOX using 
DOX-loaded micelles may result in a higher efficacy for cancer therapy.  
 
The novelty of this work is to improve control over the drug release rate through the 
design of environmental sensitive drug delivery systems.  Drug release from these 
systems is triggered at the desired site of action by changes in temperature or pH.  
Moreover, micelles self-assembling from a novel multifunctional block copolymer 
(folate-conjugated Poly(NIPAAm-co-DMAAm-co-MAm)-b-PUA) were developed. 
These micelles may provide a good carrier for delivering anticancer drugs to deep tumour 
tissues (slightly acidic) or for intracellular drug delivery (escaping from the endosomes-a 
low pH environment and thus entering the cytosols) without external heating.   
 
The results obtained from this work provide an optimal process for developing 
biodegradable and environmental-responsive polymer drug carriers with high drug 
loading level.  It was also demonstrated that both protein-loaded microspheres and 
anticancer drug-loaded micelles showed a clear thermo-responsive behavior for drug 
release.  In addition, drug-loaded micelles showed higher cytotoxicity against cancer cells 
at a temperature above the LCST. The thermo-responsive micelles may make a good 
candidate for the treatment of surface cancers by localized hypothermia. More 
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importantly, DOX-loaded folate-conjugated temperature and pH sensitive micelles would 
make a promising carrier for intracellular delivery of anticancer drugs.  
 
Recommendations for future work 
In the first part of this study, it was demonstrated that PNIPAAm-b-PLA (1:5, 0.2%) 
microspheres were able to provide a sustained release of BSA, which was faster at a 
temperature below the LCST.  Although such microspheres provided many attractive 
features such as high encapsulation efficiency and favorable release pattern, initial burst 
release of proteins from PNIPAAm-b-PLA microspheres still existed.  This initial burst 
may cause side effects in body. Therefore, the initial burst should be minimized in future 
work by adjusting polymer composition. In addition, the bioactivity of released proteins 
is not fully understood yet.  The degradation of microspheres leads to release of acidic 
oligomers, which create acidic microenvironments, making proteins prone to structure 
disruption or denaturation. However, proteins must maintain their three-dimensional 
structure in order to function properly. Thus, it would be of interest to know the 
bioactivity of proteins in microspheres and of the proteins released.  Although HPLC 
gives some information on the integrity of proteins, more analyses such as SDS-PAGE 
and ELISA should be done in future work.  
 
The results in the second part of this study show that thermo-responsive micelles, 
incorporated with anticancer drugs, displayed thermo-responsive behavior for drug 
release. However, such a system suffered from the disadvantage of not being easily 
accessible to deep organs or tumors. An alternative approach to targeting drugs to tumor 
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tissues is to use pH sensitive carriers.  Although DOX-loaded micelles showed a similar 
cytotoxicity as free DOX, the in vitro cytotoxicity against culture medium with different 
pH values should be done to test the pH-dependent cytotoxicity.  In addition, the confocal 
image alone is not enough to elucidate the mechanisms of cellular uptake of micelles. 
The integrity of the cell membrane should be examined using the trypan blue method. 
Furthermore, although initial in vivo studies show that pH triggered temperature sensitive 
micelles might target drugs to specific tissues or cell compartments without external 
heating, further modification of micelle surface is necessary to reduce accumulation in 
the liver and the spleen.  Finally, a better understanding of in vivo pharmacokinetics of 
DOX-loaded micelles, toxicology and bioavailability of drug would be of interest for 
future in vivo studies before clinical trials.   
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